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Preface 
 
The topics covered in this thesis encompass different scientific fields:  supramolecular/ 
coordination chemistry, biological physics, and medical diagnostics, under the common theme of 
magnetic interactions in matter.  The work performed presents a comprehensive analysis of the 
chemistry of some lanthanide(III) complexes of novel ligands that are of interest as magnetic 
resonance imaging (MRI) agents, and from the florescence point of view.  The first chapter 
introduces the topic of metal complex coordination chemistry, specifically lanthanide-based 
polyaminocarboxylate macrocycles, with emphasis on the underlying principles leading to 
landmark discoveries.  The historical background, coordination chemistry and underlying 
principles for both lanthanides and macrocycles are explained in detail.  The second part of the 
introduction presents the basic principles of MRI and how it can be improved using MRI contrast 
agents (MRI-CAs).  It also explains the historical significance of the MRI protocol and the role 
of ligand architecture towards improving on current contrast agents.  In the second chapter a 
detailed account of the strategy taken towards the synthesis of target lanthanide complexes will 
be explored, along with full characterization of all precursors, intermediates and final target 
complexes using NMR, ESI-MS, FTIR and in some cases X-ray crystallography.  Furthermore, 
the solution chemistry of the complexes will be described and investigated using UV-vis 
spectroscopy, luminescence spectroscopy and cyclic voltammetry (CV).  Using these techniques 
it was then possible to ascertain the pKas, the number of hydration waters (q) and 
electrochemical behavior of these complexes across the pH range 2 to 12.  However, the main 
aim of this work was to investigate the effect of suitable buffers by observing their photophysical 
behavior and how they affect the coordination chemistry with the complexes synthesized.  In the 
third chapter the results of the above-mentioned synthetic goals, solid state chemistry and 
solution behavior are analyzed and expounded upon with three specific sections the first being 
solid state chemistry, then spectroscopic analyses (luminescence and UV-vis) followed by 
electrochemistry.  The analyses and discussion appear separately.  Finally, in the fourth chapter 
the findings are discussed and tied up with the hypothesis followed by concluding remarks for 
each investigation and some future work suggestions. 
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Abstract 
 
 
This work describes work related to the search for new and improved MRI contrast agents.  It is 
a focused study that describes the synthesis and characterization of three novel macrocyclic 
ligands, two of which incorporates a pendant β-amino alcohol (cyclohexyl) arm for complexation 
with Eu3+ and Gd3+.  The target products were synthesized successfully in quantitatively high 
yields and confirmed using general analytical characterization techniques including NMR, ESI-
MS, FTIR and in some cases X-ray crystallography.   
 
Crystal structures of two of the N-substituted cyclen based ligands, namely molecules 2 and 3 are 
reported.  They both formed in the monoclinic crystal system and found to be in the P21/c and 
P21/n space group, respectively.  Although 2 crystallized as a free base, 3 formed a complex with 
sodium with iodide as a counter ion.  In addition, three lanthanide crystal structures are reported 
and each adopts a distorted capped square anitiprismatic geometry.  Molecule 2 formed crystals 
with both Eu3+ and Gd3+ to give molecule 5 and 6, respectively.  They both formed in the 
triclinic and orthorhombic crystal system and found to be in the P-1 and Pcca space group, 
respectively.  Efforts to grow lanthanide crystals with 7 failed, however its Eu3+ complex was 
satisfactorily synthesized.  For comparative purposes molecule 9 was synthesized and the crystal 
structure is reported.   
 
In an effort to elucidate the solution structure of these new Eu3+ complexes in the absence and 
presence of KHP, their interaction with the metal center and ligand were studied further using 
luminescence and UV-visible analyses to determine pKas spectroscopically.  Comparing the pKa 
for the hydrolysis of water in 5 and 9 in MCB with KHP, it was observed that the pKa for 5 is 
larger.  This increase is attributed to the compression induced by the cyclohexyl moiety which 
consequently causes an overall decrease in bond distance between the metal center and amidic 
oxygen donors as shown in the solid-state data.   Furthermore, the hydrophobic nature of the 
cyclohexyl side arm which replaces one of the acetamide arms in 9 also contributes to the overall 
decrease in pKa observed.  Comparing the pKa for the hydrolysis of water in 5 and 7 in MCB 
excluding KHP, again it was observed that the pKa for 5 is larger.  The coordinated water in 5 
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appears to be more acidic than for 7, possibly due to the weaker inductive effect of 7 which 
possess arms that are of a sp3 nature and impossible to deprotonate.  
 
 In addition, the number of coordinated water molecules (q) to the metal center were determined 
using luminescent lifetime measurements and corrected for the estimation according to structural 
functionalities innate to the complexes in this study.  In solution, the q values obtained agreed 
well with the proposition that the phthalate moiety coordinates with the central Eu3+ ion in a 
unidentate fashion and maintains a nine coordination number.  The q values also agree with 
luminescent spectroscopic data which shows two valid spectroscopic pKas; the deprotonation of 
the phthalate carboxylate and the deprotonation of the water molecule coordinated to the metal 
center.  The mean pKa values were found to be pK1 = 4.67 ± 0.06 and pK2 = 8.69 ± 0.12, 
respectively.  The q values obtained for 5 in MCB with KHP from pH 4.710 and 9.484 ranged 
from 1.77 to 0.70 using Equation 3.1 and from 1.79 to 0.72 using Equation 3.2, respectively.  It 
is proposed that the due to the coordination of the phthalate moiety the hydroxyl group of the 
cyclohexyl moiety no longer coordinates itself to the metal center.  The q values obtained for 5 in 
water from pH 4.375 and 8.645 ranged from 0.94 to 0.55 using Equation 3.1 and from 0.95 to 
0.56 using Equation 3.2, respectively.  The slight increase in the q value is attributed to the 
hydrogen bonding the cyclohexyl group is involved in with water molecules in the second 
coordination sphere which is very close to 0.5.   
 
Finally, the electrochemical behavior of complex 5 and 9 across the pH range were investigated 
using CV.  Only a single electrochemically active species exists for both complexes.  The results 
for 5 show that the metal is encapsulated between pH 3 to 10 (E1/2 = -0.83 V), however above pH 
11 the complex is demetalated (E1/2 = -1.02 V).  The results for 9 show that the metal is 
encapsulated between pH 3 to 10 (E1/2 = -0.83 V), however below pH 11 the complex shows a 
decrease in overall current (E1/2 = -0.90 V).  This result shows that complex 9 is more resistant to 
oxidation as compared to complex 5, meaning that having four acetamide arms at higher pH is 
better than having three.  This difference can also be related to the role and tautomeric effect of 
the amidic arms in stabilizing the complex.  In addition, the standard rate constant was 
determined for electron transfer and is close to 1.0 for both complexes investigated, which means 
the reductions in both complexes are not diffusion controlled but the electrochemically active 
 | P a g e  
 
 
5
species are adsorbed on the electrode surface.  The above electrochemical results show that the 
metal remains encapsulated for most of the pH range and only becomes toxic free metal above 
pH 11.  This vast pH range of complex intactness is a favorable attribute if it were to be 
considered in its application as a potential MRI agent.   
 
Key words:  MRI, europium(III), gadolinium(III), polyazamacrocycles, luminescence, cyclic   
                      voltammetry, MRI contrast agent.
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Chapter One Introduction 
 
1.1        Solid state and Supramolecular Chemistry of Polyazamacrocycles and their    
       Lanthanide Complexes 
1.1.1 General Background to Supramolecular Chemistry 
 
In the past decade supramolecular chemistry has been transformed by the revolution in small 
molecule crystallography and much of the interest in this area lies in the manipulation, 
understanding and construction of new architectures and topologies.  Supramolecular chemistry 
has been defined by one of its leading proponents, Jean-Marie Lehn, who won the Nobel Prize 
for his work in the area in 1987, as the ‘chemistry of molecular assemblies and of intermolecular 
bonds’.1  If we regard supramolecular chemistry in its simplest sense as involving some kind of 
(non-covalent) binding or complexation event, we must immediately define what is doing the 
binding.  In this context we generally consider a molecule (a ‘host’) binding another molecule (a 
‘guest’) to produce a ‘host-guest’ complex or supermolecule.  Commonly the host is a large 
molecule or aggregate such as an enzyme or synthetic cyclic compound possessing a sizeable, 
central hole or cavity.  The guest may be a monoatomic cation, a simple inorganic anion, an ion 
pair or a more sophisticated molecule such as a hormone, pheromone or neurotransmitter.  More 
formally, the host is defined as the molecular entity possessing convergent binding sites (e.g. 
Lewis basic donors, hydrogen bond donors etc.).  The guest possesses divergent binding sites 
(e.g. spherical, Lewis acidic metal cation or hydrogen bond acceptor halide anion).  In turn a 
binding site is defined as a region of the host or guest capable of taking part in a non-covalent 
interaction.1  Ligand design is currently of great importance in coordination chemistry.  The 
word ligand is derived from the Latin verb ligare meaning “to bind”.  In a coordination complex, 
the central atom (the metal) is coordinated to one or more molecules or ions (ligands). The atom 
in the ligand that is directly bound to the central atom or ion is called the donor atom.   
 
Supramolecular chemistry, as it is now defined, is a young discipline dating back to the late 
1960s and early 70s.  However, its concepts and roots may be traced back almost to the 
beginnings of modern chemistry itself.  Much of supramolecular chemistry has sprung from 
 | P a g e  
 
 
28
developments of macrocyclic ligands for metal cations.  The design of new macrocylic ligands 
continues to be an expanding area with exploration of ring size and investigation into various 
combinations of donor set.  New macrocycles with larger compartments are being designed that 
may allow use in nanoscale chemistry as devices.2 Many new wheel clusters have been 
discovered that incorporate several types of transition metal ions3 as well as some examples with 
lanthanides.4  Ligand design has also played a major role in producing unexpected 
architectures5,6 and functional cages that can facilitate photochemical reactions in a confined 
space.7 
 
The encapsulation of metal ions with a cavity or superstructure offers many possibilities for 
control of reactivity and the development of host guest chemistry.  Recently there has been a 
resurgence of interest in the coordination chemistry of lanthanide complexes in aqueous solution.  
Interest in this work may be related to an enhanced appreciation of the rich functionality of the 
ground and excited states of lanthanide complexes.  The high-spin paramagnetism and long 
electronic relaxation time of Gd3+ has made it pre-eminent among contrast agents for magnetic 
resonance imaging (MRI).8,9  Related complexes of Dy and Tm with much shorter electronic 
relaxation times are effective NMR shift reagents.10 The controlled modulation of Lewis acidity 
across the series is allowing the development of complexes exhibiting phosphatase activity, 
while the redox activity of cerium, samarium, and europium may be expected to allow the 
development of further selective oxidants and reductants.4  The first section of the thesis focuses 
on the development in design, synthesis, and self-assembly of lanthanide-based architectures 
together with macrocyclic ligands designed to aid the construction of new MRI contrast agents. 
 
However, much of the current research into the chemistry of lanthanide complexes is carried out 
in the solution states.  It is the properties of these complexes in aqueous solution that are of great 
interest in their application in science and medicine.  Furthermore, potentially important 
interactions between the complex and its environment in solution and specifically the interaction 
with solvent water molecules may be probed through the study of the solid-state structure where 
the exact information about conformation, bond distances and bond angles can be obtained.  Of 
specific interest is the geometric ‘makeup’ of nine-coordinate lanthanide complexes where there 
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H 
N 
C 
is at least one ligating water molecule present.  With respect to MRI contrast agents, those in 
which the number of bound water molecules is one (q = 1) is of particular interest. 
 
1.1.2 Introduction to Polyazamacrocycles 
 
Cyclen (1,4,7,10-tetraazacyclododecane), shown in Figure 1.1 is a representative of macrocyclic 
polyamines shown in Figure 1.2.   Many of its derivatives accommodate metal cations with 0.7 
or 0.8 Å ionic radii in their 12-membered rings, but few examples were reported to effectively 
encapsulate larger metal ions like transition metals or lanthanides.    Although the cyclen ring is 
too small to include alkali and alkaline earth metal ions, the ring often adopts a well defined 
“square” conformation and its arm-functionalization with mixed pendant donors can offer the 
topology suitable for effective encapsulation of the larger lanthanide metal ions like 
gadolinium.11-13  It has been used extensively in metal complexation14-16 and as a synthetic 
precursor to related pendant-armed17-21 and bridged polydentate ligands,20-23 some of which have 
biomedical applications.22-25  The decrease in cost and ease of synthesis of cyclen has generated 
substantial interest in this area of research.24 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: 3D image of Cyclen.26 
 
 
The coordination chemistry of macrocyclic ligands is well documented and specifically the 
synthetic, kinetic and structural aspects27,28 of polyazamacrocyclic complexes have received 
considerable attention.29-35  Polyaminocarboxylates featuring cycloalkyl pendant groups directly 
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grafted onto cyclen feature interesting properties such as higher rigidity and better kinetic 
inertness.  The relationship of electronic properties and reactivity of these synthetic macrocyclic 
complexes to those of naturally occurring macrocycles, such as porphyrins36 and corrins, 
continues to promote great interest in their design and preparation.  They mimic important 
biological ligands developed by nature, for example the porphyrin prosthetic group of many 
metalloproteins.  These types of ligands impart thermodynamic and kinetic stabilities to their 
metal complexes uncommon or non-existent with ligands of acyclic origin that dramatically 
accentuates the advantages of macrocyclic ligands. 
 
A successful design strategy for the development of effective metal ion complexes is to 
preorganize the host molecule to obtain a single conformation that is optimal for metal 
encapsulation; in other words the sites for binding must be optimally positioned to structurally 
complement the metal ion.37-39  The more preorganised a ligand is the more closely are the ligand 
donor atoms arranged as required for coordination to the metal ion.  However examples of the 
deliberate design of highly efficient preorganized hosts remain limited.40  By introducing the 
cyclohexyl ring as a pendant amino alcohol donor it is envisaged to bring about an increase of 
metal compression due to steric intermolecular interaction provided by the ligand backbone.  
This increased compression consequently leads to faster water exchange of the metal-bound 
water molecule. 
NH
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Figure 1.2: Different types of polyazamacrocycles. 
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1.1.3 Coordination Chemistry of Polyazamacrocycles 
 
The characteristics present in macrocycles, like the ones shown in Figure 1.2, leading to their 
stable metal complexes can be grouped together under the term “molecular organization”.1  The 
two major areas of molecular organization, as related to coordination chemistry, are 
complementarity and constraint factors.1  To design the ultimately stable metal-ligand complex, 
both of these factors should be maximized.  Complementarity is the sum of size, geometry and 
electronics matching between the metal ion and the ligand and is conceptually the simpler of 
these two to understand and to manipulate.  For a given metal ion, selection of the electronic 
properties, number, geometrical arrangement and bond distance of donor atoms to maximize 
complex stability, either using predictive theory or by iterative experimentation or a combination 
of the two, results in the best pairing from the range of possibilities.  Much of the theory and 
experimentation necessary to make an advantageous selection is well established and constitutes 
the vast database of coordination chemistry knowledge.  Complementarity of metal ion and 
ligand geometries can often be predicted on the basis Ligand Field Stabilization Energy (LFSE).  
This value is the extra stabilization over a corresponding spherical field that is attributable to the 
partial population of the d-orbitals.  Certain metal ions, corresponding to specific numbers of d 
electrons, gain considerable energetic stabilization in a specific ligand field geometry.  Since 
there are a finite number of metal ions, donor types, geometries and useful ligand sizes, it is 
apparent that for a given metal ion, the complementarity of a ligand can be maximized.  
However, maximizing complementarity is only the first step in maximizing metal-ligand 
complex stability.  It is only through the exploitation of the constraint factors that metal-ligand 
binding can be increased further.   
 
Constraint is concerned with the number and flexibility of the connections between those donor 
atoms.  Complementarity is a necessary, but not sufficient condition for maximum stability of a 
complex.  Complementarity may be described as a “first-order” factor for complex stability; it is 
a requirement of stable complexes, but can only be improved to a finite level, because the 
number of donor types, geometries, and sizes is finite.1 
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Constraint, on the other hand, might be described as a “second-order” factor and is concerned 
with factors of seemingly infinite variability.1  These parameters can be manipulated to produce 
large jumps in complex stability, compared to ligand systems that lack them, if care is taken to 
maintain the difficultly achieved complementarity relationships.1  The components of constraint 
are topology, meaning the interconnectedness of ligand donor atoms, and rigidity, how fixed in 
space those donor atoms are with respect to each other.  Among the two, topology is the most 
well studied, and described in the chelate, macrocyclic, and cryptate effects.1  Rigidity, although 
intimately involved in the three effects just mentioned, has been less well treated both 
theoretically and experimentally.1  In this study the role of hydroxycycloalkyl substitution on 
cyclen and the feasibility to perform such N-alkylations is examined in detail.  
 
Selective N-alkylation of cyclen (1,4,7,10-tetraazacyclododecane) is an important step in the 
preparation of functionalized nitrogenous macrocycles.  To date, several synthetic routes have 
been reported for the selective mono N-alkylation of such frameworks.   However, these usually 
involve multi-step syntheses, which often require the temporary protection of several of the 
amines in the cyclic framework prior to their selective alkylation.  There are many examples of 
such synthetic strategies that involve the use of common protecting groups such as tert-
butyloxycarbonyl (Boc),41-44 p-toluene-sulfonyl (tosyl)45-47 or the formyl48-52 group in the 1, 4 and 
7 positions of cyclen, followed by the alkylation of the remaining amino moiety and then 
deprotection.  An alternative method often employed is the introduction of bulky substituents on 
three of the nitrogens of the macrocycle.  Glyoxal53,54 or transition metal carbonyls55 such as 
Mo(CO)6, are the most commonly used for this kind of protection.  However, boron or 
phosphorus derivatives have also been used for this purpose.56,57  Again, a final deprotection step 
is necessary to provide the desired mono N-alkylated product.  Direct alkylation of cyclen has 
been much more rarely observed.  
 
Wong and co-workers recently reported the preparation of various mono N-alkylated derivatives 
of such macrocycles.59  However, both bis and tris substitutions were often observed, which led 
to the need for purification by column chromatography, which is a real drawback in macrocyclic 
chemistry60 as we have actually experienced.  Furthermore, the cyclen, used in excess as the 
 | P a g e  
 
 
33
starting material, was not recovered.  Generally, the purification methods utilized were tedious 
and challenging, except in a few rare cases.   
 
Considering how few direct N-alkylations exist in known literature and the fact that the 
formation of bis and tris-N-alkylated adducts cannot be avoided,60 apart from using excess 
cyclen,61,62  strategies based on the use of temporary nitrogen protection groups 63, 64-66 avoid the 
formation of mixtures due to over-alkylation and consequently avoid purification by column 
chromatography.  Hence, there exists a need for an improved strategy for the introduction of 
cyclic β-amino alcohol groups into such macrocycles in both high yields and in a versatile 
manner. 
 
1.1.4 Selectivity of Cation Complexation 
 
The thermodynamic selectivity of a given host for a particular cation represents the ratio between 
the host’s affinity for a given metal (e.g. Gd3+) and the other guest cations.  Strong but selective 
binding is the basis of molecular recognition.  Thus a successful host exhibits a strong affinity 
for one particular guest and much lower affinity for other cations.  Designing a synthetic host 
that will be highly selective for a given cation is a very complicated task because the selectivity 
is governed by an enormous number of factors,67 some of the most important of which are listed 
below: 
¾ size complementarity between cation and host cavity; 
¾ electronic complementarity between cation and the host binding sites; 
¾ solvent (polarity, hydrogen bonding and coordination ability);  
¾ electronic charge; 
¾ degree of host preorganization; 
¾ enthalpic and entropic contributions to cation-host interactions; 
¾ cation and host free energies of solvation; 
¾ nature of the counter-anion and its interactions with solvent and the cation; 
¾ cation binding kinetics; and 
¾ chelate ring size and donor group orientation. 
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Figure 1.3 illustrates the change in orientation of the pendant arms as the size of the metal 
center is varied.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2      Lanthanides 
1.2.1 Historical Background and Relevance 
 
The lanthanides comprise the fifteen elements of the top row in the ‘f-block’ of the Periodic 
Table and have the electronic configuration [Xe] 6s24fn, but with exceptions for La, Ce, Gd and 
Lu which have a 5d14fn-1 configuration where n varies from 0 to 14.  Their relative atomic 
positions on the periodic table is shown in Figure 1.4.  Also known as ‘rare earth elements’ due 
to the etymology of the term ‘lanthanide’ (derived from the Greek lanthanein, meaning ‘to lie 
hidden’) and the uncommon oxides from which they were first isolated, lanthanides are in actual 
fact neither ‘rare’ nor ‘earths’, an old term used to describe certain metal oxides such as lime and 
magnesia.69  Even the rarest lanthanides, thulium and lutetium are nearly 200 times more 
Figure 1.3: Different permutations of pendant arms from small to large metal centers.68 
 | P a g e  
 
 
35
abundant than gold.70  Yet, the name ‘rare earths’ has persisted, perhaps due to the enigmatic 
nature of these unusual metals, and their ability to ‘hide’ behind each other in minerals.  Indeed, 
the similar chemical properties of lanthanides make their separation quite difficult, even today. 
 
 
Figure 1.4: Showing lanthanides on the Periodic Table. 
 
Lanthanides have found uses in a wide variety of industries and materials, such as catalysts, 
glasses, ceramics, permanent magnets, optics and electronics.71,72 Solid phosphors containing 
europium, cerium and terbium are major contributors to commercial markets in fluorescent 
lighting and color displays.  Various lanthanide ions can be used in lasers, with neodymium as 
the most famous in yttrium aluminum garnet (Nd-YAG).  The green, blue and red luminescent 
bands in Euro banknotes are attributed to europium complexes.73  Certain lanthanides (Eu, La, 
Lu, Nd, Pr, Sm, Th, Tm and Yb) are used as tracers in wine chemistry to discriminate wines 
according to geographical region.74  The ratio of europium, which is almost entirely (~ 97%) 
formed in stars, to other rare earth elements in meteorites has helped decipher much of the 
history of processes in our solar system, such as the early development of the feldspar-rich lunar 
crust.75  In aqueous solution, lanthanides are most stable in the 3+ oxidation state, leading to high 
coherent behavior and hence making them difficult to separate and purify.  The preference for 
the trivalent oxidation state is due in part to the energy of the 4f electrons being below those of 
the 5d and 6s electrons (except in the cases of La and Ce).  When forming ions, electrons from 
the 6s and 5d orbitals are lost first, so that all Ln3+ ions have [Xe] 4fn electronic configurations.  
This, coupled to the high enthalpies of hydration for trivalent lanthanides, results in the stability 
of the 3+ oxidation state.  In reducing conditions, europium, samarium and ytterbium can be 
stable in the divalent form; cerium has also been known to adopt a +4 oxidation state.  
Lanthanide ions possess relatively high charge densities and have a strong electrostatic nature in 
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their bonding, as the ions are polarizing and can be classified as hard Lewis acids.  The 4f 
orbitals in Ln3+ ions are well shielded by the 5s and 6p orbitals, and therefore do not participate 
directly in bonding.  Therefore, π-bonding is not possible, and no Ln=O or Ln≡N multiple bonds 
are known for lanthanide complexes. 
 
The importance of the luminescence of lanthanide ions is related to its peculiar characteristics, 
for example long lifetime and line-like emission bands in the visible, which make these ions 
unique among the species that are known to luminesce.  Because of these characteristics, 
lanthanide ions are widely used as luminescent species in non-molecular solids. In solution, 
application of complexes of lanthanide ions with conventional ligands is hindered by their 
kinetic lability.  Luminescence can be classified into two types based on the origin of the 
emission of the excited molecules: fluorescence and phosphorescence. Fluorescence is the 
emission from an excited singlet state, while phosphorescence is the emission from an excited 
triplet state.  In phosphorescence, some energy may be dissipated through the intersystem 
crossing which arises when the electron in the singlet state relaxes to a triplet state instead of 
directly to the ground state.  Figure 1.5 illustrates the different energy levels involved in 
fluorescence and phosphorescence in lanthanides.  Phosphorescent bands have a longer 
wavelength and a much longer luminescence lifetime than the fluorescent bands.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5: Energy levels involved in fluorescence and phosphorescence in lanthanides.76 
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In Eu3+ the transitions are 5D0→7FJ where the most common are those of J = 0, 1, 2, 3 and 4, 
shown in Figure 1.6, which corresponds to λem = 580 nm, 592 nm, 616 nm, 653 nm, 685 nm and 
700 nm, respectively.  With J = 4 having two bands at 685 nm and 700 nm. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6:  Energy level transitions from 5D0→7FJ characteristic for J = 0, 1, 2, 3 and 4.76 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7:  Schematic representation of the "antenna effect" involving distinct absorbing  
                      (species) and emitting (metal ion) components.77 
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The recognition of ions and molecules is of great interest in supramolecular photochemistry.78  
Effective excitation can be performed via a light-harvesting antenna incorporated into the ligand 
backbone and is capable of transferring the excitation energy to the metal center.  Figure 1.7 
shows a schematic representation of the "antenna effect" involving distinct absorbing (species) 
and emitting (metal ion) components.  This is well established and europium and terbium have 
been sensitized with, among others, benzyloxyquinoline,79 acridone derivatives,80 
phenanthridine,81 pyridines82 and dansyl groups.83,84  Sensitization of Nd3+, Yb3+and Er3+ is 
possible with fluorescein,85,86 pyrene,87 Pd-porphyrins,88 eosin,89 Tb3+-complexes,90 rhenium2+ 
and ruthenium2+ bipyridyl moieties,91,92 and quinoline.93  However, efforts to control the degree 
and extent of sensitization by the antenna are more limited.  Attention has focused mainly on the 
visible-emitting europium and terbium complexes,94,95,96 which have found applications in fields 
as diverse as pH-sensing,97 DNA-,98 oxygen-,99 organophosphate-100 and Cu+1- detection.  
 
The need to devise structural and lanthanide probe complexes for biomolecules in particular has 
received much attention recently.101  These lanthanide probes can be classified into two 
categories, the first involves systems that are effectively coordinatively saturated in aqueous 
media, involving octa- or nonadentate ligands that form kinetically stable 1:1 complexes as 
mentioned earlier.9,102,103  The interaction with a given biomolecule or ion is likely to be 
determined primarily by the nature of the ligand, defining complex size, geometry, 
hydrophilicity, and relative disposition of hydrogen-bond donors and acceptors.  The second 
category relates to complexes of heptadentate ligands that are typically diaqua systems of overall 
stability with respect to lanthanide ion dissociation.104  Here stepwise displacement of the bound 
water molecules leads to monoaqua and then q = 0 species, the latter being particularly favored 
with chelating oxyanions.   
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1.2.2 Coordination Chemistry of Lanthanides 
 
Coordination to trivalent lanthanides tends to be ionic in character, which leads to a strong 
preference for negatively charged or neutral donor groups possessing large ground state dipole 
moments.  Therefore, combinations of amines and carboxylic acid groups are often used in 
lanthanide complexation.105,106  This ionic character of binding also means lanthanide complexes 
tend to undergo facile exchange of the ligands.74  Coordination geometries in lanthanides are 
determined by ligand steric factors as opposed to orbital overlap or crystal field effects.107,108  In 
aqueous solution, donor groups containing neutral oxygen or nitrogen atoms generally bind when 
present in multidentate ligands (podands, crown ethers, cryptates, etc.).109-112  Relatively few 
complexes of unidentate nitrogen donors exist, reinforcing the oxophilic tendency of lanthanide 
binding.  This preference for oxygen donors also makes lanthanides quite lithophilic, and 
explains their occurrence in silicates as opposed to metallic or sulphidic minerals.113 
 
The coordination number of [Ln(H2O)n]3+ is normally 9 for the early lanthanides (La-Eu) and 8 
for those later in the series (Dy-Lu), with the intermediate metals (Sm-Dy) exhibiting a mixture 
of species.  However, the coordination number can be dictated by the steric bulk of the 
coordinating ligands, and species with coordination numbers as low as 2 and as high as 12 are 
known.75,105  As the 4f electrons of the lanthanides are well shielded from the environment, the 
spectroscopic and magnetic properties of these ions (e.g., electronic spectra and crystal field 
splittings) are largely independant of environment (solvent, coordinated ligands, etc.).114  The 
number of configurations for n electrons rapidly increases with the number of unpaired electrons, 
with the lowest energy term for each ion consistent with the predictions of Hund’s first and 
second rules.115,116 Since all configurations have different energies, the lanthanides tend to 
exhibit rich and complex energy level structure.117  Due to spin-orbit coupling, the excited states 
of the lanthanides are well separated from the ground state manifold. Thus, the excited states are 
thermally inaccessible and ideal for electronic transitions.  With the exceptions of the 4f0, 4f1, 
4f13 and 4f14 species (La3+, Ce3+, Yb3+ and Lu3+, respectively), all lanthanide ions absorb 
electromagnetic radiation, primarily in the visible region, which is manifested in f-electrons from 
the partially filled 4f subshell being excited from the ground state to an excited state.  These f–f 
transitions can be excited by both magnetic dipole and electric dipole radiation.  Magnetic dipole 
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transitions are Laporte allowed, while electric dipole transitions are Laporte forbidden.103,118  
Electric dipole transitions are much weaker in lanthanides (ε ~ 0.1 mol-1 dm3 cm-1) than in the 
transition metals, meaning magnetic dipole transitions can often be seen.113,111  Electronic 
transitions must involve promotion of an electron without a change in its spin (S = 0) and with a 
variation of either the total angular momentum and the total angular quantum number of one unit 
at most (L = ±1,0; J = ±1,0).  Though absorption of radiation can in theory promote the 
lanthanide ion to any energetically accessible state, emission normally occurs only from the 
lowest lying spectroscopic level of the first excited term due to rapid internal conversion.119  In 
cases of low symmetry or vibronic coupling, the f–f  transitions can gain intensity through f- and 
d-state mixing with higher electronic states of opposite parity.  Broad 4fn → 4fn-1 5d1 transitions 
can also be seen in the infrared region for some lanthanides. The electronic configuration of 
lanthanides is split due to a variety of interactions.  The initial configuration is split into 
spectroscopic terms by electronic repulsion, with separations on the order of 104 cm-1.120   
 
These terms can be further split into spectroscopic levels, or J states, due to spin-orbit coupling 
effects. The energy differences between split J states lies in the range of 103 cm-1.121  These 
levels, in turn, can be split again into what are termed Stark sublevels due to ligand field effects 
from the coordination sphere around the lanthanide; Stark sublevel splitting is on the order of 102 
cm-1.122  This results in the overall emission peak position remaining largely unchanged as the f-
electrons remain shielded, but the emission profile of a lanthanide (defined as the relative 
intensity and degree of splitting of emission peaks) can vary greatly depending on modulation of 
these influences.123,124  The number of Stark sublevels depends on the site symmetry of the 
lanthanide ion, and these can be thermally populated at room temperature, yielding more 
complex emission spectra.  Filling of the inner 4f electron shell across the lanthanide series 
results in a diminution of the ionic radius by as much as 15% from lanthanum to lutetium, 
referred to as the lanthanide contraction.125  Though atomic radius contraction is not unique 
across a series (i.e., the actinides and the first two rows of the d-block), the fact that all 
lanthanides primarily adopt the trivalent oxidation state means that this particular row of 
elements exhibits a traceable change in properties in a way that is not observed elsewhere in the 
periodic table.  Lanthanides behave similarly in reactions as long as the number of 4f electrons is 
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conserved.126 Thus, lanthanide substitution can be used as a tool to tune the ionic radius in a 
lanthanide complex without changing its chemistry, to better understand how the size of the 
metal cation affects various properties especially geometry. 
 
1.2.3  Donor Group Orientation and Chelate Ring Size Effects 
 
A key criterion for a complementary host for metal cations is that the host geometry should allow 
the metal to bond to all the donor atoms or groups of the ligand at the optimal metal-ligand 
distance.  Moreover in metal-donor atom bonds that have some degree of covalency there must 
be the correct alignment of ligand orbitals (e.g. lone pair orbitals) and the metal orbitals in order 
to achieve optimum bond strength.  Similarly, in ionic metal-ligand bonds the orientation of the 
ligand dipoles with respect to the metal ion must be in such a way as to result in optimum 
electrostatic interaction.  For sp3 hybridised amine nitrogen donors the strongest interaction with 
metals occurs when M-N-X angle has a value of 109.5 ° and the M-N-C-X torsion angle has a 
value of ± 60 or 180 °.  This corresponds to the M-N axis being coincident with the orientation of 
the amine lone pair.  Any deviation from this angle weakens the M-N interaction, thus a 10 ° 
compression of the M-N-C angle weakens the bond interaction by 2.9 kJ.mol-1.   
 
When multiple donor groups are included within a ligand framework then the constraints of the 
ligand backbone can result in an inability of all the donor groups to simultaneously form optimal 
interactions with the metal center.  We can represent the donor group orientations as lines drawn 
along the vectors of optimal metal ion approach.  In a perfectly preorganised ligand these vectors 
will overlap at a single point at the optimal M-L bond length.  The more widely the vectors 
diverge from the situation the less preorganised the ligand will be.1  
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1.2.4  Introduction to Stereochemistry of Lanthanide Complexes 
 
It is well established that macrocyclic complexes show high thermodynamic stability, 
conformational rigidity, and kinetic inertia.  For example Ln-1,4,7,10-tetraaza-1,4,7,10-tetrakis-
(carboxymethyl)-cyclododecane (DOTA) complexes are the result of a very good match between 
sizes of Ln3+ ions and the preformed cavity of the DOTA ligand.127  From the reported X-ray 
solid-state structures of Ln3+(DOTA) complexes (Ln ) Eu,128 Gd,129,130 Lu131 ), it is known that 
the ligand provides eight coordination sites (four nitrogens and four oxygens) arranged in a 
square-antiprismatic geometry around the lanthanide ion.  A ninth coordination site, at a capping 
position above the plane of the four oxygens, is occupied by one water molecule.  In solution this 
water molecule is exchanging rapidly with the bulk solvent, and, in the case of Gd(DOTA), it 
results in an overall, remarkable increase in the relaxation rate of the solvent water protons. 
These two properties have been of primary importance in promoting the use of Gd(DOTA) as a 
contrast agent for magnetic resonance imaging applications.132  The square-antiprismatic 
geometry of Ln(DOTA) complexes implies the occurrence of two helicities (one belonging to the 
cycle and one associated with the layout of the acetate arms) which may give rise to two 
enantiomeric pairs of diastereoisomers.133   
 
Two isomers were observed in solution in the 1H- and 13C-NMR spectra of all Ln(DOTA) 
complexes in slow exchange at room temperature.  Their structures were determined from the 
analysis of the dipolar shifts in the 1H-NMR spectrum of Yb(DOTA).134  Because of their 
relative concentrations in the Yb(DOTA) solutions, the relative intensities of the corresponding 
resonances in the 1H-NMR spectrum, these isomers were called M (major) and m (minor).135 The 
structure found for the M isomer closely resembles those observed in the X-ray diffraction 
studies of Eu,128 Gd,129 Y,130 and Lu(DOTA)130 complexes, displaying a regular antiprismatic 
geometry of the DOTA ligand around the lanthanide ion.  Conversely, a less regular coordination 
geometry has been found for the m isomer, whose structure may be envisaged as an inverted 
antiprism, strongly distorted toward a regular prism.136  Thus, on going from the M to the m 
structure the O4 square rotates around the symmetry axis, changing both the sign and the 
magnitude of the antiprism tilt angle. This m-type structure may be recognized in several X-ray 
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solid-state structures of other macrocyclic complexes such as La(DOTAM) where (DOTAM ) = 
1,4,7,10-tetrakis(2-carbamoylethyl)-1,4,7,10-tetraazacyclododecane),137 Eu(THP) where (THP) 
= 1,4,7,10-tetrakis(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane),138 Y(DOTPBz4) where 
(DOTPBz4) = 1,4,7,10-tetraazacyclododecane tetrakis(methylenebenzylphosphinic acid),139 and 
Gd(DO3MA) where (DO3MA) = (1R,4R,7R)-R,R,R-trimethyl-1,4,7,10-tetraazacyclododecane-
1,4,7-triacetic acid).140 An analogous structure made up of eight nitrogens has been reported for 
the sodium salt of a pyrazole functionalized tetraazamacrocycle Mn2+ complex.141,142 
 
In 1999, Aime and co-workers143 performed a study where the stereochemical properties of these 
complexes lanthanide DOTA complexes were investigated using variable temperature, -pressure, 
and -ionic strength 1H NMR of different trivalent cations (Sc, Y, La, Ce, Lu).   They reported 
that a two-isomer equilibrium cannot explain the newly observed apparent reversal of the isomer 
ratio at the end of the series.  As both conformers may lose their inner sphere water molecule, a 
coordination equilibrium may be superimposed on this conformational equilibrium, as shown by 
large positive reaction volumes for the isomerization of [Ln(DOTA)(H2O)x]- (Ln ) Yb, Lu; x ) 1, 
0). The isomerization of [Nd(DOTA)(H2O)]- and [Eu(DOTA)(H2O)]- is purely conformational, 
as shown by near-zero reaction volumes.  The measured isomerization enthalpies and entropies 
agree with this model.  The shift of the isomerization equilibria by a variety of non-coordinative 
salts depends on the ligand conformation rather than the presence or absence of the inner sphere 
water molecule. This results from weak ion binding and water solvent stabilization of one ligand 
conformation, rather than the decrease of the activity of the bulk water in the solution, as shown 
by UV-vis measurements of the coordination number sensitive transition 5F0 to 7D0 of Eu3+ as a 
function of ionic strength.  Fluoride ions replace a water molecule in the inner coordination 
sphere, preferentially for one of the conformational isomers, as proven by 19F-NMR shifts and 
the appearance of a third set of resonances corresponding to [Eu(DOTA)F]-2 in the 1H-NMR 
spectrum of [Eu(DOTA)(H2O)]-. 
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Figure: 1.8:  LnDOTA− complexes exist as a mixture of  stereoisomeric complexes, related as   
                      two enantiomeric pairs. These stereoisomers interconvert by ring inversion or arm   
                      rotation.  Sequential ring inversion and arm rotation interconverts enantiomers.144 
 
In 2003, Sherry and coworkers explored the coordination geometry of Gd(DOTA).  Their 
approach was controlling water exchange by influencing the coordination geometry of the 
complex derivative by selective substitution.144  LnDOTA− complexes exist as a mixture of two 
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coordination isomers:134,145 a capped square anitiprismatic geometry (SAP) that exhibits slower 
water exchange and a capped twisted square antiprismatic geometry (TSAP) that exhibits faster 
water exchange.144,146–150  These two coordination isomers interchange by one of two processes: 
ring inversion or arm rotation as illustrated in Figure 1.8.144  However, it has been shown that by 
appropriate substitution of the pendant arms, arm rotation can be halted.146,151–153 Likewise, 
appropriate substitution of the macrocyclic ring will halt ring inversion.154  Their study combined 
these two effects to halt all intramolecular exchange in this type of complex.144  Each 
coordination isomer is defined by the relative conformation of the macrocyclic ring (δδδδ or 
λλλλ) and the pendant arm orientation (Δ or Λ), and each of these is in turn defined by the 
configuration at the chiral carbon.  One may therefore obtain either coordination isomer by 
careful selection of the chirality at each chiral center in the complex.  Two stereoisomeric 
complexes of the ligand NO2BnDOTMA, S-RRRR-1 and S-SSSS-1, were previously shown to 
adopt a SAP and TSAP coordination geometry, respectively as shown in Figure 1.9. They were 
also found to exhibit significantly different water residence lifetimes, τM = 120 ns (S-RRRR-1) 
and τM = 15 ns (S-SSSS-1), the latter value falling within the optimal range for use in high 
relaxivity or targeted contrast agents at 20 MHz.155,156 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9:  Targeted enantiopure derivatives of LnDOTA.  
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Figure 1.11:  Researchers continue to search for cancer treatments that effectively destroy tumor   
                       cells while protecting surrounding healthy tissue and the body. One intriguing   
                       approach involves photoactivated drugs: an inactive precursor would be administered,   
                       then the diseased tissue could be irradiated to convert the drug into its cytotoxic form   
                       locally.161 
Figure 1.10:  The structure of Arsphenamine has 
been proposed to be akin to the azobenzene (A), 
but mass spectral studies published in 2005 
suggest that it is actually a mixture of the trimer 
B and the pentamer C.160 
 
 1.3      Metal Complex Coordination meets Medical Imaging 
1.3.1 Introduction 
 
The use of metal complexes in therapy and diagnostic imaging occurs in several protocols.  
Throughout history, both ancient and modern, metals and metal compounds have been used in 
medicine to treat a variety of medical conditions.  In the last century, metal complexes were used 
to treat diseases ranging from syphilis (organoarsenic compounds)157 illustrated in Figure 1.10, 
arthritis (gold compounds)158 and to cancer (platinum anti-tumor drugs)159 shown in Figure 1.11.  
The use of metal complexes as diagnostic agents is a relatively new area of medical research, and 
has flourished during the last 50 years. 
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Coordination chemistry of macrocyclic-based ligands has indeed been a fascinating area of 
current research interest to the inorganic chemists worldwide. The continued interest and quest in 
designing new macrocyclic ligands stem mainly from their use as: a) models for protein-metal 
binding sites in a substantial array of metalloproteins in biological systems, b) synthetic 
ionophores, c) models to study magnetic exchange phenomena, d) therapeutic reagents in chelate 
therapy for the treatment of metal intoxication, e) cyclic antibiotics that owe their antibiotic 
actions to specific metal complexation, f) guests in host-guest interactions, g) catalysts.  A more 
recent development is the use of paramagnetic lanthanide macrocyclic complexes for enhancing 
contrast of magnetic resonance imaging (MRI).  Recognition of the importance of complexes 
containing macrocyclic ligands has led to a considerable effort being invested in developing 
reliable inexpensive synthetic routes for these type of compounds.162-166 
 
 
 
1.3.2 Suitable Imaging Characteristics of Lanthanides and their Applications in Medicine 
 
Florescence is a useful tool for studying Eu+3 analogues of Gd+3 which facilitates investigation of 
coordination, water exchange and others features of such complexes.  Although Eu3+ is a poor 
relaxation agent compared to Gd3+ and Eu2+, it is an efficient luminescent species.  The similarity 
of ionic radii allows Eu3+ to be used as a structural probe for corresponding Gd3+ analogues.167  
This aids the development of new contrast agents, as solution structures can be developed and 
evaluated using Eu3+ with less expensive equipment like fluorimeters.  Binding of MRI-CAs to 
biomolecules and synthetic analogues can be scrutinized by luminescence studies to analyze 
where binding may occur.  Interactions of this nature may be enhanced through rational ligand 
design.  In our study we aim at understanding the intrinsic interaction that occurs between 
buffering agents e.g KHP and Eu+3 complexes at molecular level.  In Section 1.4.8 buffers are 
described briefly. 
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Figure 1.12:  The different kinds of radiation emitted when a lanthanide is excited.168 
 
 
Lanthanides feature significant spectral resolution due to their large Stokes shifts and narrow 
emission lines, and temporal resolution due to long lifetimes.  This allows for the use of time-
gated techniques and band pass filters to reduce interference from native or auto-fluorescence in 
the sample, which occurs on the nanosecond timescale.169,170  Lanthanide complexes also do not 
suffer from photobleaching as organic dyes do, because lanthanides are effective quenchers of 
triplet states.171  These qualities allow for the construction of robust sensors for a variety of 
applications.  Of all the lanthanides, Eu3+, Tb3+ and Gd3+ are the best ions in terms of efficient 
excited state population, with energy gaps of 12,300 cm-1 (5D0 → 7F 6), 14,800 cm-1 (5D4 → 7F0) 
and 32,200 cm-1 (6P7/2 → 8S7/2), respectively.  The different kinds of radiation emitted when a 
lanthanide is excited is depicted in Figure 1.12.   While europium and terbium both emit in the 
visible region, gadolinium emits in the ultraviolet, making it unfeasible for use in most sensing 
applications due to significant absorption and emission interference of these high-energy 
wavelengths.  Though not suitable as luminescent sensors, Gd3+ complexes do have a large 
number of unpaired electrons ([Xe]4f7) and isotropic magnetic properties.  The electronic energy 
levels are illustrated in Figure 1.13 below.  These properties, coupled to a long electron spin 
relaxation time of 10-9 s, makes this lanthanide highly NMR-active meaning active as an NMR-
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relaxing agent.172  When coordinated to one or more water molecules, Gd3+ enhances the water 
proton relaxation efficiency by lengthening the rotational correlation time.173 Thus, many 
gadolinium complexes with one free binding site for solvent coordination, such as Gd(DTPA) 
and Gd(DOTA), have been developed for use as MRI contrast agents.174-176  Besides providing 
diagnostic tools for MRI imaging, there are many other medically relevant applications of 
lanthanides, for example, as hypophosphatemic agents for kidney dialysis patients, as 
luminescent probes in cell studies, and for palliation of bone pain in osteosarcoma.167   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.13:  Simplified energy diagram showing the lowest lanthanide excited states and the  
                       estimated triplet state of some lanthanides where the red arrows indicate the   
                       movement of electrons from the excited to ground state. 
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In addition, the attachment of polyamino acids to Gd3+ chelates has applications in targeted 
imaging.177 Some recent examples include polyornithine, polyarginine, and polylysine.  Gd3+ 
chelates containing pendant phosphonate and carboxylate groups were conjugated with the 
positively charged groups on the polyamino acids.177  By chemically attaching the polyamino 
acid to the Gd3+ chelate, the structure stays intact and the binding is strong enough to withstand 
the varying conditions of blood serum.  In terms of applications, targeted imaging can also be 
achieved since positively charged polyamino acids selectively bind to tumor cells that have a 
surplus net negative charge as opposed to non-tumor cells.  Accumulation of the contrast agent at 
the tumor site can help determine extent of tumor growth and morphology.  The preceeding 
Section 1.4 will describe the MRI protocol, from its historical background and principle 
biophysical parameters to the development of more efficient MRI-CAs. 
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1.4     Magnetic Resonance Imaging 
1.4.1 Applications of MRI 
 
Magnetic Resonance Imaging (MRI), is a non-invasive and high resolution imaging technique 
and is primarily used in medical settings to produce high quality internal images of the human 
body.  It has evolved into one of the most powerful tools in diagnostic clinical medicine and 
biomedical research.8  MRI is based on the principles of nuclear magnetic resonance (NMR), a 
spectroscopic technique used to obtain microscopic chemical and physical information about 
molecules.  Medical practitioners use MRI to help diagnose medical conditions and disorders of 
the central nervous system, brain and organ tumors, reproductive system problems, bone and 
joint damage or infection, breast cancer and may other diseases.179  MRI is the method of choice 
because of the incredible ability to tailor the examination of the patient to the particular medical 
question being asked and it eliminates the need for invasive diagnostic procedures.178  Figure 
1.14 shows the versatility of examining different anatomical regions of the body.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.14:  MRI scan of human abdomen, spine, head, entire body, head and articular   
                       cartilage.178,179 
              Abdomen                              Spine                                   Heart 
     Entire Body                Head                            Articular Cartilage 
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1.4.2 Historical Background  
 
The physical principle of MRI is strongly related to the independant work of Felix Bloch and 
Edward Purcell for their development of NMR spectroscopy in 1946, for which they were 
awarded the 1952 Nobel Prize.180-182  In the period between 1950 and 1970, NMR was developed 
and used for chemical and physical molecular analysis.  In 1971, Raymond Damadian showed 
that the nuclear magnetic relaxation times of normal tissues and cancerous tissue differed, thus 
motivating scientists to consider magnetic resonance for detecting disease.183 
 
In 1973 MRI was first demonstrated on small test tube samples by Paul Lauterbur, who used the 
principles of NMR with strong and weak magnetic fields to identify the position of a particular 
nucleus, as the strength of the field is proportional to the radiofreqency.184  Lauterbur did not 
make any postulations as to the potential application for this research, although he did suggest 
that there was a signal difference between cancerous tissue and normal tissue.  In 1975, Richard 
Ernst proposed MRI using phase and frequency encoding, and the fourier transform, which is the 
basis for current MRI techniques.185  In 1977, Raymond Damadian demonstrated MRI of the 
whole body.  In this same year, Peter Mansfield developed the echo-planar imaging (EPI) 
technique.186,187  The in vivo potential of paramagnetic ions was first published in 1978, when 
Lauterbur et al. used a  manganese(II) chloride solution at a dose of 0.1 mmol/kg body weight in 
a dog model for the differentiation of infracted and normal myocardium.184,188  Edelstein and 
coworkers189 demonstrated imaging of the body using Ernst’s technique in 1980.  A single image 
could be acquired by this technique in about five minutes.  By 1986, the imaging time was 
reduced to about five seconds, without sacrificing too much on image quality.  Recently, in 2003, 
the works of Lauterbur and Mansfield in the field of MRI were recognized by the Nobel Prize in 
Physiology and Medicine. 
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1.4.3 Principles of MRI 
 
The MRI technique relies upon observation of the 1H nucleus of in vivo water molecules, 
utilizing a radiofrequency pulsed technique similar that employed by conventional laboratory 
nuclear magnetic resonance (NMR) spectrometers.  The Larmor frequency is such that when a 
dipole is placed in a magnetic field, a torque induced on it, called a 'magnetic moment', causes it 
to align with the magnetic field.  For an electron, however, the magnetic moment is produced by 
the orbital motion of the electron about the nucleus. This produces a force, B0, which causes the 
magnetic moment to precess around the direction of the magnetic field at a frequency termed the 
Larmor frequency (LF).   
 
The local equilibrium magnetization M0 is the net difference between dipoles aligned with the 
field and opposite to the field, but it is not directly observable because it is many orders of 
magnitude weaker than B0.  However, if all the dipoles that contribute to M0 could be tipped 90°, 
they would all precess around the field at the same rate.  Thus, the magnetization M0 would also 
tip 90° and begin to precess around the main field.   
 | P a g e  
 
 
54
Tipping over the magnetization produces a measurement, transient signal, and the tipping is 
accomplished by the RF pulse.  During the transmit part of the basic NMR experiment, the 
oscillating RF current in the coil creates in the sample an oscillating magnetic field B1 
perpendicular to B0.  The field B1 is in general several orders of magnitude smaller than B0.  
Nevertheless, this causes the net magnetic field, the vector sum of B1 and B0, to wobble slightly 
around the B0 direction.  Initially M0 is aligned with B0, but when the net field is tipped slightly 
away from B0, the magnetization M0 begins to precess around the new net field.  If the oscillation 
frequency B1 is different from the precession frequency v0, not much happens to M0 except a little 
wobbling around B0.  But if the RF frequency matches the precession frequency, a resonance 
phenomenon occurs.   
 
As the net magnetic field wobbles back and forth, the magnetization precesses around it in 
synchrony.  The effect is that with each precessional rotation M0 tips farther away from B0, 
tracing out a growing spiral.  After a time, the RF field is turned off, and the M0 then continues to 
precess around B0.  The net effect of the RF pulse is thus to tip M0 away from B0, and such pulses 
are usually described by flip angles they produce (e.g., a 90° pulse or a 30° pulse).   
 
The flip angle can be increased either by increasing the amplitude of B1 of by leaving B1 for a 
longer time.  It is remarkable that a magnetic field as weak as B1 can produce arbitrarily large 
flip angles.  From an energetics point of view, tipping the net magnetization away from   B0 
increases the orientational energy of the dipoles: the nuclei absorb energy from the RF pulse.  
This transfer of energy is possible even with small B1 fields because B1 oscillates at the resonant 
frequency of the nuclei, the precession frequency. 
 
 
 
 
 
 
 
 
 | P a g e  
 
 
55
 
 
 
 
 
 
 
 
Figure 1.15: (A) Procession of protons in an external magnetic field.  
                     (B) Proton spin energy in a magnetic field.  
                     (C) Change in proton spin energy with increasing RF energy at the LF).190 
 
In short, MRI is based on the magnetic fields of protons within the body, producing two-
dimensional views of internal organs or tissues.  Differentiation between biological tissues is the 
primary objective for imaging use in clinical diagnosis, and requires that the 1H signal intensities 
vary depending on the tissue type.191-194  By changing parameters, the MRI system can cause 
tissues in the body to take on different appearances.  MRI gives a distribution of MR signal 
intensity resulting from the T1 (longitudinal relaxation times – in simple terms, the time taken for 
the protons to realign with the external magnetic field) and the T2 (transverse relaxation times – 
the time taken for the protons to exchange energy with other nuclei) of tissue water protons as 
indicated in Figure 1.15.9  MRI instruments employ a gradient magnetic field, allowing 1H NMR 
signals to be acquired as a function of three-dimensional space, with a final image consisting of a 
computer-reconstructed signal intensity map of the spatially encoded 1H2O NMR signals.   
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1.4.4 The biological parameters T1 and T2 in MRI 
The relaxation process in resonance imaging is controlled by these parameters T1 and T2.  These 
parameters are tissue dependant, introducing the possibility to separate different tissue types in 
the human body.  T2 - named the spin-spin relaxation time - is the time constant for the relaxation 
process in the xy-plane, whereas T1 - named spin-lattice relaxation time - is the time constant in 
the z-direction.  T1 and T2 are related to physical interaction phenomena in the tissue.8  
 
T2 effect 
The T2 effect in the relaxation process is due to dephasing of the individual proton magnetic 
dipole moment (MDM) because of the existence of a non-stationary magnetic field.  Each proton 
will experience the external, stationary magnetic field B0 along with the self-generated magnetic 
field of the neighboring protons.  Since the angular frequency of a proton is proportional to the 
experienced magnetic field, the protons will precess at different frequencies, depending on the 
actual field.  When the protons precess at different frequencies, some MDM's will be ahead and 
others behind compared to the ideal frequency - the Larmor frequency, resulting in a net decrease 
of magnetic moment in the xy-plane as time goes on.  At some point the magnetic moment will 
become zero, when all the MDM's equalize one another.  The time period from maximum value 
to zero is characterized by T2.  The value of T2 depends on the mobility of the protons, since a 
large mobility results in an average magnetic field variation of zero, resulting in a long T2 period. 
 
T1 effect 
The T1 effect in the relaxation process is due to the return of the high state protons to the low 
energy state.  Over the time period T1 the high state protons exchange the "extra" energy with the 
neighboring protons, resulting in heat and thermal energy.  The value of T1 is dependant of the 
proton’s ability to exchange the energy.8  However, most human tissues contain about the same 
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amount of water and therefore do not allow significantly large tissue differentiation on the basis 
of water content.195 
Table 1.1:  Examples of T1 and T2 values of different tissues in the brain.8 
 
 
 
 
The relaxation process is a result of both T1 and T2, and due to the exponential nature of this 
process some tissues might not be distinguishable, if recording the signal in the xy-plane directly.  
For this reason it is necessary to introduce control of the relaxation process by introducing a 
dependency of one of the two biological parameters in the recorded signal. 
The signal intensity of various tissues in MRI could be amplified by varying the multiplicity of 
image acquisition parameters resulting in high intrinsic image contrast where damaged tissues 
can be distinguished from normal tissue.  In some cases the T1 and T2 relaxation times of water 
protons may vary markedly depending on tissue type, and therefore, may be used as a source of 
contrast in MR images.  However, these relaxation times are relatively slow (~seconds), 
increasing the time required to obtain clinically useful images and negatively affecting image 
quality.  While some improvement in contrast can be made by T1- or T2-weighting, paramagnetic 
metals can shorten the T1 or T2 of water molecules in tissues through which they pass far more 
effectively for the purpose of MRI contrast.196  The innate tissue contrast in images is not 
sufficient to distinguish between normal and pathogenic tissues when they produce similar signal 
intensity.  To overcome this problem, and to enhance contrast between tissues, metal complexes 
are injected into the body that lead to significant improvement in the contrast of T1-weighted and 
T2-weighted MR images, by increasing the difference in the signal intensity from two types of 
tissue as shown in Figure 1.16 where MRI images of the brain are recorded.  Figure 1.17 
illustrates the advantages of using MRI-CAs as opposed to not using MRI-CAs.  
 
 
 Tissue    type      T1 (ms)       T2 (ms) 
 White Matter 871 87 
 Gray Matter 515 74 
 Cerebrospinal fluid 1900 250 
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Figure 1.16: MRI images of the brain. T1-weighted (left) and T2-weighted (right).196 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17: (A) Transverse fast acquisition breast MRI images at same level without contrast   
                     (upper) and with contrast (lower). The anomalies, emphasized by the green   
                     circles, show how the abnormality in the lower breast image on the right is  
                    "highlighted" by the contrast agent (gadolinium DTPA or Magnevist).   
                     (B) MRI scans of breast without  (upper) and with (lower) contrast agent   
                     (Magnevist).197 
 
Top of Brain Eye Level of Brain 
Mid-nose Level in Brain
(A) (B) 
 | P a g e  
 
 
59
1.4.5   Factors related to Image Quality 
Physical Factors  
 
Improvements in image quality was made possible by the development of new equipment, 
software for image generation, and the design of more organ specific MRI-CAs.  These 
combined effects significantly contributed to the improvement of the body images and thus to a 
much more accurate diagnosis.196,198  Effective imaging can be achieved by: 1) increasing the 
sensitivity and specificity of the visualisation procedure; 2) improving the selectivity in tissue 
characterisation; 3) reducing intrinsic image artefacts; and more recently 4) acquiring more 
functional information on the image process.199   
 
 
Chemical Factors 
 
The general coordination chemistry of the Gd3+ ion lends itself to its application as a relaxation 
agent; fast water exchange rates are crucial for attaining high relaxivity, and the ionic radius of 
Gd3+ is ideal for fast exchange.  Due to lanthanide contraction200-204, lanthanide sizes decrease 
across the 4f row of the periodic table, resulting in higher coordination numbers for the early 
lanthanides and smaller coordination numbers for those toward the end of the series.  Since the 
Gd3+ ion is situated in the middle of the row, a low energy barrier exists between the eight and 
nine coordinate states, favoring fluctuation between the two. However, the rate of water 
exchange of the Gd3+, once complexed, is slowed significantly relative to that of the free ion, 
often to the extent that it is no longer in the optimal range for high relaxivity.   
 
In addition, there is a significant decrease in the number of inner-sphere water molecules as they 
are replaced by ligating atoms in a chelating ligand.  When designing new contrast agents an 
important trend to consider, which  is related to water exchange, is the inherent decrease in 
proton relaxation rates with increasing magnetic field strength.205,206  New high-field scanners 
(100 MHz and above)  now appearing in medical facilities give better signal-to-noise ratios, and 
this effect becomes significant. Thus, short water residence times (or fast water exchange rates) 
become increasingly important at high field, with the optimal value for τM decreasing to about 1 
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ns for 2.4 T scanners (100 MHz proton Larmor frequency).  Thus to attain high relaxivities at 
high fields, the coordination chemistry challenge involves the design of ligands that effectively 
chelate Gd3+ while limiting the decrease in the water exchange rate and reduction in q once the 
ion is bound. 
 
 
1.4.6 Luminescence Lifetime Studies in the Rapid-Exchange Limit 
 
Europium is commonly used as an analogue in the luminescence study of the hydration state of 
gadolinium due to their similar ionic radii (atomic radii: Eu3+ = 1.09 Å, Gd3+ = 1.08 Å) and 
because Gd3+ complexes are not susceptible to OH or OD quenching due their extremely large 
energy gaps between emissive and ground states.   The relaxivity of a contrast agent scales 
linearly with the number of water molecules, q, that are in the first coordination sphere of the 
agent’s metal ion.207-216  One of many approaches to develop contrast agents with higher 
relaxivities has been to create complexes with larger q-values, producing more paramagnetically 
affected water molecules to exchange with the bulk solvent.   Deactivation of the luminescence 
from excited trivalent lanthanide ions in solution occurs by means of a vibrational energy 
transfer process involving high-energy vibrations of solvent molecules like water and deuterium 
oxide shown in Figure 1.18.   
 
Many of the early investigations of non-radiative relaxation in lanthanide systems sought to 
identify the nature and relative importance of these interactions.207-216  It was established that OH 
oscillators of coordinated water molecules provide an efficient non radiative pathway for de-
excitaion of the emissive state of certain lanthanide ions.  Furthermore, these oscillators act 
independantly and OD oscillators of coordinated D2O molecules are quite inefficient at 
accomplishing this deactivation.  In 1979, Horrocks and Sudnick calibrated this effect by 
measuring the luminescence decay rates of a series of crystalline solids containing Eu3+ 
complexes separately prepared in H2O and D2O where the number of metal ion coordinated 
water molecules was known from X-ray diffraction studies.217,218   
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Figure 1.18:  Vibrational quenching of Eu3+ emissive state by water. An offset has been   
                        applied so that the lowest vibrational level of OH/OD is shown at the same      
                        energy as the  highest level of the ground-state manifold of the Eu3+.8 
 
The linear plot of the differences in the reciprocals of the excited state lifetimes in ms-1 
(exponential decay constants) measured for the complexes crystallized in H2O and D2O is 
described by Equation 1.1: 
 
q = A[τ-1H2O - τ
-1
D2O]………Equation 1.1 
 
where the constant A was determined to be 1.05 (water molecules·ms) for Eu3+ and the estimate 
error in the resulting approximation was q-value ±0.5 water molecules.  Even though Equation 
1.1 has proven to be very useful in the prediction of q for various complexes in aqueous solution, 
it frequently produces non-integer q values often greater than expected integer value.  Several 
reasons account for this observation.  First, the europium ion may form more than one type of 
particular complex with a particular ligand in solution.  The presence of more than a single 
unique Eu3+ species in solution can easily be verified since the energy of the 7F0 →5D0  
excitation transition between non-degenerate states is dependant on the identity of the atoms in 
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the first coordination sphere of Eu3+.219  The presence of more than one singlet peak in the  7F0 
→5D0 excitation spectrum of a Eu3+ complex  indicates multiple environments.220  If the Eu3+ 
does exist in multiple coordination environments with different q-values, the q-value determined 
using Equation 1.1 depends on the rate of exchange of the Eu3+ between its different 
coordination environments.  There are three possibilities namely, slow exchange, fast exchange 
and intermediate exchange,221 depending on whether the rate of exchange of the Eu3+ between its 
coordination environments in slower, faster or similar to the luminescence decay rate of the 
excited state Eu3+ ion, respectively.  For Eu3+ coordination environments containing differing 
numbers of first coordination sphere water molecules in the fast exchange, the q-value measured 
by Equation 1.1 will represent a concentration-weighted average of the q-values of each unique 
Eu3+ environment, and will typically be non-integral.  The q-value of individual Eu3+ complexes 
in slow exchange can be determined by monitoring the luminescence decay of the corresponding   
7F0→5D0 excitation transition.  It is difficult to obtain q values of the Eu3+ complexes in 
intermediate exchange because the luminescence decay of the excited Eu3+ ion is non-
exponential.   
 
Secondly, ligands containing X–H oscillators can also shorten Eu3+ excited state lifetimes to 
varying degrees.  If these X–H moieties contain exchangeable hydrogen atoms, the                    
[τ-1H2O - τ
-1
D2O]-values will be affected.  Oscillators with exchangeable hydrogen atoms include 
alcoholic O–H and amine N–H oscillators in which the O or the N atom is directly coordinated to 
the metal.  Amide N–H oscillators that have their carboxylic oxygen coordinated to the metal ion 
have also been found to shorten Eu3+ excited state lifetimes to a small extent.  For the purpose of 
counting water molecules coordinated to Eu3+ ion, appropriate corrections need to be applied 
when these X–H oscillators are present. 
 
Thirdly, the reason for non-integral and larger than expected q-values is that water molecules in 
the second coordination sphere of the Eu3+ ion, also called ‘closely diffusing water molecules’ 
are known to shorten luminescence lifetimes to a small extent.222,223  Equation 1.1 is easily 
modified to account for the effects of  X–H oscillators and water molecules beyond the first 
coordination sphere yielding Equation 1.2.222,224 
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q = A[τ-1H2O - τ
-1
D2O - kXH] ………Equation 1.2 
where kXH = α + βnOH + λnNH + δnO=CNH 
 
where nOH is the number of alcoholic O–H oscillators in the first coordination sphere of Eu3+, 
nNH is the number of secondary amine N–H oscillators in the first coordination sphere of Eu3+, 
and nO=CNH is the number of amide N–H oscillators in which the amide carbonyl oxygen is in the 
first coordination sphere of Eu3+.  The respective contributions of these X–H oscillators to the 
quenching of the 5D0 state of Eu3+ are β =  0.44 ms-1, γ  = 0.99 ms-1 (calculated as the average of 
0.759,225 1.0,225 and 1.2222), and δ222,223  = 0.075 ms-1.  The contribution to the q-value of a single 
O–H oscillator in the first coordination sphere of Eu3+ is calculated as half the contribution of a 
water molecule, i.e. β = 1/(2A).  The value α is the quenching of the excited state of Eu3+ by 
second coordination sphere water molecules. 
 
 
 
1.4.7 Biomedical Considerations Toward the Development of MRI-CAs 
 
Toxicity of the free Gd3+ used in the MRI-CAs needs to be considered.  As gadolinium has a 
radial size approximately equal to calcium(II), competition occurs and as a result it can disrupt 
calcium2+ mediated signalling, forming strong complexes that can accumulate within the body.188  
This displacement of calcium in a physiological milieu is a driving force for many therapeutic 
and diagnostic applications.  However, the correct choice of ligand can prevent this in vivo 
transmetallation from occurring.  MRI-CAs used in the body should be biocompatible and 
include requirements such as rapid renal excretion, water solubility, stability in aqueous 
conditions, and a low osmotic potential when in solution for clinical work.168  Also, at least one 
water molecule must be bound to the metal center (i.e. within the coordination sphere) and this 
undergoes rapid exchange with water molecules of the surrounding solution to affect the 
relaxation time of all the solvent protons.155 
 
 
 | P a g e  
 
 
64
Factors controlling relaxivity 
 
Relaxivity is controlled by two mechanisms that are essential to the understanding and design of 
contrast agents.  The Solomon–Bloembergen–Morgan equations bring these important 
parameters together and have been outlined and discussed in previous reviews and further details 
by Botrill et al.,226 Kowalewski et al.,227 and Aime et al.228 The inner sphere relaxation 
mechanism utilizes gadolinium and directly bound water interactions, and the outer sphere 
mechanism is based upon interactions between the second sphere and closely diffusing water 
molecules.227  Figure 1.18 demonstrates the different parameters that need optimization for high 
relaxivity.  These include the hydration of the metal ion, the mean residence time of the water 
molecule in the first coordination sphere (τM), and the tumbling rate of the species, which is 
characterized by the rotation correlation time (τR).228 
 
 
Inner sphere relaxivity 
 
The relaxivity of a contrast agent at commonly used imaging fields (0.5–1.5 T) can most 
effectively be controlled when the complexes are designed with the inner sphere relaxation 
mechanisms in mind.  These mechanisms are governed by the following equation:228  
                        
 
 ………………………Equation 2.1 
 
The Equation 2.1 shown above represents the inner sphere contribution to relaxivity, where C = 
molar concentration of paramagnetic compound, q = number of bound water molecules, τM is the 
mean water residence time, and T1M = longitudinal relaxation time of the bound water protons.228  
T1M, is controlled by the molecular rotational correlation time, τR, whereby slower tumbling of 
the contrast agents leads to faster relaxation rates, and hence relaxivity.228 
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Figure 1.19:  Illustration of the different parameters that require optimisation for maximum    
                       relaxivity of gadolinium contrast agents.8 
 
 
The number of bound water molecules, q, is usually 1 (especially in current commercially 
available contrast agents) due to the octadentate chelators used for metal encapsulation.227  These 
are very stable complexes, and prevent the release of the metal within the body.  However, there 
have been recent examples of stable hepta-coordinated contrast agents containing two water 
molecules bound to the gadolinium.9  This is an attractive development as higher numbers of 
water molecules present enhance the relaxivity of the complex.  Figure 1.19 depicts the different 
parameters that require optimisation for maximum relaxivity of gadolinium contrast agents.8  As 
mentioned previously, T1M is dominated by molecular reorientation τR.228  It also depends on the 
residence time of the bound water, τM, and electron paramagnetic relaxation, T1e and T2e.  τD is 
defined as the diffusion coefficient of proximal water molecules.  Aime et al. provide a full and 
detailed explanation of these factors in their recent review article.228  In basic terms, T1e and T2e 
are frequency dependant, which means that at usual field strengths (0.5–1.5 T) τM, T1e and T2e are 
insignificant.228 Hence at these fields consideration is mainly given to the molecular rotation 
correlation time. 
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Outer sphere relaxivity 
 
Contrast agents can display relaxivity even when q = 0.  In the absence of coordinated water 
molecules observed relaxivity arises from outer sphere contributions.229  Outer sphere 
contributions originate from: (i) second sphere relaxation where water molecules hydrogen 
bonded to the carboxylate oxygen atoms are relaxed via dipolar mechanisms and (ii) outer sphere 
relaxation which arises due to diffusion of water molecules in the bulk near to the Gd3+ 
complex.9,230  The parameters of importance are the electronic relaxation time of the metal, the 
distance of the closest approach of solvent and solute and the sum of their diffusion 
coefficients.155  The outer sphere relaxivity is usually estimated by equations proposed by Freed 
et al.231  It is important to note that this model is only an approximation for the 
polyaminocarboxylate ligands used in contrast agents because it does not take into account 
interactions of water with the complex, which for these ligands are important.228  On the whole it 
seems that outer sphere contributions to relaxivity are not very well understood, and this 
phenomenon is somewhat overlooked when contrast agents are being developed.9  The primary 
developmental focus of next-generation MRI contrast agents has been on derivatization of 
aminocarboxylate systems used in general practice.232  Figure 1.20 shows some commercially 
available aminocarboxylate-based MRI contrast agents in current usage. 
 
Features of compounds based on ligands such as DTPA and DOTA include inexpensive 
streamlined syntheses as well as adequate solubility and toxicological parameters.233,234   The 
following examples illustrate several approaches toward optimizing the aminocarboxylate 
system en route to more efficient relaxation agents.  Research efforts in new contrast-agent 
design are generally directed towards the optimization of one or more of the afore-mentioned 
relaxation parameters through ligand structural modification.  For example, Merbach and co-
workers have reported numerous studies that probe the factors influencing the water exchange 
rate of aminocarboxylate Gd3+ complexes.235-239  The main explanation for increased water 
exchange rates is steric crowding at the water binding sites, a property that favors the release of 
the coordinated water molecule in a dissociative exchange process.   
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Figure 1.20:  Commercial aminocarboxylate-based MRI contrast agents (Bayer Schering 
                       Parma AG).232 
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Derivatives of DTPA, shown in Figure 1.21, have been synthesized with varying numbers of 
carbon atoms in the ligand scaffold. 
 
 
 
 
 
 
 
 
 
Figure 1.21:  The DTPA ligand and two of its derivatives prepared for water exchange  
                       rate studies.235,236 
 
As shown by the τM values, water exchange is accelerated in the resultant Gd3+ complexes, with 
values approaching the optimal range for high relaxivity at higher magnetic fields (60–100 
MHz).  This rate enhancement is achieved, however, at the cost of thermodynamic stability, as 
measured by the relatively low pGd∗ values tabulated in Figure 1.21. This phenomenon of 
decreased stability upon increasing water exchange rates is common for aminocarboxylate 
ligands and must be addressed when considering these complexes as high-relaxivity agents, 
particularly at the high magnetic field strengths of future clinical scanners.  Increased water 
exchange rates for macrocyclic complexes based on [Gd(DOTA)(H2O)] have also been reported. 
The pyridine-N-oxide derivative of DOTA illustrated in Figure 1.22 resulted in a gadolinium 
complex with a significantly faster water exchange rate than the parent complex (τM = 39 vs. 244 
ns).240  As with the linear aminocarboxylates mentioned above, the rate of increased water 
exchange was attributed to an increase in steric crowding.    
                                                 
 
1∗  pGd = -log[Gd]free ; [Gd]total=1 μM, [ L]total =10 μM (pH 7.4, 25 °C, 0.1 M KCl). 
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A monophosphinic acid derivative shown in Figure 1.22 was found to possess an even faster 
exchange rate, with τM = 16 ns.241  Steric crowding owing to the bulky phosphinate group is 
given as a rationale for the increased rate, as well as a possible favorable arrangement of water 
molecules in a second coordination sphere. The relaxivity of this complex is 6 mM-1s-1 (20 MHz, 
25 °C), an improvement over commercial agents.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.22:  The DOTA ligand and derivatives prepared to increase water exchange 
                       rates.240,241 
 
Aminocarboxylate complexes with q>1 have also been reported in efforts to achieve higher 
relaxivity.  Relaxivity is highly dependant on q, and relaxivity values will be limited for 
complexes that possess only one coordinated water molecule (q=1).  Two examples of q=2 
complexes are depicted in Figure 1.23.  In each case, DTPA complexes are tethered to a central 
core to produce dinuclear Gd3+ complexes with increased hydration numbers (q=2). The 
relaxivity values of [Gd2{pX- (DTTA)2}(H2O)4]2- and [Gd2{mX(DTTA)2-(H2O)4]2- are 12.8 and 
11.6 mM-1s-1 (20 MHz, 37 °C), respectively, and represent significant increases over that of the 
parent DTPA complex (r1p = 4.3 mM-1s-1).242  These values are influenced by the higher q value 
and (owing to increased molecular weight) by an increase in the rotational correlation time τR.189 
N
N
N
N
COOHHOOC
HOOC COOH
DOTA
N
N
N
N
HOOC
HOOC COOH
N
O
DO3A-pyNox
N
N
N
N
PHOOC
HOOC COOH
O
OH
NH2
DO3APABn
 | P a g e  
 
 
70
A supramolecular approach was used to generate another dinuclear q=2 complex via iron 
terpyridine complexes derivatized with DTPA shown in Figure 1.23.243  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.23:  Examples of dinuclear, q=2 DTPA-based Gd3+ complexes proposed as  
                       improved high-relaxivity MRI contrast agents.243 
 
The high relaxivity of [Fe(tpy-dtta)2Gd2(H2O)4] (15.7 mM-1s-1, 20 MHz, 37 °C) is attributed to 
an increase in q as well as a long τR value resulting from the higher molecular weight and 
rigidity of the complex.201  While the relaxometric properties of such q=2 compounds are 
improved, the thermodynamic chelate stability suffers greatly in both cases.  The increase in q is 
made possible by removing a carboxylate arm of the parent DTPA to open up a metal 
coordination site.  As is observed for increased water exchange in aminocarboxylate complexes, 
higher number of coordinated water molecules via a decrease of ligand denticity is accompanied 
by a dramatic decrease in thermodynamic stability.  The pGd values for the para- and meta-
substituted xylene-based complexes (16.2 and 15.1, respectively) are significantly lower than the 
value of 19.1 for the parent DTPA complex.9  Even less stable is the iron terpyridine complex; its 
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pGd value of 10.6 represents a decrease by more than five orders of magnitude in stability 
relative to the DTPA-BMA complex (pGd = 15.8), the ligand with the lowest pGd value of all 
clinically approved agents.  This effect of decreased stability resulting from increased q or water 
exchange rates raises a key concern in contrast agent design. The optimization of one parameter 
will often hamper that of another, making the goal of high-relaxivity of practical agents a major 
challenge.  To achieve a practical high-relaxivity agent, the optimal combination of all relevant 
parameters must be accomplished while maintaining solubility and chelate stability.  As an 
example of a gadolinium-based contrast agent not focused on traditional aminocarboxylate 
ligand scaffolds, Wilson and co-workers have reported several studies of Gd3+ encapsulated 
inside fullerene cages.244-246  The peripheries of these cages are decorated with solubilizing 
groups to allow for application of C60 in aqueous media.  Relaxivities ranging from about 10 to 
as high as 38.5 mM-1s-1 (30 MHz, 26 °C) are due entirely to second and outer-sphere relaxation, 
as there are no inner-sphere water molecules directly coordinated to the gadolinium ion. In 
solution, these “gadofullerenes” aggregate, resulting in large assemblies with long rotational 
correlation times and consequent high relaxivities.9  However, practical concerns such as in vivo 
toxicity and deaggregation in the presence of various salts (thereby limiting the effect of long τR 
values on relaxivity)247 may preclude considering such systems for contrast agent applications. 
 
A second approach to MR contrast is based on magnetic polymer particles, e.g. dextran-
stabilized colloidal magnetite solutions as T2 relaxation agents for MR, was initially patented by 
Owen et al. followed by several patents on biocompatible magnetic particles.248,249  The first 
product based on magnetic particle technology, AMI-25 or ferrioxidases, appeared on the market 
in 1995, distributed under the license as Endorem® (Laboratoire Guerbet SA, France) or 
Ferridex® I.V. (Berlex laboratories Inc., U.S.A. ;Tanabe, Seiyaku Company, Japan).  
 
As mentioned earlier, the interaction of the Eu+3 metal center and biological buffers are 
examined across the pH range in this work.  In the preceeding Section 1.4.8 the buffers used in 
this study are briefly introduced with respect to their origin, structure and properties.   
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1.4.8 Biological Buffers 
 
Biological buffers are predominantly synthetic compounds serving widely to the pH stabilization 
and for the pH control in the pH range of 5.5–11.4.250  They are soluble in water and have a high 
chemical stability and compatibility in various biological systems.  Today, biological buffers are 
predominantly utilized as chemical agents for analytical chemistry. They are used in buffer 
exchange processes and as mobile phases during some chromatography steps, too.257 These 
buffer compounds provide alternate buffer compounds with pKa values near physiological 
conditions for biological applications.251,252  The biological buffers are free of chromophores 
absorbing light above 200 nm.  In spite of this, it was reported recently that some of the buffers 
weaken markedly the passing light under some experimental condition.253  There have been no 
studies that have previously reported interactions of these biological buffers with lanthanide(III) 
complexes in solution specifically on whether their absence or presence changes derived physical 
quantities.   
 
 
Good Buffers 
 
In 1966, Good and coworkers discovered, developed and introduced a special group of 
zwitterionic biological buffers, called Good buffers.254  Later, in 1980, they were patented and 
they also introduced a new generation of biological buffer compounds based on the zwitterionic 
character of Good buffers.252 Good buffers stabilize pH of solution and they are used as protein 
solubilization agents in aqueous solutions too.255  The pKa values of these biological buffers lie at 
or near physiological pH area.251,254 Popularity of using of biological buffers increased in 
analytical chemistry and followed two phenomena.  The first being photometric detection that is 
accounted for using modern instrumental analytical methods.  The second phenomenon is the 
fact that biological buffers are free of chromophores absorbing ultraviolet light above 200 nm.  
To ensure these biological buffers are free of chromophores they are further tested by the passing 
a short wavelength UV-light beam through aqueous solutions.253,256  One of the main attributes 
exploited by Good buffers is the fact that the pKa of sulfonic acids are very low.  The buffers 
used throughout this work are tabulated in Table 1.2.  
 | P a g e  
 
 
73
Potassium hydrogen phthalate (KHP) 
Potassium hydrogen phthalate, often called simply KHP, is an acidic salt compound. It forms 
white powder, colorless crystals, a colorless solution, and an ionic solid that is the mono-
potassium salt of phthalic acid.   The hydrogen is slightly acidic, and it is often used as a primary 
standard for acid-base titrations because it is solid and air-stable, making it easy to weigh 
accurately.   It is also used as a primary standard for calibrating pH meters because, besides the 
properties just mentioned, its pH in solution is very stable. 
In water KHP dissociates completely giving the potassium cation (K+) and hydrogen phthalate 
anion (HP- or Hphthalate-).  As a weak acid hydrogen phthalate reacts reversibly with water to 
give hydronium (H3O+) and phthalate ions. 
HP- + H2O ⇌ P2- + H3O+ 
KHP can be used as a buffering agent (in combination with hydrochloric acid (HCl) or sodium 
hydroxide (NaOH) depending on which side of pH 4.0 the buffer is to be. In acidic solutions 
KHP becomes phthalic acid, which is a dibasic acid, with pKa's of 2.98 and 5.28.  Phthalic acid is 
one of three isomers of benzenedicarboxylic acid, the others being isophthalic acid and 
terephthalic acid.  Sometimes the term "phthalic acids" is used to refer to this family of isomers, 
but in the singular, "phthalic acid", refers exclusively to the ortho- isomer. 
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Table 1.2:  Common Buffers Used in Study. 
Buffers Structure pKa at 
25 ºC 
pH Range
Potassium 
hydrogen phthalate  
O OH
O
O- K+
 
5.51 4-8 
 
 
 
 
 
 
CHES 
NH2
S
O
O
O
 
9.49 8.6 – 10.0 
 
 
 
 
 
MES 
O NH CH2 CH2 S
O
O
O
 
6.10 5.5 – 6.7 
 
 
 
 
 
Tris/HCl 
HO
HO NH2
OH
H Cl
 
 
 
 
 
8.3 7.0 – 9.0 
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Buffers Structure pKa at 
25 ºC 
pH Range
MOPS 
N
O
CH2 CH2 CH2 S O
O
O  
 
7.20 6.5 – 7.9 
Multi-component 
buffer (1 mM 
CHES, 1 mM MES, 
2 or 10 mM Tris, 1 
mM MOPS, 1 mM 
and or Potassium 
hydrogen 
phthalate) 
  2.0 – 10.0 
 
 
1.5 Scope and Objectives of the Research Project 
 
The aims of this work are to enhance metal complexation of macrocyclic ligands through new 
structural features introduced into ligand backbones and pendant moieties using selectivity trends 
observed for transition metal complexes.  Specifically, we planned to enhance complexation 
stability of lanthanides (Eu and Gd) by encapsulation of the metal within macrocyclic cavities 
based on cyclen with grafted cyclohexyl on pendant amino alcohol donors.  The target ligands 
are illustrated in Figure 1.24.  Initial feasibility studies toward target intermediates were carried 
out with the aim of finding the most suitable pathways.  Many of the synthetic routes envisaged 
have been developed in our laboratories or have been reported by others in the scientific 
literature. 
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 Target Ligands to be Synthesized 
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Figure 1.24:  Target Ligands. 
 
For the ligand feasibility study, three clearly distinct methodologies or possible strategic 
pathways taken toward the target molecules were defined as shown below in Figure 1.25, namely 
(i) direct alkylation, (ii) mono-protection and (iii) tri-protection methods, respectively.  The 
success and reproducibility of any chosen path was vital in unraveling and understanding the 
synthetic considerations that needed to be taken into account when synthesizing mono N-
substituted cyclen derivatives.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.25:  Strategic paths taken toward target molecules. 
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(i) In the direct alkylation path, the pendant cyclic moiety was added selectively to one 
of the nitrogen atoms on the cyclen backbone, followed by further alkylation with 
pendant acetamides to form target ligands.   
 
(ii) Conversely, in the mono-protection strategy, one of the nitrogen’s is selectively 
protected typically with a tosyl protection group.  Once that was achieved the product 
was further alkylated with pendant arms to form an intermediate. This compound is 
further deprotected to remove the protecting group leaving an available site for attack 
by the pendant cyclic moiety. 
 
(iii) In the tri-protection approach, three of the nitrogens are selectively protected typically 
with boron or molybdenum/tungsten derivatives.  This leaves one free nitrogen site 
available that can be selectively alkylated with a pendant cyclic moiety.  Once this is 
achieved, the central protecting metal can be removed using the appropriate 
procedures, and once cleaned further alkylated with pendant arms to form the final 
target ligands.  
 
Through the different strategies mentioned and the various synthetic tools used, this 
demonstrates how diverse the chemistry of 1,4,7,10-tetraazamacrocycles is.  The chelates to be 
synthesized are to take into consideration the effect of: 
(i) Using  different types of pendant donors. 
Amide groups used as pendant donors have donor atoms that allow for the manipulation of the 
hydration sheath of the metal complex as well as the overall complex charge.  A comparison of 
our findings with DOTA and DOTAM will show how changing one of the pendant donors to a 
pendant amino alcohol donor changes the system.  
 
(ii) Grafting aliphatic groups such as cyclohexyl into pendant donor backbones. 
The bulkier pendant moieties may allow for intramolecular interactions that favor metal 
encapsulation of metal ions of smaller ionic radius and an increase in exchange rate of the 
coordinated water molecule envisaged. 
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(iii) Characterize all products 
All compounds from precursors, ligands and their respective metal complexes will be thoroughly 
analyzed using appropriate scientific instrumentation namely NMR spectroscopy, mass 
spectroscopy, Fourier transform infrared spectroscopy and X-ray crystallography (where 
possible). 
 
(iv) Clearly define the effects of intramolecular interactions arising from changes in ligand 
topology that result in enhanced Lewis acidity of the complexed metals. 
 
f) Studies on Eu(III) Complexes 
(i) Luminescence Studies and UV-visible to determine spectroscopic pKas, and hence    
          elucidate the solution structure of Europium-Complexes. 
(ii) Determination of q, number of coordinated water molecules to metal center, using     
           luminescent lifetime measurements. 
(iii) Investigate the solution chemistry of metal complexes using Cyclic Voltammetry. 
 
g)  The general hypotheses proposed in this study are as follows: 
 
 Introducing cyclic groups onto the macrocyclic ring nitrogens imparts greater rigidity to the 
macrocyclic ring that slows down the kinetics of demetalation.  This occurs since the protonation 
of the nitrogen donor atoms in the sterically crowded macrocyclic cage becomes more difficult.   
 
(i) Although the number of coordinated water molecules plays an important role in 
enhancing the performance of a contrast agent, the rate and mechanism of water 
exchange is equally crucial.  These are intimately related to the inner-sphere solution 
structure and reported water exchange rates for different Gd3+ complexes may vary by 
as much as four orders of magnitude.  A dissociatively activated water exchange 
mechanism is often suggested since it is supposed that there is no space for a second 
water molecule to enter before a bound water has departed in nine coordinate Gd3+ 
complexes of octadentate ligands.  The greater steric crowding of the coordination 
polyhedron, induced by the bulkier backbones of the pendant donor atoms, is 
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proposed to decrease the activation energy required to reach the eight coordinate 
transition state thereby increasing the rate of exchange with the bulk solution.  
 
(ii) There have been few examples of studies conducted with lanthanide complexes with 
commonly used buffer systems namely Good’s Buffers on which earlier work have 
been reported.  This project ultimately aims at preparing and studying new cyclen-
based Ln3+ metal chelates exhibiting improved resolution and functionality and 
investigating the effects of buffer systems involving potassium phthalate (KHP).  The 
fact that these buffers contain both NH, CH and OH oscillators and in the case of 
KHP a chromophore that may affect photophysical and electrochemical behavior in 
solution merits the need for investigation.  
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Chapter Two Experimental 
2.1      Materials and Methods 
2.1.1 General  Materials 
 
Deionised water was produced by a Millipore RO unit, and further purified by reverse osmosis 
using a Millipore MilliQ Ultra-Pure system (18 MΩ cm).  All glassware was washed thoroughly 
with liquid soap, rinsed with distilled water, rinsed with commercial acetone and dried in an 
oven set at 100 °C.  All reagents were the highest commercially available grades and used 
without further purification unless otherwise indicated (Section 2.1.2).  However, the solvents 
that were utilized were appropriately dried.  The reagents used are listed in Table 2.1.  All 
masses were calculated according to exact mass range.   
 
Table 2.1:  Materials used in this study. 
REAGENT SUPPLIER GRADE % PURITY 
Acetone Merck CR  
Acetonitrile Agros-Organics AR  
Argon Afrox AR  
Calcium chloride BDH GR Anhydrous 
Cesium carbonate Sigma AR  
Chloroacetyl chloride BDH CP  
Cyclen Strem Chemicals CR  
Dimethyl ammonium hydrochloride Sigma AR  
Chloroform-d, contains 
1 % v/v tetramethylsilane 
Aldrich AR 
99.8 atom % D 
Diethyl ether Aldrich CP  
Dimethylformamide Sigma CP  
Deuterium oxide Aldrich AR 99.9 atom % D 
Deuterium Chloride Sigma AR  
Ethanol Absolut puriss. p.a. Aldrich CP  
Ethyl acetate Aldrich CP  
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REAGENT SUPPLIER GRADE % PURITY 
Europium triflate Aldrich AR 98 % 
Gadolinium triflate  Aldrich AR 98 % 
Hydrochloric Acid Saarchem GR 32 % 
Iodine, chips Aldrich GP 99+ % 
Liquid nitrogen Afrox CR  
Magnesium Turnings Riedel-de Haën CP ≥99.5 %  
Magnesium sulfate anhydrous SaarChem AR uniLAB 
Methyl ammonium hydrochloride Sigma AR  
Nitrogen gas Afrox AR  
Potassium chloride Aldrich AR  
Potassium carbonate Sigma AR  
Potassium dihydrogen phosphate Merck GR  
Potassium iodide BDH GR  
Potassium hydrogen phthalate Saarchem GR 99.995  % 
Phosphorus pentoxide Sigma CP  
Nitric Acid Ampoule VBH AR 99.995%   
Sodium Deuteroxide Sigma AR  
Sodium Hydroxide Pellets Merck uniLAB  
Sodium Hydroxide Ampoule (0.1 M) VBH AR 99.995%   
Sodium nitrate Aldrich AR 99.995%   
CHES  Sigma AR 99 % 
MOPS Sigma 
AR 99.5 % 
 
MES  Sigma AR 99.5 % 
Tris  Merck  AR  
 
Key: AR = Analytical Reagent  CR = Commercial Reagent          
CP = Chemically Pure  GR = General Reagent 
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2.1.2 Distillation of Solvents 
2.1.2.1 Acetonitrile 
 
Acetonitrile was dried by refluxing over di-phosphorus pentoxide (DPP), in an argon 
atmosphere. The dried solvent was stored over molecular sieves (4 Å).257 
 
 
2.1.2.2 Ethanol 
 
Although absolute ethanol was utilized it was further dried using 5 g of magnesium turnings and 
0.5 g of iodine per 100 ml solvent.  The mixture was heated until a vigorous reaction occurred 
and turned from yellow to clear.  1 L of ethanol was then added to the flask, and the mixture 
refluxed for about an hour (under an argon atmosphere), before the dried ethanol was 
collected.257 
 
Note:  The common drying agent used for the drying tubes was calcium chloride (anhydrous) as 
it has a large capacity for absorption of water.  After use, it was stored in at oven set at 100 ºC. 
 
 
2.1.3 General Analytical Characterisation Techniques 
2.1.3.1  Nuclear Magnetic Resonance Spectroscopy (NMR) 
 
1H and 13C NMR spectra were recorded on a Bruker Avance 300 Spectrometer operating at 300 
MHz (1H) and 75 MHz (13C).  Samples were calibrated with TMS (1H) and with the triplet of 
CDCl3 for 13C at 77.00 ppm.  COSY experiments were performed to elucidate complex spectra 
of macrocyclic chelates obtained using a Bruker 500 MHz spectrophotometer.  Samples were 
either dissolved in D2O or d-chloroform depending on the sample being analyzed.  In some cases 
D2O was spiked with NaO3S(CH2)3SiMe3 for referencing in 13C spectra. 
 
All NMR Data are found in Appendix A 
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2.1.3.2 Electrospray Ionization-Mass Spectroscopy (ESI-MS) 
 
Low-resolution mass spectra were recorded on a Thermo Finnigan LXQ Mass Spectrometer. The 
polarity used was positive. The ionisation method used was Electrospray Ionization (ESI). 
Samples were prepared in de-ionised water or methanol mixtures. Elution was performed using 
either methanol in 0.1 % formic acid or a 50:50 methanol:water mixture in 0.1 % formic acid. 
The data obtained were processed using the Xcalibur Version 2.0.7 software, and are quoted as 
m/z values. 
 
All MS Data are found in Appendix B 
 
2.1.3.3  Fourier Transform Infrared Spectroscopy (FTIR) 
Samples were recorded on a Bruker TENSOR 27 Standard System FT-IR spectrometer and the 
measurements obtained were processed using the OPUS v5.5 software.  Samples of either solid 
or liquid were analyzed with air as a background on a diamond sampler.  The signal resolution 
was 4 cm-1 and the scan range from 400-4000 cm-1.     
All FTIR Data are found in Appendix C 
 
2.1.3.4   Melting Point Determination 
 
The melting point was determined using a JM instruments (model 628) standard laboratory 
melting point apparatus equipped with a microscope and a heating stage. 
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2.1.3.5       Solid State Chemistry of Polyazamacrocycles and their Complexes with       
      Lanthanides 
2.1.3.5.1 Crystal Growth Techniques Employed 
 
Crystal growth involves a phase change from liquid or gas to a solid, such as the precipitation of 
a solute from a solution or the formation of a solid from condensation of a gas.  This occurs 
through two processes, nucleation and growth, which are favored by using supersaturated 
solutions and/or temperature gradients.  When several molecules in solution approach each other 
in appropriate orientations, they form a submicroscopic nucleus upon which additional molecules 
may adsorb. Continued adsorption results in an ordered extended crystal structure.  The 
probability that a crystal will form depends on the nature and concentration of the solute (i.e. the 
distance between solutes), as well as solvent conditions such as temperature, pH, ionic strength, 
viscosity, polarity, etc.  To grow single crystals suitable for X-ray diffraction analysis, relatively 
few nuclei should be formed rather than multiple sites of nucleation that will yield 
microcrystalline solids.   
 
High quality crystals may only be obtained when the rate of deposition onto a nucleation site is 
kept at a rate sufficiently low to allow oriented growth.  A high growth rate may lead to defects 
in the crystal forming multibranched or dendritic crystallites through rapid growth in too many 
directions.  As molecules in the gas phase or solvent interact with the surface of the growing 
crystal, they may or may not be preferentially adsorbed.  That is, nucleation sites that contains 
steps, ledges, or surface depressions is more easily able to allow more efficient crystal growth 
due to the prolonged interaction of suspended molecules with the surface.  
  
Experimentally, the successful growth of single crystals on the order of 0.01-0.1 mm is not 
trivial.  In this work crystals were mainly grown by dissolving the solid target compounds into a 
minimal amount of suitable solvent (acetonitrile, ethanol) that was then allowed to slowly 
evaporate at room temperature to acquire good quality single crystals.  In some cases however, 
single crystal growth was achieved by spiking the solution with a type of solvent that the solid 
does not necessarily dissolve in (e.g. diethyl ether).  This was done to force the single crystals 
out of solution. 
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2.1.3.5.2 Solving Crystal Structures 
 
Single-crystal determination for compounds namely polyazamacrocycles and their corresponding 
lanthanide complexes were carried out using a Bruker SMART Apex II diffractometer at 173 K 
using graphite-monochromated CuKα radiation.258   The data was corrected for Lorentz and 
polarization259 effects and absorption using SADABS.260  The structure was solved by use of 
Patterson mapping.  Least squares refinement on F2 was used for all reflections.  Structure 
solution, refinement and the calculation of derived results was performed using the SHELXTL261 
software package.  The non-hydrogen atoms were refined anisotropically.  The hydrogen atoms 
were located and then placed in theotretical positions.  Images were created using the ORTEP IV 
program obtained from the Cambridge Structural Database (CSD).262 
 
All X-ray crystallographic Data are found in Appendix G (Data Disc) 
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2.2 Synthetic Aspects and Strategies of Designing Lanthanide Complexes under Standard 
Laboratory Conditions 
 
H2O in
H2O out
CaCl2 Drying Tube
Set Temp RPM
Thermometer
Anhydrous Solvent
Initially Flushed with Ar(g)
Remove stopper and 
equip with powder 
funnel to add reactants
 
Figure 2.1:  General reaction set up for all synthetic reactions in this work. 
 
Without resorting to longer acyclic syntheses or high dilution techniques, the six membered 
cyclohexyl derivatives were viably obtained using a direct alkylation strategy.  The general 
experimental set up for all synthetic reactions in this work is illustrated in Figure 2.1.  It was 
possible to synthesize the following ligands shown earlier in Figure 1.24, and their 
corresponding europium and gadolinium complexes.  DTMA was chosen as a target ligand 
merely for comparative purposes, to observe the effective differences between both moieties. 
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The generalized synthetic strategy is summarized in Figure 2.2 below.   
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(i)Dry EtOH, 80 °C, 48 hrs. (ii)Dry CH3CN, 90 °C, N-methyl-chloroacetamide, CsCO3, 10 hrs. 
(iii)Dry CH3CN, 90 °C, Di-methyl-chloroacetamide, CsCO3, 10 hrs. (iv) Dry EtOH, 90 °C, N-
methyl-chloroacetamide, K2CO3, 48 hrs.(v) Dry CH3CN, 90 °C, Europium Triflate, 90 hrs. (vi) 
Dry CH3CN, 90 °C, Gadolinium Triflate, 90 hrs. 
 
Figure 2.2:  Generalized reaction conditions toward respective target molecules. 
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2.2.1 Synthesis of Precursor:  Preparation of N-methyl-chloroacetamide 
 
O
Cl Cl
CH3NH2.HCl
NaOH
DCM O
Cl NHCH3  
 
Figure 2.3:  Preparation of N-methyl-chloroacetamide. 
 
The reaction scheme shown in Figure 2.3 describes the synthesis of α-chloroamide and was 
originally based on work performed by Parker et. al. from chloroacetyl chloride with the 
appropriate amine.263  NaOH (14.5 g, 3.63×10-1 mol) was in dissolved 20 ml distilled water, 
allowing the solution to cool to room temperature before adding 100 ml of dichloromethane.  
This mixture was then placed in an ice/ethanol-bath at approx 5 °C.  Methylamine hydrochloride 
(11.9 g, 3.96×10-1 mol) was then added to the cooled mixture with continuous stirring.  
Chloroacetyl chloride (20.8 g, 1.86×10-1 mol) dissolved in 40 ml of dichloromethane was added 
in a dropwise fashion to the cooled mixture.  The solution was allowed to stir for a further 2 
hours.  The organic layer was removed and then washed with deionised water.  The organic 
extracts were further dried with drying agent (K2CO3) and collected.  The solvent was removed 
under reduced pressure to afford the product, N-methyl-chloroacetamide (9.54 g, 8.91×10-2 mol) 
as a crystalline solid in 48% yield.   
 
Empirical Formula: C3H6ClNO   
1H NMR (CDCl3): δ 6.71 (s, NH, 1H), δ 4.06 (s, CH2, 2H), δ 2.91-2.80 (d, CH3, 3H). 
13C NMR (CDCl3): δ 166.45 (s, CO, 1C), δ 42.53 (s, CH2, 1C), δ 26.46 (s, CH3, 1C). 
FTIR: C-Clstr: (medium, sharp) 758.09cm-1, C-Hbend (strong, sharp) 1262 - 1410cm-1, C=Ostr: 
(strong, sharp) 1650.92cm-1, N-Hstr: (strong, broad) 3322.01cm-1, C-Hstr: (weak, broad) 2800-
3100cm-1. 
Melting point (m.p) 35-37 °C 
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2.2.2 Preparation of Di-methyl-chloroacetamide 
 
O
Cl Cl
(CH3)2NH.HCl
NaOH
DCM O
Cl N(CH3)2  
 
Figure 2.4:  Preparation of Di-methyl-chloroacetamide. 
 
The reaction scheme depicted in Figure 2.4 is based on the preceding reaction and has been 
modified accordingly since an oil product was isolated instead of a solid.  Similarly, NaOH (7.15 
g, 1.79×10-1 mol) was dissolved in 10 ml distilled water, allowing the solution to cool to room 
temperature before adding 50 ml of dichloromethane.  This mixture was then placed in an 
ice/ethanol-bath at approx 5 °C.  Dimethylamine hydrochloride (15.26 g, 1.35×10-1 mol) was 
then added to the cooled mixture with continuous stirring.  Chloroacetyl chloride (10.13 g, 
8.96×10-2 mol) dissolved in 20 ml of dichloromethane was added in a dropwise fashion to the 
cooled mixture.  The solution was allowed to stir for a further 2 hours.  The organic layer was 
removed and then washed with deionised water.  The organic extracts were further dried with 
drying agent (K2CO3) and collected.  The solvent was removed of under reduced pressure to 
afford the product, Di-methyl-chloroacetamide (9.54 g, 8.91×10-2 mol) as a colorless oil in 66% 
yield.   
 
Empirical Formula: C4H8ClNO 
1H NMR (CDCl3): δ 4.10 (s, CH2, 2H), δ 3.11 (s, CH3, 3H), δ 2.99 (s, CH3, 3H). 
13C NMR (CDCl3): δ 166.35 (s, CO, 1C), δ 41.08 (s, CH2, 1C), δ 37.47 (s, CH3, 1C), δ 35.79 (s, 
CH3, 1C). 
FTIR: C-Clstr: (strong, sharp) 756.72cm-1, C=Ostr: (strong, sharp), 1639.98cm-1, 2959.24cm-1 C-
Hstr: (medium, sharp), 1263.04- 1547.41cm-1, C-Hbend (strong, sharp), N-Hstr 3006.96 cm-1. 
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2.2.2.1 Synthesis of β-amino alcohol Intermediate: 1-(2-Hydoxycyclohexyl)-1,4,7,10-
tetraazacyclodecane (1) 
 
NH HN
HNNH
O NH N
HNNH
OH
Ethanol
80 oC
1  
Figure 2.5:  Preparation of 1-(2-Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1). 
 
The reaction scheme presented in Figure 2.5 is based on work originally performed in our 
laboratory by de Sousa et al.264 and has been optimised in this work.  The macrocycle, cyclen 
(2.3 g, 1.34×10-2 mol) was dissolved in 100 ml of anhydrous ethanol by stirring.  Cyclohexene 
oxide (1.1 g, 1.12×10-2 mol) was added to this mixture and refluxed for 48 hrs at 80 oC under a 
CaCl2 drying tube.  On removing the solvent, a pale yellow oil was obtained.  This was placed 
under reduced pressure affording a white amorphous solid.  Trituration with minimal volume (10 
ml) of cold acetone for 1 hr afforded a solid precipitate.  The precipitate was filtered and purified 
by crystallization from hot ethyl acetate.  The re-crystallization procedure was repeated until 
only the mono-substituted product, 1-(2-Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane 
(0.9828 g, 3.64×10-3 mol) was isolated in 27% yield. 
 
 
Empirical Formula:  C14H30N4O 
1H NMR (D2O): δ 3.40-3.60 (m, CH, 1H), δ 2.90-2.40 (m, Hcyclen, 16H), δ 2.40-2.30 (m, CH2, 
1H), δ 2.10-1.90 (t, CH2, 1H), δ1.90-1.80 (t, CH2, 1H), δ 1.80-1.60 (m, CH2, 2H). 
13C NMR (D2O): δ 70.26 (s, CO, 1C), δ 64.84 (s, CH, 1C), δ 47.24 (s, CH2, 4C), 45.48 (s, CH2, 
2C), δ 44.32 (s, CH2, 2C), δ 33.77 (s, CH2, 1C), δ 24.92 (s, CH2, 1C), δ 24.06 (s, CH2, 1C), δ 
23.35 (s, CH2, 1C). 
ESI-MS (+): [M + H]+ = m/z (271) and [M + Na]+ = m/z (293).   
m/e (relative intensity): 270.24 (100.0%), 271.25 (16.1%), 271.24 (1.5%), 272.25 (1.4%). 
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FTIR: N-Hstr: (weak, broad) 2801.59-2930.50cm-1, C-Hstr: (strong, sharp) 2946.57cm-1, O-Hstr: 
(medium, broad) 3280.46cm-1, C-Hbend: 1243–1410.71cm-1 (strong, sharp). 
Melting point (m.p) 144-146 °C 
 
 
 
2.2.3  Synthesis of N-substituted Cyclen based Ligands 
2.2.3.1  Preparation of 1,4,7-tris[N-methylcarbomylmethyl]-10-2(hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane (2) 
 
 CH3CN 
90 oC
NH
NH
HN
N OH Cl NHCH3
O
KI, Cs2CO3
N
N
N
N OH
O
MeHN
O
MeHN
O NHMe24 hrs 2  
Figure 2.6:  Preparation of 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)- 
                     1,4,7,10-teraazacyclododecan (2). 
 
Although two different methodologies were utilized to synthesize the above target 2 using DMF 
and CH3CN as solvents, purification was easier using CH3CN.  The reaction scheme shown 
above in Figure 2.6 is based on work originally performed by de Tsukube et al.8 and has been 
modified in this work.  A solution of 1-(2-Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane or 
Cy-cyclen (0.3032 g , 1.12×10-3 mol), N-methyl chloroacetamide (0.4025 g, 3.76×10-3 mol), KI 
(0.6646 g, 4.01×10-3 mol) and CsCO3 (1.8185 g, 5.58×10-3 mol) was refluxed in dry CH3CN (50 
ml) for 24 hrs and then filtered to remove the excess metal salts.  Acetonitrile was removed and 
the residue washed with diethyl ether to remove any unreacted Cy-cyclen.  The preparation was 
further dried under reduced pressure.  The product, 1,4,7-tris[N-methylcarbomylmethyl]-10-2-
(hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (0.5402 g, 1.12×10-3 mol) was isolated as a 
white powder in 99 % yield. 
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Empirical Formula: C23H45N7O4 
1H NMR (CDCl3): δ 3.65-4.00 (m, CH2, 4H), δ 4.14-4.25 (m, CH2, 1H), δ 4.25-4.38 (m, CH2, 
1H), δ 4.48-4.68 (m, CH2, 2H), δ 5.10-5.30 (m, CH3, 9H), δ 5.30-5.51 (m, CH2, 6H), 5.51-6.05 
(m, CH2, 14H), 6.05-6.40 (m, CH2, 5H), 6.41-6.61 (m, CH, 2H). 
13C NMR (CDCl3): δ 175.45 (s, CO, 1C), δ 174.19 (s, CO, 1C), δ 167.87 (s, CO, 1C), δ 68.33 (s, 
CH, 1C), δ 63.88 (s, CH, 1C), δ 58.70 (s, CH2, 2C), δ 57.64 (s, CH2, 4C), δ 51.02 (s, CH2, 2C), δ 
49.15 (s, CH2, 2C), δ 33.08 (s, CH2, 1C), δ 25.74 (s, CH2, 1C), δ 24.25 (s, CH2, 1C), δ 23.46 (s, 
CH2, 1C), δ 21.74 (s, CH3, 3C). 
ESI-MS (+): [M + H]+ = m/z (484), [M + Na]+ = m/z (506), [M + K]+ = m/z (522) and [M + Cs]+ 
= m/z (616)   
m/e (relative intensity for free ligand): 483.35 (100.0%), 484.36 (26.4%), 485.36 (4.2%), 484.35 
(2.6%). 
m/e (relative intensity for Na complex): 506.343 (100.0%), 507.346 (25.6%), 508.350 (3.1%), 
507.340 (2.6%). 
m/e (relative intensity for K complex): 522.317 (100.0%), 523.320 (25.6%), 524.315 (7.2%), 
524.324 (3.1%), 523.314 (2.6%), 525.318 (1.9%). 
m/e (relative intensity for Cs complex): 616.259 (100.0%), 617.262 (25.6%), 618.265 (3.1%), 
617.256 (2.6%). 
FTIR: C-Hbend (medium, sharp) 1439.83-1, C=Ostr :(strong, sharp) 1670.17cm-1, N-Hstr: (strong, 
broad) 2832.41-1, C-Hstr: (weak, broad) 2800-3100cm-1 O-Hstr: (strong, broad) 3253.24cm-1. 
Melting point (m.p) 192-194 °C 
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2.2.3.2 Preparation of 1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane (3) 
 
 CH3CN 
90 oC
NH
NH
HN
N OH Cl NMe2
O
Cs2CO3
N
N
N
N OH
O
Me2N
O
Me2N
O NMe210 hrs 3  
Figure 2.7:  Reaction scheme showing preparation of 1,4,7-tris[N,N-dimethylcarbamylmethyl]-  
                     10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (3). 
 
The reaction scheme shown above in Figure 2.7 is based on the preceding reactions to form 2 
and has been modified accordingly to achieve the target 3.  A solution of 1-(2-
Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane (0.3412 g, 1.26 mmol), Di-methyl 
chloroacetamide (0.7804 g, 6.42 mmol) and CsCO3 (6.0823 g, 18.67 mmol) was refluxed in dry 
acetonitrile (50 ml) for 10 hrs and then filtered to remove the excess CsCO3.  Acetonitrile was 
removed and the preparation was further dried under reduced pressure.  The sample was 
completely dissolved in distilled water and the pH adjusted to <1 using concentrated 
hydrochloric acid.  The solution was placed in an extracting funnel and extracted with 
dichloromethane (3 × 30 ml) to remove any excess chloroacetamides.  The aqueous fraction was 
then frozen using liquid nitrogen and lyophilized to render the hydrochloride salt of the target 3, 
a light yellow powder in 97 % yield (0.8185 g, 1.22 mmol). 
 
Empirical Formula: C26H51N7O4  
1H NMR (CDCl3): δ 3.60-4.00 (m, CH2, 4H), δ 4.10-4.40 (m, CH2, 2H), δ 4.45-4.70 (m, CH, 
1H), δ 5.25-5.35 (m, CH2, 3H), δ 5.35-6.35 (m, CH3/CH2, 36H), δ 6.40-6.90 (m, CH2, 4H). 
FTIR: C-Hbend (medium, sharp) 1402.87cm-1,C=Ostr :(strong, sharp) 1627.94 m-1, N-Hstr: (strong, 
broad) 2939.51cm-1, O-Hstr: (strong, broad) 3349.30cm-1. 
ESI-MS (+): [M + H]+ = m/z (527) and [M + Na]+ = m/z (549).   
m/e (relative intensity): 525.40 (100.0%), 526.40 (31.7%), 527.41 (4.3%), 527.40 (1.6%). 
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2.2.3.3  Preparation of 1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10   
             tetraazacyclodecane (4) 
EtOH 
90 oC 
K2CO3 
48 hrs
NH
NH
HN
HN
Cl NHCH3
O
N
N
N
N
O
MeHN
O
MeHN
O NHMe
NHMe
O
4
 
Figure 2.8:  Preparation of 1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetra-  
                     azacyclodecane (4). 
 
This reaction scheme shown above in Figure 2.8 was based on earlier publications of Aime et 
al.146 and Parker et al.265  Cyclen (0.200 g, 7.40×10-4 mol) and potassium carbonate (0.6610 g, 
4.79×10-4 mol) was placed in a two neck round-bottom flask under argon.  To this, N-methyl 
chloro-acetamide (0.5500 g, 5.14×10-3 mol) was added followed by 20 ml of dried ethanol 
transferred using a gas tight syringe.  (Care was taken to make sure that during the transfer 
process, the flask was kept under argon atmosphere).  The mixture was heated to reflux for 48 
hours at 90 °C.  Upon cooling excess potassium carbonate was filtered off and the solvent was 
removed under reduced pressure. The residue was taken up in hot ethanol, cooled and filtered.  
The target 4 namely 1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (or 
simply DTMA) was further dried under reduced pressure and isolated in 100 % yield (0.3382 g, 
7.41×10-4 mol). 
 
Empirical Formula: C20H40N8O4 
1H NMR (D2O): δ 2.65-2.75 (s, CH2, 16H), δ 2.75-2.85 (s, CH3, 12H), δ 3.05-3.25 (s, CH2, 8H).  
13C NMR (D2O): δ 177.19 (s, CO, 1C), δ 60.34 (CH2 methylene), δ 54.59 (CH2 cyclen ring), δ 
28.20 (CH3 acetamide arms). 
ESI-MS (+): [M + H]+ = m/z (457), [M + Na]+ = m/z (479) and [M + K]+ = m/z (495).   
m/e (relative intensity of free ligand): 456.32 (100.0%), 457.32 (23.0%), 458.32 (3.9%), 457.31 
(3.0%). 
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m/e (relative intensity of Na complex): 479.307 (100.0%), 480.310 (22.2%), 480.304 (3.0%), 
481.314 (2.4%). 
m/e (relative intensity of K complex): 495.281 (100.0%), 496.284 (22.2%), 497.279 (7.2%), 
496.278 (3.0%), 497.288 (2.4%), 498.282 (1.6%) 
FTIR: C-Hbend (medium, sharp) 1406.83cm-1,C=Ostr : (strong, sharp) 1670.02cm-1, N-Hstr: 
(strong, broad) 2864.65 cm-1, O-Hstr: (strong, broad) 3345.68cm-1. 
 Melting point (m.p) 222-224 °C 
 
 
 
2.2.4  Synthesis of Eu3+ and Gd3+ Macrocyclic Complexes  
2.2.4.1 Metal Complexation of 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-
hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane with Europium 
 
Europium Triflate
90 oC
 90 hrs
 CH3CN
5
N
N
N
N
O
MeHN
O
MeHN
O NHMe
N
N
N
N
O
MeHN
O
MeHN
O NHMe
Eu
OHOH
 
Figure 2.9:  Preparation of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-  
                       hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5). 
 
This ligand complexation reaction scheme shown above in Figure 2.9 was based on work 
performed by Parker and coworkers.265  Europium triflate (0.4141 g, 6.90×10-4 mol)  was 
dissolved in dry acetonitrile to give a 0.02 M solution.  1-(2-hydroxycyclohexyl)-4,7,10-tris-
(acetamide)-1,4,7,10-tetraazacyclodecane (0.300 g, 6.21×10-4 mol) was dissolved in dry 
acetonitrile to give a 0.03 M solution.  This was added to the triflate solution via a dropping 
funnel under argon. The solutions were allowed to react in a 1.1:1 molar ratio.  The mixture was 
refluxed at 90 °C for 90 hrs under a CaCl2 drying tube.  Upon completion of the reaction, the 
solvent was removed to dryness under reduced pressure.  The crude product was redissolved in a 
minimal amount of dry acetonitrile to which diethyl ether was added dropwise until the solution 
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became turbid.  Refrigeration overnight afforded Europium-1,4,7-tris[N-methylcarbamylmethyl]-
10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (0.6284 g, 5.81×10-4 mol) and was 
isolated in 94 % yield as a triflate salt. 
 
1H NMR (D2O): The spectrum showed the presence of the paramagnetic center characteristically 
indicated by several broad resonances appearing over a large ppm range as in the case of 
compound 5 these appeared at 27.785, 25.484, 22.741, 19.378 (axial protons on cyclen ring), 
10.264 to -6.150 (equatorial protons on the cyclen ring and CH3 protons of pendant arms) -6.150 
to -16.768 (CH2 protons on pendant arms).    
FTIR: C-Hbend (weak, sharp) 1407.43 cm-1, C=Ostr :(strong, sharp) 1631.83 cm-1, N-Hstr: (weak, 
broad) 2949.60 cm-1, C-Hstr: (weak, broad) 2800-3100 cm-1 O-Hstr: (weak, broad) 3293.37 cm-1. 
ESI-MS (+): [M + 2H]2+ = m/z (318), [M + 1TfO]+ = m/z (784),  [M + 2TfO]+ = m/z (934).  
m/e (relative intensity): 785.23 (100.0%), 783.23 (86.8%), 786.23 (27.5%), 784.23 (24.0%), 
787.23 (5.8%), 787.22 (4.3%), 785.22 (3.9%), 786.22 (3.6%), 784.22 (2.9%), 788.23 (1.7%) 
 
 
  
2.2.4.2  Metal Complexation of 1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-   
 hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane with Europium 
 
Europium Triflate
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Figure 2.10:  Reaction scheme showing preparation of Europium-1,4,7-tris[N,N-  
                      dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10- 
                      tetraazacyclododecane (7). 
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The complexation reaction scheme shown in Figure 2.10 was based on work performed by 
Parker and co-workers265 as mentioned earlier.  Europium triflate (0.3485 g, 58 mmol) was 
dissolved in dry acetonitrile to give a 0.02 M solution.  The hydrochloride salt of 1,4,7-tris[N,N-
dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (0.3055 g, 
0.45 mmol) ( 3) was dissolved in dry acetonitrile to give a 0.03 M solution.  This was added to 
the triflate solution via a dropping funnel under argon. The solutions were allowed to react in a 
1.3:1 molar ratio.  The mixture was refluxed at 90 °C for 90 hrs under a CaCl2 drying tube.  
Upon completion of the reaction, the solvent was removed to dryness under reduced pressure.  
The crude product was redissolved in a minimal amount of dry acetonitrile to which diethyl ether 
was added dropwise until the solution became turbid.  The flask was stopped and placed in the 
refrigerator overnight and allowed to crystallise.  No crystallization occurred and the product was 
redissolved in acetonitrile.  Further attempts to crystallize using diethyl ether and benzene were 
unsuccessful.  The solvent was removed and further dried under reduced pressure.  A minimal 
amount of water (5 ml) was used to redissolved the product and 20% NH4OH was added 
dropwise until the solution reached a pH of 10.  The solution was filtered using a celite plug to 
remove the excess europium as Eu(OH)3.  The filtrate was further frozen using liquid nitrogen 
and lyophilised to give a yellow oily resin. The Europium-1,4,7-tris[N,N-
dimethylcarbamylmethyl]-10-(2-hydroxy-cyclohexyl)-1,4,7,10-tetraazacyclododecane product   
(7) isolated  in 98 % yield (0.3003 g, 0.45 mmol). 
 
1H NMR (D2O): The spectrum showed the presence of the paramagnetic center characteristically 
indicated by several broad resonances appearing over a large ppm range as in the case of 
compound 7 these appeared at 32.433, 29.149, 27.248, 22.870, (axial protons on cyclen ring), 
12.443 to -9.217, (equatorial protons on the cyclen ring and CH3 protons of pendant arms) -9.217 
to -18.146, (CH2 protons on pendant arms).    
ESI-MS (+): [M + 2H]2+ = m/z (414), [M + 2TfO]+ = m/z (976),  [M + 2TfO]+ = m/z (976).  
m/e (relative intensity): 827.27 (100.0%), 825.27 (87.2%), 828.28 (30.5%), 826.28 (27.1%), 
829.28 (6.1%), 827.28 (5.3%), 829.27 (5.3%), 828.27 (4.5%), 826.27 (3.0%), 830.27 (1.4%), 
830.28 (1.0%). 
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2.2.4.3  Metal Complexation of 1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-  
 tetraazacyclodecane with Europium 
Europium Triflate
90 oC
 90 hrs
 CH3CN
9
N
N
N
N
O
MeHN
O
MeHN
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O
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O NHMe
NHMe
O Eu
 
Figure 2.11:  Preparation of Europium-1,4,7,10-Tetrakis-(methylcarbamylmethyl)-1,4,7,10- 
                       tetraazacyclodecane (9). 
 
The complexation reaction scheme shown in Figure 2.11 toward the syhthesis of molecule 9 was 
successfully accomplished.  Europium triflate (0.3610 g, 6.02×10-4 mol) was dissolved in dry 
acetonitrile to give a 0.02 M solution.  (0.207 g, 4.54×10-4 mol) DTMA was also dissolved in dry 
acetonitrile to give a 0.03 M solution.  The europium triflate and DTMA react in a 1.3:1 molar 
ratio.  The triflate solution was placed in a flask and the DTMA solution added dropwise via a 
dropping funnel under argon.  The solution was then refluxed at 90 °C for 90 hrs under a CaCl2 
drying tube.  Upon completion of the reaction, the acetonitrile was removed under reduced 
pressure.  The crude product was redissolved in a minimal amount of dry acetonitrile (5 ml) to 
which diethyl ether was added dropwise until the solution became turbid.  Refrigeration 
overnight afforded the product,  9, (0.4747 g, 4.49×10-4 mol) in 99% yield. 
 
1H NMR (D2O): The spectrum showed the presence of the paramagnetic center characteristically 
indicated by several broad resonances appearing over a large ppm range as in the case of 
compound 9 these appeared at 26.908 (axial protons on cyclen ring), 7.00 to 0, (equatorial 
protons on the cyclen ring and CH3 protons of pendant arms) -15.00 to 0, (CH2 protons on 
pendant arm).    
FTIR: C-Hbend (weak, broad) 1459.94cm-1, N-Hstr: (weak, broad) 2873.21cm-1, O-Hstr: (weak, 
broad) 3341.11cm-1. 
ESI-MS (+): [M - H]+ = m/z (607), [M + 1TfO]+ = m/z (757),  [M + 2TfO]+ = m/z (907) 
 | P a g e  
 
 
99
m/e (relative intensity): 758.19 (100.0%), 756.19 (89.7%), 759.19 (27.9%), 757.19 (24.6%), 
760.19 (6.8%), 758.18 (4.0%), 760.20 (2.8%), 758.20 (2.5%), 761.19 (1.2%), 759.20 (1.1%) 
Melting point (m.p)  264-266 °C 
 
 
 
2.2.4.4 Metal Complexation 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane with Gadolinium 
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Figure 2.12:  Preparation of Gadolinium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-  
                       hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (6). 
 
The gadolinmium complexation reaction scheme shown in Figure 2.12 adopts the same protocol 
as for europium complexation.  Gadolinium triflate (0.4587 g, 7.58×10-4 mol) was dissolved in 
dry acetonitrile to give a 0.02 M solution. The hydrochloride salt of 1,4,7-tris[N-
methylcarbomylmethyl]-10-2-(hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (0.3243g, 
6.71×10-4 mol) was also dissolved in dry acetonitrile to give a 0.03 M solution.  The gadolinium 
triflate and ligand react in a 1.1:1 molar ratio.  The triflate solution was placed in a flask and the 
ligand added dropwise via a dropping funnel under argon.  The solution was then refluxed at 90 
°C for 90 hrs under a CaCl2 drying tube.  Upon completion of the reaction, the acetonitrile was 
removed under reduced pressure.  The crude product was redissolved in a minimal amount of dry 
acetonitrile to which diethyl ether was added dropwise until the solution became turbid.  
Refrigeration overnight afforded 6 (0.7341 g, 6.65×10-4 mol), which is a triflate salt in 99% 
yield. 
 
ESI-MS (+): [M + 2H]2+ = m/z (395), [M + 1TfO]+ = m/z (789),  [M + 2TfO]+ = m/z (939)  
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2.2.4.5  Metal Complexation of 1-(2-hydroxycyclohexyl)-4,7,10-tris-(N’-N’-dimethyl-
acetamide)–1,4,7,10-tetra-azacyclodecane with Gadolinium 
 
Gadolinium Triflate
90 oC
 90 hrs
 CH3CN
8
N
N
N
N
O
Me2N
O
Me2N
O NMe2
N
N
N
N
O
Me2N
O
Me2N
O NMe2
Gd
OHOH
 
 
Figure 2.13:  Preparation of Gadolinium-11,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-  
                       hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (8). 
 
Similarly, the gadolinmium complexation reaction scheme shown in Figure 2.13 adopts the same 
protocol as for europium complexation.  Gadolinium triflate (0.4851 g, 0.80 mmol) was 
dissolved in dry acetonitrile to give a 0.02 M solution.  The hydrochloride salt of 1,4,7-tris[N,N-
dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (0.2960 g, 
0.47 mmol) was also dissolved in dry acetonitrile to give a 0.03 M solution.  The gadolinium 
triflate and ligand react in a 1.1:1 molar ratio.  The triflate solution was placed in a flask and the 
ligand added dropwise via a dropping funnel under argon.  The solution was then refluxed at 90 
°C for 90 hrs under a CaCl2 drying tube.  Upon completion of the reaction, the acetonitrile was 
removed under reduced pressure.  The crude product was redissolved in a minimal amount of dry 
acetonitrile to which diethyl ether was added dropwise until the solution became turbid.  The 
flask was stopped and placed in the refrigerator overnight and allowed to crystallize.  No 
crystallization occurred and the product was redissolved in acetonitrile.  Further attempts to 
crystallize using diethyl ether and benzene were unsuccessful.  The solvent was removed and 
further dried under reduced pressure.  A minimal amount of water (5 ml) was used to redissolved 
the product and 20% NH4OH was added dropwise until the solution reached a pH of 8.6.  The 
solution was filtered through a celite plug to remove the excess gadolinium as Gd(OH)3.  The 
product, 8, was isolated as a yellow amorphous solid in 82 % yield (0.2466 g, 0.385 mmol). 
 
ESI-MS (+):Mol. Wt.: 682.98 g.mol-1,  [M + 2TfO]+ = m/z (982). 
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m/e (relative intensity): 981.23 (100.0%), 979.23 (91.4%), 983.23 (81.5%), 980.26 (55.7%), 
978.23 (55.2%), 982.23 (36.7%), 984.23 (30.5%), 980.23 (29.1%), 981.26 (19.7%), 985.23 
(8.6%), 983.22 (8.5%), 977.23 (7.8%), 980.22 (6.8%), 981.22 (6.7%), 982.26 (5.7%), 985.24 
(5.7%), 983.24 (4.8%), 982.27 (3.9%), 986.23 (2.5%), 979.22 (2.1%), 984.24 (2.0%), 983.26 
(1.7%), 986.24 (1.1%) 
 
 
2.3        Solution Chemistry of Complexes with Lanthanides 
2.3.1  General Apparatus and Materials 
2.3.1.1  pH Measurements and Calibration of pH meter 
 
pH measurements were performed using a Metrohm 813 pH meter and a 6.0234 combination 
glass electrode.  The instrument was calibrated against the standard N.I.S.T buffers pH 4 and pH 
7 obtained from Sigma Aldrich at 25.0 °C.  After calibration, the pH was tested with the pH 9 
standard buffer to observe accuracy.   
 
 
2.3.1.2   Preparation of Standard Solutions 
 
A 0.1 M standard NaOH ampoule (purchased from VWR suppliers) was emptied into a dry clean 
1 L volumetric flask and made up to mark.  This standard solution was further used in 
preparation of 0.05 M NaOH standard solution by transferring 500 ml into a 1 L volumetric 
flask.  Similarly, a 0.1 M standard HNO3 ampoule (also purchased from VBH) was emptied into 
a dry clean 1 L volumetric flask and made up to mark.  This standard solution was further used in 
preparation of 0.05 M HNO3 standard solution by transferring 500 ml into a 1 L volumetric flask.  
These solutions were standardized by titrating against a known concentration of potassium 
hydrogen phthalate (KHP) with NaOH and then with HNO3 with NaOH as a titrant.  Each 
standard solution used in this study was prepared such that the ionic strength was 0.1 M; for this 
an appropriate amount of anhydrous NaNO3 was used for ionic strength adjustment. The KHP 
solution was used to determine the concentrations of other standard solutions (where indicated) 
by means of an acid-base titration, using phenolphthalein as an indicator. 
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2.3.2 Luminescence Studies and UV-visible Studies: Determination of Spectroscopic pKas 
of Europium Complexes in Multicomponent Buffer Solutions (MCB) 
 
Luminescence measurements for the three target Eu3+ complexes were recorded using a Varian 
Cary Eclipse Fluorescence Spectrophotometer with software v.5.1 using Hellma quartz 
SUPRASIL® cells (type: 111-QS, path length = 10 mm).  The excitation wavelength to be used 
for the luminescence study was determined from UV-Visible absorbance spectra, obtained using 
a Varian Cary 3E UV-Visible Spectrophotometer, using Hellma quartz SUPRASIL® cells (type: 
110-QS, path length = 10 mm).  Combined luminescence-absorption pH titrations were carried 
on solutions with absorbances < 0.3 at wavelengths ≥ λex to avoid errors due to the inner filter 
effect.  Luminescence spectra for the complexes were obtained by exciting at 240 nm.  Points 
were recorded at 1 nm intervals with 0.1 s integration time.  The pH was raised accordingly in 
0.25 value increments across the pH range 2 to 12 using a solution of saturated NaOH and 2 ml 
aliquots of the solution were decanted at each pH and left to equilibrate for 96 hrs.   The 
phosphorescence emission and absorbance spectra were then recorded as a function of pH with 
approximately 35-40 points per titration.  Standard lease square techniques using suitable 
programs, namely CURVEFIT266 or in some cases Sigmaplot267 were used to determine 
deprotonation constants from absorbance and luminescence intensity data. 
 
The experimental data were fitted using a non-linear least-squares program employing a Newton-
Raphson procedure to a binding isotherm (Equations 2.1 to 2.4), which is relevant when one to 
four acid/base equilibria are present. 
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IT =  I1*[H+] + I2*[H+]*K1            (2.1) 
 
          K1 + [H+] 
 
 
IT =  I1*[H+]2 + I2*[H+]*K1 + I3*K1*K2           (2.2) 
 
       K1*K2 + [H+]*K1+ [H+]2 
 
 
IT = I1*[H+]3 + I2*[H+]2*K1 + I3*[H+]*K1*K2 + I4*K1*K2*K3          (2.3) 
 
                      
                 K1*K2*K3 + [H+]*K1*K2 + [H+]2*K1 + [H+]3 
 
 
IT =  I1*[H+]4 + I2*[H+]3*K1 + I3*[H+]2*K1*K2 + I4*[H+]*K1*K2*K3 + I5*K1*K2*K3*K4   (2.4) 
 
K1*K2*K3*K4 + [H+]*K1*K2*K3 + [H+]2*K1*K2 + [H+]3*K1 + [H+]4 
 
In Equations 2.1 to 2.4, IT is the intensity at the J = 0, 1, 2, 3, and 4 monitoring wavelength, K1 to 
K4 are the acid dissociation constants and Ii is the intensity of the ith species. 
 
 
2.3.2.1       Preparation of Europium Complexes in Multicomponent Buffer (MCB) with   
      Potassium  Hydrogen Phthalate (KHP)  
2.3.2.1.1 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane (5) 
 
Initially, the pH of deionised water (250-260 ml) was reduced using conc. HCl to a pH of < 2.  
This initial acidification of deionised water was carried out for all luminescence solution studies.   
Molecule 5 (0.1395 g, 5.15×10-4 M), KHP (0.05218 g, 1.02 mM), Tris (0.0712 g, 2.35 mM), 
CHES (0.0548 g, 1.06 mM), MES (0.0496g, 1.02 mM) and MOPS (0.0553 g, 1.06 mM) were 
carefully added to an empty A grade 250 ml volumetric flask  and filled up to mark with the 
aforementioned acidified solution.  For all luminescence studies that followed the weighing vials 
were re-measured to ensure the correct masses were indeed transferred and the pH was raised in 
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0.25 increments per pH unit using small amounts a saturated solution of NaOH to minimize the 
effects of dilution.   
 
2.3.2.1.2 Europium-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-    
tetraazacyclodecane (9)  
 
Molecule 9 (0.1368 g, 5.18×10-4 M), KHP (0.05218 g, 1.02 mM), Tris (0.0711 g, 2.35 mM), 
CHES (0.05461 g, 1.05 mM), MES (0.0499g, 1.02 mM), MOPS (0.0556 g, 1.06 mM) were 
carefully added to an empty A grade 250 ml volumetric flask and filled up to mark with acidified 
solution.  Solutions were made basic by addition of small amounts of saturated NaOH in 0.25 
increments per pH unit across the pH range 2 to 12.  
 
2.3.2.2       Preparation of Europium Complexes in MCB excluding KHP 
2.3.2.2.1  Preparation of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-  
                   hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5)  
 
Molecule 5 (0.1589 g, 5.87 ×10-4 M), Tris (0.0722 g, 2.38 mM), CHES (0.0564 g, 1.09 mM), 
MES (0.0531g, 1.09 mM), MOPS (0.0531 g, 1.08 mM) were carefully added to an empty A 
grade 250 ml volumetric flask  and filled to mark with the acidified solution.   Similarly, 
solutions were made basic by addition of small amounts of saturated NaOH in 0.25 increments 
per pH unit across the pH range 2 to 12.   
   
 
2.3.2.2.2   Preparation of Europium-1,4,7-tris[N’-N’-dimethylcarbamylmethyl]-10-(2-   
        hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (7) 
  
Molecule 7 (0.1650 g, 5.92×10-4 M), Tris (0.0721 g, 2.38 mM), CHES (0.0565 g, 1.10 mM), 
MES (0.0532g, 1.09 mM), MOPS (0.0533 g, 1.08 mM) were carefully added to an empty A 
grade 250 ml volumetric flask  and filled to mark with the acidified solution. Likewise, solutions 
were made basic by addition of small amounts of saturated NaOH in 0.25 increments per pH unit 
across the pH range 2 to 12.   
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2.3.2.2.3 Preparation of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-   
                  hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane Complex (5) in Water 
 
Molecule 5 (0.1611 g, 5.95 × 10-4 M) was carefully added to an empty A grade 250 ml 
volumetric flask and filled to mark with the acidified solution.   Again, solutions were made 
basic by addition of small amounts of saturated NaOH in 0.25 increments per pH unit across the 
pH range 2 to 12.   
 
All Spectroscopic Data are found in Appendix E (See Data Disc) 
 
2.3.3  Luminescent Lifetime Measurements on Europium-1,4,7-tris[N-methyl-  
carbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5):  
Determination of q  
 
Luminescence lifetime measurements were measured using a Varian Cary Eclipse Fluorescence 
Spectrophotometer with software v.5.1 using a Hellma quartz SUPRASIL® cells (type: 111-QS, 
path length = 10 mm) in lifetime scan mode using a Phosphorescence Life Time (Short) setting 
with an excitation wavelength,  λex = 240 nm and the emission of Eu3+ complexes were detected 
at 580 nm.    The complexes were thoroughly dried under vacuum for a day prior to the 
measurements.  The concentrations of the solutions were ca. 5.00 ×10-4 M to 6.00 ×10-4 M.  The 
lifetime data were processed using the build in software program on a Varian Cary Eclipse 
Fluorescence Spectrophotometer, by fitting the decay curves to a mono-exponential equation, I = 
I0(− tk ).  The natural log of the average intensity of the scans was plotted against time and the 
slope was used as the decay rate. This was performed in water and D2O.   All fits showed a 
standard deviation of < 10 %.  The revised Equation 3.1 and 3.2 was used to calculate q values 
at 580 nm.221-224,268  
 
q = 1.11(kH2O-kD2O-0.985) …………….....Equation 3.1
 
q = 1.11(kH2O-kD2O-0.965) …………….....Equation 3.2
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2.3.3.1.1 Preparation of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2- 
      hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5) Solutions in Water (H2O) 
2.3.3.1.2 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane (5) in MCB with KHP in Water  
 
The same solutions used for the luminescence studies in Sections 2.3.2.1.1 were utilized for this 
study.  Specifically, the pH of the solutions analyzed were: 4.710, 5.320, 7.423, 8.172, 8.710, 
9.382 and 9.484, respectively. 
 
2.3.3.1.3 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-
1,4,7,10-tetraazacyclododecane (5) in Water  
 
The same solutions used for the luminescence studies in Sections 2.3.2.3 were utilized for this 
study.  Specifically, the pH of the solutions analyzed were: 4.375, 4.795, 8.275 and 8.645, 
respectively. 
 
2.3.3.2       Preparation of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-    
      hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5) Solutions in Deuterated  
      Water (D2O) 
2.3.3.2.1 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
      1,4,7,10-tetraazacyclododecane (5) in Multi-component Buffer with KHP 
 
Similar to preparations in water, the pH of deuterated water (ca. 25-26 ml) was reduced using 
conc. DCl to a pH of < 2.  This initial acidification of deuterated water was carried out for all 
luminescence lifetime studies.  A six figure balance was utilized for the preparation of D2O 
solutions.    5 (0.016163 g, 5.97×10-4 M), KHP (0.005494 g, 1.08 mM), Tris (0.0070769 g, 2.34 
mM), CHES (0.005339 g, 1.03 mM), MES (0.005259g, 1.08 mM), MOPS (0.005317 g, 1.02 
mM) were carefully added to an empty A grade 25 ml volumetric flask  and filled up to mark 
with the aforementioned acidified D2O solution.  The weighing paper for each compound was re-
measured to ensure the correct masses were indeed transferred.  The pH was adjusted 
accordingly using sodium deuteroxide (NaOD) in a thermostated cell equipped with a stirrer bar 
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set at 25.0 ± 0.2°C.  The following pH solutions were analyzed:   4.695, 5.321, 7.424, 8.174, 
8.714, 9.382 and 9.485. 
 
2.3.3.2.2 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
1,4,7,10-tetraazacyclododecane (5) in Deuterated Water 
 
 5 (0.016292 g, 6.02 ×10-4 M), was carefully added to an empty A grade 25 ml volumetric flask 
and filled up to mark with the acidified D2O solution.  Again, the weighing paper for the 
complex was re-measured to ensure the correct mass was indeed transferred.  The pH was raised 
accordingly using sodium deuteroxide (NaOD) in a thermostated cell equipped with a stirrer bar 
set at 25.0 ± 0.2°C.  The following pH solutions were analyzed:   4.375, 4.799, 8.298 and 8.646, 
respectively. 
 
All Lifetime Data are found in Appendix F (See Data Disc) 
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2.3.4 Using Cyclic Voltammetry to Observe Solution Behavior of Europium Complexes 
 
Cyclic voltammetry (CV) was performed using an Autolab PGSTAT10 potentiostat (EcoChemie 
B. V., Netherlands) and contolled by GPES (General purpose electrochemical systems, GPES 
AUTOLAB software, v. 4.5, Eco EcoChemie B. V., Netherlands, 1997).  The scan rate was 
varied between 10 -1000 mV s-1.  A 5 mm diameter glassy carbon electrode was used as the 
working electrode.  The electrode surface was prepared on a regular basis by polishing it with a 6 
micron diamond paste followed by sonication.  Ag/AgCl was used as the reference electrodes 
and the Pt wire as the auxiliary electrode.  All CV experiments were performed on 5 cm3 of 
5.15×10-4 mol.dm-3 solution of the europium complexes in 1 ×10-3 mol.dm-3 (2 ×10-3 mol.dm-3 
for Tris) under nitrogen atmosphere in a thermostated cell (25.0 ± 0.2°C).269, 270   
 
 
2.3.4.1        Preparation of Multi-component Buffer with Europium Complexes 
2.3.4.1.1 Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
1,4,7,10-tetraazacyclododecane (5) 
 
The pH of the solutions were determined using a Metrohm 813 pH meter calibrated against 
standard buffer solutions and adjusted with HCl or NaOH, as appropriate.  Initially, the pH of 
deionised water (250-260 ml) was reduced using conc. HCl to a pH of < 2.  This initial 
acidification of deionised water was carried out for all cyclic voltammetry solution studies.     5 
(0.1395 g, 5.15×10-4 M), KHP (0.05218 g, 1.02 mM), Tris (0.0712 g, 2.35 mM), CHES (0.0548 
g, 1.06 mM), MES (0.0496g, 1.02 mM), MOPS (0.0553 g, 1.06 mM) were carefully added to an 
empty A grade 250 ml volumetric flask  and filled up to mark with the acidified solution.  The 
weighing vials were re-measured to ensure the correct masses were indeed transferred.  For this 
electrochemical study, 100 ml of the solution was placed into a thermostated cell equipped with a 
stirrer bar and connected to a circulating water bath set at 25.0 ± 0.2°C.   The pH was raised in 
0.25 value increments accordingly using a solution of saturated NaOH and 2 ml aliquots of the 
solution were decanted at each pH and left to equilibrate for 96 hrs.  The following pH solutions 
were selected and analyzed: 3.221, 6.294, 8.731 and 11.847. 
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2.3.4.1.2 Europium-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-
tetraazacyclodecane (4) 
 
Molecule 4 (0.1368 g, 5.18×10-4 M), KHP (0.05218 g, 1.02 mM), Tris (0.0711 g, 2.35 mM), 
CHES (0.05461 g, 1.05 mM), MES (0.0499g, 1.02 mM), MOPS (0.0556 g, 1.06 mM) were 
carefully added to an empty A grade 250 ml volumetric flask  and filled up to mark with 
acidified solution as mentioned earlier.  Similarly, the weighing vials were re-measured to ensure 
the correct masses were indeed transferred.  As before, 100 ml of the solution was placed into a 
thermostated cell equipped with a stirrer bar and connected to a circulating water bath set at 25.0 
± 0.2°C.   The pH was raised in 0.25 value increments accordingly using a solution of saturated 
NaOH and 2 ml aliquots of the solution were decanted at each pH and left to equilibrate for 96 
hrs.    The following pH solutions were selected and analyzed: 3.201, 6.212, 8.657 and 11.856. 
 
All CV Data are found in Appendix H (See Data Disc) 
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Chapter Three Results and Discussion  
3.1      Synthetic Comments 
3.1.1   Synthesis of Precursors 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1:  Mechanism of Reaction Toward Target Precursors. 
 
The target product N-methyl-chloroacetamide was successfully synthesized by a nucleophilic 
acyl substitution reaction.  The mechanism of reaction toward the target α-chloroacetamide is 
illustrated in the above reaction scheme Figure 3.1.  The nucleophile methylamine hydrochloride 
must be deprotonated first before it adds onto the carbonyl of the chloroacetyl chloride, but 
initially forms a tetrahedral intermediate which was not isolated.  Because the chloroacetyl 
chloride has a leaving group in the form of a chloride, the tetrahedral intermediate can further 
react by expelling the chloride.   The white solid was produced in 48% yield.  For the target Di-
methyl-chloroacetamide the same mechanism applies and the product was formed in a yield of 
66%.  It was noted that during the synthesis care had to be taken to ensure the rate of addition of 
chloroacetyl chloride was slow and that the flask it was added to had been in an ice /ethanol-bath 
for approximately 10-15 mins prior to addition.  These small changes optimized the yield and 
ensured exclusive formation of the product. 
O
Cl Cl
O
Cl NHCH3
CH3NH2.HCl
O-
Cl NHCH3
Aqueous/Organic Wash
Cl
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3.1.2  Synthesis of  β-amino alcohol Intermediate: 1-(2-Hydoxycyclohexyl)-1,4,7,10-  
          tetraazacyclodecane 
NH HN
HNNH
O
NH N
HNNH
OH
NH N
HNNH
O
H+
1  
 
Figure 3.2:  Mechanism of Reaction Toward Target Intermediate. 
 
The target product 1-(2-hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane,  1, was successfully 
synthesized by a nucleophilic addition reaction.  The mechanism of reaction toward the target 
intermediate 1 is illustrated in the above reaction scheme in Figure 3.2.  Using a 10% excess of 
cyclohexene oxide to the tetraazamacrocycle cyclen, adds on a single cyclohexene oxide to give 
the target.  This is a useful result, as it leaves three nitrogen donors free for substitution with 
donor groups like acetamides.  An amine lone pair proceeds to react with the carbocation on the 
epoxide alpha to the oxygen.  This results in ring opening of the expoxide and formation of the 
β-amino alkoxide intermediate which further reacts with H+ in the ethanol to form the β-amino 
alcohol.  The clean white crystalline solid was needle like and produced in 27% yield.  It was 
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noted that during the synthesis care was taken to ensure that the trituration process was executed 
with minimal amounts of acetone and recrystallization several times was key in achieving the 
product exclusively in reasonable yield.  Using cold acetone or acetone at room temperature did 
not affect the overall yield.  
 
3.1.3  Synthesis of N-substituted Cyclen based Ligands 
 
The target ligand was successfully synthesized by base catalyzed nulceophilic addition reaction 
and the reaction mechanism is shown in Figure 3.3.  The amine lone pairs react with the carbon 
alpha to the carbonyl as it is more positively charged and subsequently expels the chloride 
leaving group.   The crystalline solid was beige/to off white color and produced in 99% yield.  
The N-methyl chloroacetamide was reacted with 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-
hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane in 3.3:1 ratio.  Care was taken to wash the 
crude product thoroughly with diethyl ether to remove any unreacted cyclen to afford the target 
product exclusively.  The Di-methyl derivative was also successfully produced employing the 
same mechanism in 97% yield with five equivalents of Di-methyl chloroacetamide.  Using the 
same ratios for the Di-methyl was not adequate toward the synthesis of target 3 which resulted in 
mixtures of bi- and tri-substituted derivatives.   The same reaction mechanism also applies to the 
synthesis of 4 which was a synthesized as a white crystalline solid in 100% yield.  The major 
difference between the two preceding reactions and this one is the use of K2CO3 as a base and 
the absence of the KI which is the non participating halogen exchange agent.  The product yields 
are much higher than those reported by Tsukube et. al.68 who achieved 26% yield after 
purification by column chromatography.    
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Figure 3.3:  Mechanism of Reaction Toward Target Ligands. 
 
3.1.4  Lanthanide Complexation of Target Ligands 
 
In similar complexation reactions involving kinetically inert macrocycles, the complexation 
reaction proceeds through the quick formation of a metastable species leading, after a slow 
reorganization of the macrocycle, to thermally stable complexes.  Specific stability of the 
complexes that have been synthesized in this study were not determined, however their specific 
in vivo inertness arises from transitory bonds between the central lanthanide metal ion and the 
oxygen of the cyclohexyl pendant moiety and the three pendant arms bearing carboxylate groups. 
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3.2         Solid State and Supramolecular Chemistry 
3.2.1      Crystal Analysis Polyazamacrocyclic Ligands 
3.2.1.1  Crystal Structure of 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxy-  
              cyclohexyl)-1,4,7,10-tetraazacyclododecane or (2): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4:  Conformation of 2 - Ortep illustration. 
 
Molecule 2 was formed by reacting 1-(2-hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1) 
with excess N-methyl chloroacetamide by refluxing in dry DMF.  Cesium carbonate was used as 
the base to neutralize HCl formed as a by-product and KI as a halogen exchange agent.  Excess 
metal salts were removed by filtration and further purification of the filtrate to remove unreacted 
1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane 
was accomplished by washing in hexane and diethyl ether.   Furthermore, to remove excess N-
methyl-chloroacetamide, the pH of the solution was lowered and washed with dichloromethane a 
number of times.  The pH of the solution was raised with NaOH and again washed with 
dichloromethane.  To grow crystals, the water was removed by lyophilisation and a minimal 
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amount of dry acetonitrile (5 ml) was used to dissolve the product to which diethyl ether was 
added dropwise until the solution became turbid.  This set up was left to slowly evaporate at 
room temperature to afford colourless crystals.  The reported molecular structure shown in 
Figure 3.4 is a free chelator that crystallized with one molecule of water in the P21/c space group 
and found to be in the monoclinic crystal system.  The conformations of 2 are stabilized by 
multiple and cooperative intramolecular N―H⋅⋅⋅O and O―H⋅⋅⋅O hydrogen bonding interactions.  
The average torsion for N―C―C―N angle in the cyclen ring was determined to be 62.45°(8).  
The crystal data, collection and structure refinement parameters for 2 are shown in Table 3.1.   
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5:  Packing of 2 in the unit cell along a axis- Ortep illustration. 
 
There are four molecules within the unit cell which arrange themselves in a double helical 
fashion, one helix for the macrocyclic backbone and the other for acetamide arms as illustrated in 
Figure 3.5.  
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3.2.2.2  Crystal Structure of Na-1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxy-  
             cyclohexyl)-1,4,7,10-tetraazacyclododecane or (3): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Conformation of 3 - Ortep illustration: Hydrogen atoms removed for clarity. 
 
 
 Molecule 3 was formed by reacting 1 with excess Di-methyl chloroacetamide by refluxing in 
dry DMF.  A similar protocol to that which was adopted for the purification of 2 was also 
utilized for 3.  This set up was left to slowly evaporate at room temperature to afford the 
colourless crystals.  The molecular structure illustrated in Figure 3.6 is a sodium complex of 3 
that crystallized with an iodide counter ion (iodide originates from the halogen exchange agent 
used in the synthesis) and is in the P21/n space group with monoclinic crystal system.  Similarly, 
the conformations of molecule 3 are stabilized by multiple and cooperative intramolecular 
N―H⋅⋅⋅O and O―H⋅⋅⋅O hydrogen bonding interactions.  The presence of the OH group on the 
cyclohexyl moiety is known to have an affinity for smaller metal ions like sodium.8  The sodium 
ions are coordinated to the four nitrogen atoms on the cyclen, the three oxygen atoms of the 
carboxylic amides and to one oxygen on the cyclohexyl pendant moiety.  The average Na―N 
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and Na―O bond lengths for the coordination of cyclen ring and oxygen donors were 2.595 Å 
and 2.563 Å, respectively. The average torsion for N―C―C―N angle in the cyclen ring was 
determined to be 60.76(5) °.             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7:  Packing of 3 in unit cell along b axis - Ortep illustration. 
 
There are four molecules within the unit cell which arrange themselves in a double helical 
fashion, one for the macrocyclic backbone and the other for acetamide arms as illustrated in 
Figure 3.7.  The iodide counterion also forms part of the unit cell alternating between each 
molecular species.  
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Table 3.1:  Crystal Data, Collection and Structure Refinement Parameters for Ligands. 
 
 Structural formula C23H45N7O4 
(Molecule 2) 
C26H50N7NaO4 
(Molecule 3) 
M  488.16 675.63 
Crystal size (mm3) 0.40 x 0.37 x 0.25  0.48 x 0.33 x 0.14 
Crystal system  Monoclinic Monoclinic 
Space group (Z) P21/c (4) P2(1)/n (4) 
a (Å) 9.6189(2)  9.7838(3) 
b (Å) 32.1984(7)  11.5254(3) 
c (Å) 8.6632(2)  28.5330(8 
α (°) 90 90 
β (°) 99.5380(10) 94.156(2) 
γ (°) 90 90 
Volume (Å3) 2646.02(10)  3208.98(16) 
Density Mg/m3 1.225  1.398 
F(000) 1066.9 1408 
μ mm-1 0.086  1.053 
Temperature K 173(2)  173(2) 
Wavelength Å 0.71073  0.71073 
Rint  0.0283 0.0708 
θ range (°) 1.26 to 25.00 1.43 to 28.00 
Completeness to theta  100.0 %  100.0 %  
Goodness-of-fit on F2 1.161 1.182 
Unique reflections 4668  7729 
wR2(R1) 0.1847 (0.0761) 0.1352 (0.0529) 
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 3.2.2      Polyazamacrocyclic Lanthanide Complexes 
 3.2.2.1   Crystal Structure of Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-  
               hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane or (5): 
 
Molecule 5 was formed by reacting 2 with excess europium triflate by refluxing in dry 
acetonitrile.  The solvent was removed on the rotary evaporator and further dried under reduced 
pressure.  A minimal amount of water (5 ml) was used to redissolve the product and 20% 
NH4OH was added dropwise until the solution reached a pH of 10.  The solution was filtered 
using a celite plug to remove the excess europium as Eu(OH)3.  The crude product was 
redissolved in a minimal amount of dry acetonitrile to which diethyl ether was added dropwise 
until the solution became turbid.  Refrigeration overnight afforded the colourless crystallized 
product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Conformation of 5 - Ortep illustration: Hydrogen atoms removed for clarity. 
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The molecular structure shown in Figure 3.8 is a europium complex of 2 that crystallized with 
three triflate counterions and two neutral acetonitrile solvent molecules and found to be in P-1 
space group with triclinic crystal system.  The central metal ion coordinated to the four nitrogens 
of the cyclen ring, the three oxygen atoms on the carboxylic amides and the hydroxyl group 
oxygen of the pendant cyclohexyl ring.  In addition, one triflate anion was coordinated to the 
metal center.  This gives rise to a nine coordinate environment as expected for Eu3+ 
azamacrocyclic type complexes.  The triflate anions and the carbons on the cyclohexyl ring 
showed some disorder.  The average Eu―N and Eu―O bond lengths for the coordination of 
cyclen ring and oxygen donors were 2.661 Å and 2.381 Å, respectively.  A summary of selected 
bond distances is shown in Table 3.2.   
 
Table 3.2:  Summary of selected bond distances in 5. 
Bond Distances Donor Type Source Length /Å 
Eu―N(1) nitrogen cyclen backbone 2.657(17) 
Eu―N(2) nitrogen cyclen backbone 2.656(17) 
Eu―N(3) nitrogen cyclen backbone 2.673(18) 
Eu―N(4) nitrogen cyclen backbone 2.658(16) 
Eu―O(1) oxygen hydroxyl group 2.408(15) 
Eu―O(2) oxygen carboxylic amide 2.363(15) 
Eu―O(3) oxygen carboxylic amide 2.380(14) 
Eu―O(4) oxygen carboxylic amide 2.373(14) 
Eu―O(5) oxygen triflate 2.443(15) 
 
Furthermore, as mentioned earlier the lanthanide that is coordinated to a single triflate 
(O―Eu=2.443 Å) and the bond length is slightly larger compared to other oxygen donors, in fact 
it is very similar to the Eu―O distance for the hydroxyl group.  
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Figure 3.9: Packing of 5 in unit cell along b axis - Ortep illustration. 
 
There are two molecules within the unit cell which arrange themselves in a double helical 
fashion, one for the macrocyclic backbone and the other for acetamide arms as illustrated in 
Figure 3.9.  The triflate counterions also forms part of the unit cell alternating between each 
molecular species and also found to cap the axial position.  The crystal packing is characterized 
by a chain structure when considering the hydrogen bond interactions between the symmetry 
related molecules.  The complex adopts a distorted monocapped square anitiprismatic geometry 
in solid-state as illustrated in Figure 3.10, with an average torsion for N―C―C―N angle of 
58.51°.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Shows the capped square anitiprismatic geometry of 5. 
2.443 Å 
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Figure 3.11: Interconversion of stereoisomers for the (R,S)-5 isomer. 
 
 
Molecule 5 has two stereogenic centers which give rise to 16 possible stereoisomers.  The major 
stereoisomer isolated shown in Figure 3.8 was the (R,S)-Λ(δδδδ) isomer.  Figure 3.11 shows a 
representation of the (R,S) isomer and can be extrapolated to the (S,R), (S,S) and (R,R) isomers, 
respectively. 
 
 
(R,S)-Δ(δδδδ)
(R,S)-Δ(λλλλ) (R,S)-Λ(λλλλ) 
(R,S)-Λ(δδδδ) 
Arm rotation 
Arm rotation 
Ring Inversion Ring Inversion 
N
N
N
N
O
MeHN
O
MeHN
O NHMe
Eu
O
H
H
N
N
N
N
O
MeHN
O
MeHN
O NHMe
Eu
O
H
H
N
N
N
N
O
NHMe
OMeHN
Eu
MeHN
O
O
H
H
N
N
N
N
O
NHMe
OMeHN
Eu
MeHN
O
O
H
H
 | P a g e  
 
 
123
3.2.2.2  Crystal Structure of Europium-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-  
              tetraazacyclodecane or (9): 
 
 
Molecule 9 was formed by reacting 4 with excess europium triflate by refluxing in dry 
acetonitrile.  The solvent was removed on the rotary evaporator and further dried under reduced 
pressure.  A minimal amount of water (5 ml) was used to redissolved the product and 20% 
NH4OH was added dropwise until the solution reached a pH of 10.  The solution was filtered 
using a celite plug to remove the excess europium as Eu(OH)3.  Similary, the crude product was 
redissolved in a minimal amount of dry acetonitrile to which diethyl ether was added dropwise 
until the solution became turbid.  Refrigeration overnight afforded the crystallized product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: Conformation of 9 - Ortep illustration. 
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The determined molecular structure shown in Figure 3.12 is a europium complex of 4 that 
crystallized with three triflate counterions and two neutral acetonitrile solvent molecules and was 
found to be in P-1 space group with a triclinic crystal system.  The central metal ion coordinated 
to the four nitrogens of the cyclen ring, the four oxygen donors on the carboxylic amides.   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Packing of 9 in unit cell along b axis - Ortep illustration. 
 
There are two molecules within the unit cell which arrange themselves in a head to tail fashion, 
as illustrated in Figure 3.13.  The crystal packing is characterized by a chain structure when 
considering the hydrogen bond interactions between the symmetry related molecules.  The 
triflate counterions also forms part of the unit cell alternating between each molecular species 
with water in the capping position.  As in the previous europium complex 5, this complex also 
gives rise to a nine coordinate environment as expected for Eu3+ azamacrocyclic type complexes.  
The average Eu―N and Eu―O bond lengths for the coordination of cyclen ring and oxygen 
donors were 2.650 Å and 2.388 Å, respectively.  Furthermore, as mentioned earlier the 
lanthanide that is coordinated to a single water molecule (O―Eu=2.437Å) and the bond length is 
slightly larger compared to other oxygen donors.  The complex adopts a distorted capped square 
anitiprismatic geometry in solid-state illustrated in Figure 3.14, with an average torsion for 
N―C―C―N angle of - 58.95°. Molecule 9 has no stereogenic centers and adopts a similar 
conformation as Ln-DOTA type complexes like Ln-DTMA.  The major stereoisomer isolated 
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shown in Figure 3.12 was the Δ(λλλλ) isomer.  Figure 3.15 shows a representation of the 
possible stereoisomers.  A summary of selected bond distances is shown in Table 3.3.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: Capped square anitiprismatic geometry of 9. 
 
Table 3.3:  Summary of selected bond distances in 9. 
Bond Distances Donor Type Source Length /Å 
Eu―N(1) nitrogen Cyclen backbone 2.649(15) 
Eu―N(2) nitrogen Cyclen backbone 2.627(15) 
Eu―N(3) nitrogen Cyclen backbone 2.643(15) 
Eu―N(4) nitrogen Cyclen backbone 2.682(15) 
Eu―O(1) oxygen Carboxylic Amide 2.346(12) 
Eu―O(2) oxygen Carboxylic Amide 2.445(12) 
Eu―O(3) oxygen Carboxylic Amide 2.399(12) 
Eu―O(4) oxygen Carboxylic Amide 2.363(12) 
Eu―O(W1) oxygen Water Molecule 2.437(12) 
 
 
 
 
2.437 Å 
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Figure 3.15:  General interconversion of stereoisomers in lanthanide complexes of cyclen-based   
                       macrocylic ligands. 
 
 
In some earlier work, dealing with the Gd3+ complex of DTMA, a distinct evaluation of water 
and prototropic exchange rates for a Gd coordinated solvent molecule were reported for the first 
time, evidencing that crystals of [Gd(DTMA)(H2O)][ClO4]3+.NaClO4.3H2O are made of 
[Gd(DTMA)(H2O)]3+ with sodium cations and perchlorate counter anions and crystallization 
water molecules.  The macrocyclic ligand acts as octadentate.  The metal ion is coordinated by 
the four nitrogens of the tetraazamacrocyclic moiety and by the amidic oxygen atoms provided 
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by the side arms.  The ninth position of the coordination sphere is occupied by an oxygen atom 
of a water molecule. The Gd–N and the Gd–O amidic bond distances spanning in the ranges 
2.621(5) to 2.649(6) and 2.351(5) to 2.455(5) Å, respectively, as well as the Gd–O (water) 
distance (2.461(5) Å) are comparable with those previously reported for analogous Gd3+ 
complexes.273-276 The resulting polyhedron, which can be described as a distorted square 
antiprism,277 capped by the water oxygen, corresponds to the usual co-ordination geometry of 
Gd3+ complexes with ligands based on the 1,4,7,10-tetraazacyclododecane structure and their 
stereochemical conformation is illustrated in Figure 3.15.273-276  
 
The tetraaza ring has a [3333] C corners conformation,278 with the four amidic chains in a head-
to-tail relative arrangement.  The four amidic nitrogen atoms have a significant sp2 character, 
indicating that the usual π conjugation takes place in each amidic functional group thus 
enhancing the donor capability of the carbonylic oxygens.  Concerning the packing, it is worth 
noting that the oxygen of the Gd3+ coordinated water molecule is very close (2.921(1) Å) to an 
oxygen atom of a perchlorate ion, suggesting that a strong hydrogen bond between 
[Gd(DTMA)(H2O)]3+ and a counter ion occurs.  In addition the water oxygen O5 is 3.483(7) Å 
from a symmetry related O5 atom.  Comparing the above mentioned Gd(DTMA) complex to the 
molecule 9  synthesized in this work, it is clear that they are very similar in terms of geometrical 
make up and certainly affirms the fact that Eu3+ can be used as a structural analogue for Gd3+. 
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3.2.2.3  Crystal Structure of Gadolinium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-  
             hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane or (6): 
 
Molecule 6 was formed by reacting 2 with excess gadolinium triflate and the same protocol was 
that was adopted for the purification of 5 and 9 was also utilized for 6.  Refrigeration overnight 
afforded the colourless crystallized product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.16: Conformation of 6 - Ortep illustration: Hydrogen atoms removed for clarity. 
 
 
The molecular structure shown above in Figure 3.16 crystallized with three triflate counterions 
and two neutral water molecules and was found to be in Pcca space group within an 
orthorhombic crystal system.  It adopts the same coordination geometry as complex 5 with a 
water molecule in the capping position giving rise to a nine coordinated polyhedron as discussed 
earlier.  The average Gd―N and Gd―O bond lengths for the coordination of cyclen ring 
nitrogens and oxygen donors were 2.659 Å and 2.376 Å, respectively.  A summary of selected 
bond distances is shown in Table 3.4.   
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Table 3.4: Summary of selected bond distances in 6. 
Bond Distances Donor Type Source Length /Å 
Gd―N(1) nitrogen cyclen backbone 2.651(3) 
Gd―N(2) nitrogen cyclen backbone 2.625(3) 
Gd―N(3) nitrogen cyclen backbone 2.699(3) 
Gd―N(4) nitrogen cyclen backbone 2.660(3) 
Gd―O(1) oxygen hydroxyl group 2.440(3) 
Gd―O(2) oxygen carboxylic amide 2.374(3) 
Gd―O(3) oxygen carboxylic amide 2.336(3) 
Gd―O(4) oxygen carboxylic amide 2.354(3) 
Gd―O(W1) oxygen water molecule 2.422(3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: Packing of 6 in unit cell along a axis - Ortep illustration. 
 
There are eight molecules within the unit cell which arrange themselves in a double helical 
fashion, one for the macrocyclic backbone and the other for acetamide arms as illustrated in 
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2.422 Å 
Figure 3.17.  The triflate counterions also forms part of the unit cell alternating between each 
molecular species with water in the capping position.   
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.18: Capped square anitiprismatic geometry of 6. 
 
 
Furthermore, as mentioned earlier the lanthanide that is coordinated to a single triflate 
(O―Eu=2.422 Å) and the bond length is slightly larger compared to other oxygen containing 
donors, in fact it is very similar to the Eu―O distance for the hydroxyl group.  The complex 
adopts a distorted capped square anitiprismatic geometry in solid-state as illustrated in Figure 
3.18, with average torsion angles for N―C―C―N angle of 57.72°. 
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Figure 3.19: Interconversion of stereoisomers for the (S,R)-5 isomer. 
 
 
Similar to molecule 5, molecule 6 has two stereogenic centers which give rise to 16 possible 
stereoisomers.  The major stereoisomer isolated shown in Figure 3.16 was the (S,R)-Δ(λλλλ) 
isomer.  Figure 3.19 shows a representation of the (S,R) isomer and can be extrapolated to the 
(R,S), (S,S) and (R,R) isomers, respectively 
 
In 2006, Aime and co-workers reported the crystal structures of Gd-DOTAM and Py-
DOTAM.279  The single crystals of [Gd(DOTAM)H2O](CF3SO3)3.3H2O were grown from slow 
evaporation of a water solution.  It crystallized with one [Gd(DOTAM)-H2O]3+ complex cation, 
three triflate counterions and three water molecules of crystallization.  Its X-ray structure 
presents a nine coordinate Gd3+ ion.  In the cation, the four nitrogen and four oxygen atoms form 
two square planes (deviations of the nitrogens and of the oxygens from their respective square 
(S,R)-Δ(δδδδ) 
(S,R)-Δ(λλλλ) (S,R)-Λ(λλλλ) 
(S,R)-Λ(δδδδ)
Arm rotation 
Arm rotation 
Ring Inversion Ring Inversion 
N
N
N
N
O
NHMe
OMeHN
Gd
MeHN
O
O
H
H
N
N
N
N
O
MeHN
O
MeHN
O NHMe
Gd
O
H
H
N
N
N
N
O
MeHN
O
MeHN
O NHMe
Gd
O
H
H
N
N
N
N
O
NHMe
OMeHN
Gd
MeHN
O
O
H
H
 | P a g e  
 
 
132
planes are 0.001 and 0.003 Å) that are parallel to each other.  The gadolinium ion is 0.716(1) Å 
out of the oxygen plane and 1.614(1) Å from the nitrogen plane.  Considering also the 
coordinated water molecule in the capping position, the coordination geometry of the metal ion 
is a capped square antiprism with the twist angle between the two planes of the nitrogen and 
oxygen comparable to the values found in Ln-DOTA complexes.280  The Gd–Ow bond distance is 
2.394(3) Å in their complex somewhat shorter than that reported for [Gd(DTPA)H2O]2+ 
2.507(10)281 [Gd(DOTA)H2O]3+ 2.458(3) Å282, but comparable with [Gd(DO3A)H2O]3+ 2.429 
Å283 with the same capped square antiprism geometry.  The Gd–O carboxylate bond distances are 
in the range 2.372(3) to 2.388(4) Å and the Gd–N 2.638(4) to 2.671(4) Å comparable to those 
found in the previously quoted [Gd(DO3A)H2O]3+.  The numerous hydrogen acceptor–donor 
atoms determine the molecular packing.  The crystals of compound 
[Gd(DOTAM)H2O].(CF3SO3-)3.0.5H2O.CH3CN were obtained by slow diffusion of water in 
acetonitrile.  It crystallizes with two independant Gd complex molecules as asymmetric units.  
The geometry around Gd3+ ions is a typical capped square antiprism with a twist angle between 
the two square planes of the four coordinated nitrogen and the four oxygens.  In general, the 
supramolecular structures in our study are very similar to those previously reported in literature 
and/or are in current use as MRI-CAs with respect to their bond distances, bond angles, torsion 
angles and general arrangement of the coordination polyhedron.  Of vital importance is that a 
single capping position in all lanthanide complexes were reported, a much needed feature 
ensuring occupancy by a single water molecule from the body which enhances contrast between 
diseased and healthy tissue.  
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Table 3.5: Crystal Data, Collection and Structure Refinement Parameters for Complexes. 
 
 
 
 
 
 
 
 
 
 
 
Structural 
formula 
C58 H99 Eu2 F18 N17 O26 S6 
(molecule 5) 
C26 H49 F9 Gd N7 O15 S3 
(molecule 6) 
C29 H53 Eu F9 N11 O15 S3 
(molecule 9) 
M  2288.82 1124.15 1214.96 
Crystal size (mm3) 0.47 x 0.28 x 0.15 0.45 x 0.15 x 0.04 0.33 x 0.23 x 0.09 
Crystal system  Triclinic Orthorhombic Triclinic 
Space group (Z) P-1 (1) Pcca (8) P-1 (2) 
a (Å) 11.8523(2) 41.2383(6 12.8612(2) 
b (Å) 13.4938(2) 13.1777(2) 14.1272(3) 
c (Å) 15.4748(3) 15.5431(2) 14.4666(3) 
α (°) 70.5800(10) 90 82.4570(10) 
β (°) 70.7790(10) 90 77.2400(10) 
γ (°) 81.9570(10) 90 68.4760(10) 
Volume (Å3) 2202.72(7) 8446.5(2) 2381.13(8) 
Density Mg/m3 1.725 1.768 1.695 
F(000) 1158 4536 1232 
μ mm-1 1.672 1.829 1.556 
Temperature K 173(2) 173(2) 173(2) 
Wavelength Å 0.71073 0.71073 0.71073 
Rint  0.0338 0.0756 0.0436 
θ range (°) 1.46 to 28.00 1.55 to 28.00 1.45 to 28.00 
Completeness to θ  100.0 % 99.9 %  100.0 % 
Goodness-fit on F2 1.044 0.895 1.066 
Unique reflections 10633 10218 11490 
wR2(R1) 0.0624 (0.0234) 0.076 (0.0384) 0.0555 (0.0222) 
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Ln+3
3.3 Solution Chemistry of Europium Complexes  
 3.3.1   Luminescence Studies and UV-vis Studies of Europium Complexes: Determination   
            of  Spectroscopic pKas 
 
 
Ligand field effects are normally studied through photophysical measurements of the metal ion, 
either absorption or emission.  For lanthanide ions the amount of information that can be 
obtained from these studies is limited by shielding of the 4f-orbitals by the 5d-orbitals.  As a 
result of this shielding the effect of the ligand field is small relative to spin-orbital coupling 
(~100 cm-1 versus ~2000 cm-1).  As a consequence, the emission spectra of lanthanide ions are 
characterized by sharp emission bands that correspond to the Russell-Saunders (spin orbit 
coupling) states of the ground state.  Figure 3.20 illustrates different lanthanide excitation and 
electronic states when associated with an antenna.  Information about the ligand field is 
contained within these sharp emission bands and can therefore only be clearly discerned at 
higher spectral resolutions. Under Laporte selection rules f-f transitions are forbidden; 
nevertheless, some transitions are permitted under electric or magnetic dipole selection rules 
through the mixing of 5d and 4f orbitals that arises from distortions of the coordination sphere by 
vibrational motion. As a consequence the intensities of f-f transitions remain low. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20:  Diagram explaining lanthanide excitation and electronic states when associated   
                       with an antenna.284 
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3.3.1.1   Europium-11,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
             1,4,7,10-tetraazacyclododecane (5)  in MCB with KHP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.21: Variation of intensity for emission spectrum of 5 in MCB with KHP upon titration   
                      with NaOH. 
 
Figure 3.21 depicts the variation of intensity for emission spectrum of 5 in multicomponent 
buffer (MCB) with KHP upon titration with NaOH.  The variation of lanthanide emission was 
found to be most intense in the physiological pH range between pH 6 to 8 for J = 0, 1, 2, 3 and 4.  
In general for all J bands a bell shaped profile was observed.  From the non-linear least square 
fits shown in Figure 3.22 it was found that two protonation equilibria arise which corresponds to 
the deprotonation phthalate carboxylate which was followed by the deprotonation of the metal-
bound water molecule.  The mean values were calculated and found to be pK1 = 4.67 ± 0.06 and 
pK2 = 8.69 ± 0.12, respectively.  Using UV-vis spectroscopy an absorbance band was observed 
at λ = 270 nm, which corresponds to the characteristic phthalate π to π* transition, and was 
monitored shown in Figure 3.23.  Similarly, a plot of absorbance versus pH shown in Figure 3.24 
was fitted using an iterative procedure for a three pKa fit model as it showed the best fit.  The 
protonation equilibria using UV-vis spectroscopy was found to be pK1 = 2.84 ± 0.24, pK2 = 5.11 
± 0.10 and pK3 = 11.12 ± 0.62, respectively.  The first two equilibria observed for UV-vis 
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spectroscopy corresponded to the deprotonation of the phthalate carboxylates and agrees well 
with the known pKas of the carboxylates found in phthalate285 which are pK1 = 2.98 and pK2 = 
5.28, respectively.  However, the value pK3 = 11.12 ± 0.62 is likely to be caused by working at 
high pH which results in demetalation of the complex. Precipitation of Eu3+ follows and the 
formation of Eu-phthalate complexes or Eu-hydroxides that are insoluble and could explain the 
slight increase in absorbance at high pH.   
 
Figure 3.24 illustrates the proposed protonation equilibria and explains the modulation observed 
for 5 in MCB with KHP upon titration with NaOH.  The phthalate moiety coordinates in a 
unidentate fashion and the coordination number of nine is preserved.  Between pH 2 and pH 4.7 
the intensity of the emission bands increases due to the binding of the phthalate carboxylate 
which gradually deprotonates and coordinates with the metal center this further enhances the 
intensity signal via an energy transfer mechanism transferred from the S1 and possibly T1 state of 
the phthalate moiety to the triplet state of the lanthanide.286  Although it is well known that the 
phthalate moiety can coordinate in a bidentate fashion with tri substituted cyclen derivatives287, 
however in molecule 5 the nona-coordinated polyhedron is fully occupied.   In addition, if 
phthalate were to bind in a bidentate fashion, the formation of a 7-membered ring chelate results 
which is highly unstable as it energetically unfavorable.288 As the pH increases to about 7 an 
increase in emission intensity is observed.  At high pH > 7, it is proposed that the cyclohexyl 
group re-coordinates to the metal center and consequently displaces of the phthalate moiety 
causing an overall decrease in emission intensity.   
 
Although the metal-bound water molecule undergoes dissociative exchange with bulk water at a 
rate of >107 s-1 at 298 K, it is very difficult to substitute it in aqueous media.  So far, only 
addition of excess fluoride has been shown to be displace the metal bound water molecule,143 
e.g., for [EuDOTAMPh]3+ and to a partial extent in  [Eu(DOTA)(H2O)]-.  In the fluoride-bound 
species, the complex seemed to adopt a preferred twisted square anti prismatic structure possibly 
formed via the TSAP mono-aqua species.  However, for molecules where q = 2 or 3, the water 
molecule is readily displaced by addition of ligating anions, especially chelating species (e.g., 
lactate, citrate, malonate, succinate).289,290,291,292  Such reactions may be monitored by following 
the enhancement of luminescence emission intensity and lifetime as bound water molecules 
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efficiently quench the excited state of, e.g., Yb3+, Nd3+, Eu3+, and Tb3+ species.  In the case of 
Eu3+ complexes, the change in the form of the emission spectrum also characterizes this process, 
since a marked decrease in intensity was observed which shows that the phthalate is no longer 
coordinated to the metal ion.  This displacement can also then be extrapolated to complex 9 
where the amidic pendant arm re-coordinates in a similar fashion. 
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Figure 3.22:  Non-linear least square fits for 5 in MCB with KHP corresponding  
                       to J = 0, 1, 2, 3 and 4.
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Figure 3.23:  Variation in absorbance of 5 in MCB with KHP upon titration with NaOH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.24: Non-linear least square fit for 5 in MCB with KHP corresponding monitoring   
                     at λ = 270 nm across pH range.
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pK2 = 5.11 ± 0.10 
pK3 = 11.12 ± 0.62 (ppt) 
R2 = 0.988 
 
270 nm 
 | P a g e  
 
 
140
-H
N
N
N
N O
H
N
N
H
N
H
O
O O
Eu
5
O
H
H
N
N
N
N OH
H
N
N
H
N
H
O
O O
Eu
5
O
H
C C OO
O- OH
H
C C OO
O- O-
N
N
N
N OH
H
N
N
H
N
H
O
O O
Eu
5
O
H
H
C
C O
O
O-
O-
-H
9-coordinate
X
C C OO
O- O-
10-coordinate
-2H
9-coordinate
N
N
N
N OH
H
N
N
H
N
H
O
O O
Eu
5
O
H
C C OO
O- O-
9-coordinate
N
N
N
N O
H
N
N
H
N
H
O
O O
Eu
5
O
H
C C OO
O- O-
9-coordinate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.25:  Proposed protonation equilibrium for 5 in MCB with KHP  
                       upon titration with NaOH.  
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3.3.1.2  Europium-1,4,7,10-Tetrakis-(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane    
             Complex (9) in MCB with KHP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.26:  Variation of intensity for emission spectrum of 9 in MCB with KHP  
                       upon titration with NaOH. 
 
 
Figure 3.26 depicts the variation of intensity for emission spectrum of 9 in multicomponent 
buffer (MCB) with KHP upon titration with NaOH.  The variation of lanthanide emission was 
found to be most intense in the pH range between pH 5 and 7 for J = 0, 1, 2, 3 and 4.  Similarly, 
for all J bands a bell shaped profile was observed from pH 4 to about pH 8.  From the non-linear 
least square fits shown in Figure 3.27 it was found that  two protonation equilibria arise which 
corresponds to the deprotonation phthalate carboxylate, followed by the deprotonation of the 
metal-bound water molecule.  The mean values were calculated and found to be pK1 = 4.99 ± 
0.63 and pK2 = 7.30 ± 0.11, respectively.  Using UV-vis spectroscopy an absorbance band was 
observed at λ = 280 nm which corresponds to the characteristic phthalate π to π* transition 
shown in Figure 3.28.   
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A plot of absorbance versus pH shown in Figure 3.29 was fitted using an iterative procedure for 
a two pKa fit model as it showed the best fit.  The protonation equilibria using UV-vis 
spectroscopy was found to be pK1 = 2.55 ± 0.16 and pK2 = 4.97 ± 0.02, respectively.  The 
equilibria observed for UV-vis spectroscopy corresponded to the deprotonation of the phthalate 
carboxylates.  Figure 3.30 illustrates the proposed protonation equilibria and explains the 
modulation observed for complex 9 in MCB with KHP upon titration with NaOH.  The same 
argument for 5 applies to 9, the difference being that the amidic arm displaces the water 
molecule. 
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Figure 3.27:  Non-linear least square fits for 9 in MCB with KHP corresponding to          
                       J = 0, 1, 2, 3 and 4. 
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Figure 3.28: Variation in absorbance of 9 in MCB with KHP upon titration with NaOH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.29:  Non-linear least square fit for 9 in MCB with KHP corresponding to monitoring at   
                       λ = 280 nm across pH range.
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Figure 3.30:  Proposed protonation equilibrium for 9 in MCB with KHP  
                       upon titration with  NaOH. 
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3.3.1.3  Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
             tetraazacyclododecane (5) in MCB without KHP 
 
Figure 3.31 depicts the variation of intensity for emission spectrum of 5 in MCB without KHP 
upon titration with NaOH.  The variation of lanthanide emission was found to be constant from 
pH 2 to 8 for J = 0, 1, 2, 3 and 4.  However, for the band J = 0 (580 nm) the intensity increased 
after pH 8 while the others decreased substantially.  From the non-linear least square fits shown 
in Figure 3.32 it was found that only one protonation equilibrium existed which corresponds to 
the deprotonation of metal-bound water molecule.  The mean pKa for all J bands were calculated 
and mean pK1 was found to be 9.04 ± 0.07.  Using UV-vis spectroscopy an absorbance band was 
observed at λ = 308 nm where the change in absorbance was monitored shown in Figure 3.33.  
Similarly, a plot of absorbance versus pH shown in Figure 3.34 was fitted using an iterative 
procedure.  For the  absorbance band at λ = 308 nm, it was observed that the absorbance between 
pH 2 and 8 remained between 0.03 to 0.05 absorbance units and increased to 0.13 at pH 11.  
Only one protonation equilibrium existed and the mean value was found to be pK1 = 9.02 ± 0.10 
which agreed well with that found when fitting the luminescence data.  Figure 3.35 illustrates the 
proposed protonation equilibrium for 5 in MCB excluding KHP upon titration with NaOH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.31:  Variation of intensity for emission spectrum of 5 in MCB excluding KHP        
                       upon titration with NaOH. 
 | P a g e  
 
 
147
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32:  Non-linear least square fits for variation of emission band intensity as a function of   
                       pH for 5 in MCB excluding KHP corresponding  to J = 0, 1, 2, 3 and 4.
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Figure 3.33: Variation in absorbance of 5 in MCB excluding KHP upon titration with NaOH. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.34:  Non-linear least square fit for variation of absorbance band intensity as a   
                                  function of pH for 5 in MCB excluding KHP corresponding to monitoring  
                                   at λ = 308 nm. 
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Figure 3.35:  Proposed protonation equilibrium for complex 5 in MCB excluding KHP upon   
                       titration with NaOH. 
 
3.3.1.4  Europium-1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
             1,4,7,10-tetraazacyclododecane (7) in MCB without KHP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.36:  Variation of intensity for emission spectrum of 7 in MCB excluding KHP   
                       upon titration with NaOH. 
 
Figure 3.36 depicts the variation of intensity for emission spectrum of 7 in MCB without KHP 
upon titration with NaOH.  The variation of lanthanide emission was found almost identical to 5 
which was found to be unchanged from pH 2 to 8 for J = 0, 1, 2, 3 and 4.  Similarly, the band J = 
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0 (580 nm) increased after pH 8 while the other J bands decreased substantially.  From the non-
linear least square fits shown in Figure 3.37 it was found that only one protonation equilibrium 
existed which corresponds to the deprotonation of the metal-bound water molecule, the mean 
value was calculated and found to be pK1 = 8.22 ± 0.08.  This value compared to that of 5 was 
understandably lower.  This was attributed to the inductive effects of the methyl groups on the 
acetamide arms in 7.  The mean pK1 could not be confirmed using UV-vis spectroscopy where 
the change in absorbance was monitored at λ = 263 nm shown in Figure 3.38.  As can be 
observed there is no definable spectroscopic pKa only scatter due to the absence of phthalate in 
solution shown on Figure 3.39.  Figure 3.40 illustrates the proposed protonation equilibrium for 
7 in MCB excluding KHP upon titration with NaOH which could only be elucidated using the 
luminescence data. 
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Figure 3.37:  Non-linear least square fits for 7 in MCB excluding KHP corresponding   
                       to J = 0, 1, 2, 3 and 4. 
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λ = 263 nm 
 
 
 
 
 
 
 
 
 
Figure 3.38: Variation in absorbance of complex 7 in MCB excluding KHP  
                      upon titration with NaOH. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.39:  Scatter of the absorbance ( λ = 263 nm) observed for 7 in MCB excluding   
                      KHP across pH range from 2 to 12. 
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Figure 3.40:  Proposed protonation equilibrium for 7 in MCB excluding KHP  
                       upon titration with NaOH. 
 
 
3.3.1.5   Europium-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
              tetraazacyclododecane (5)  in Water 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.41: Variation of intensity for emission spectrum of 5 in water  
                      upon titration with NaOH. 
 
Figure 3.41 depicts the variation of intensity for emission spectrum of 5 in water upon titration 
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J = 0, 1, 2, 3 and 4.  The J = 0 (580 nm) band increased after pH 8 while the others decreased 
substantially.  From the non-linear least square fits shown in Figure 3.42 it was found that only 
one protonation equilibrium existed which corresponds to the deprotonation of metal-bound 
water molecule where pK1 = 8.69 ± 0.07.  This was further confirmed using UV-vis spectroscopy 
where the change in absorbance at λ = 313 nm was monitored shown in Figure 3.43.  A plot of 
absorbance versus pH shown in Figure 3.44 was fitted using an iterative procedure.  Similar to 
the  behavior of the band J = 0 (580 nm) between pH 2 and 8 in luminescence, the absorbance 
band observed in UV-vis spectroscopy at λ = 313 nm remained relatively unchanged between 
0.03 to 0.05 absorbance units and increased to 0.13 at pH 11.  Again only one protonation 
equilibrium existed and the mean pKa was found to be pK1 = 8.69 ± 0.07 which agreed well with 
luminescence fits.  Figure 3.45 illustrates the proposed protonation equilibrium for 5 in water 
upon titration with NaOH.  
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Figure 3.42: Non-linear least square fits for complex 5 in water corresponding  
                      to J = 0, 1, 2, 3 and 4. 
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Figure 3.43: Variation in absorbance of 5 in water upon titration with NaOH. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.44:  Non-linear least square fit for 5 in water corresponding monitoring at         
                       λ = 313 nm across pH range. 
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Figure 3.45: Proposed protonation equilibrium for 5 in water upon titration with NaOH. 
 
 3.3.2 Lifetime Studies- Determination of q for Europium-1,4,7-tris[N-methylcarbamyl-  
           methyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane (5) 
 
The Eu3+ ion is an attractive candidate for studying transitions of the 4f electrons because the 
emissive 5D0 state (λ = 580 nm), being non-degenerate, is not split by the ligand field.  This 
means that transitions from 5d0 to the 7fJ manifold exhibit ligand field patterns arising solely 
from the degeneracy of the J-state of the 7f ground state.  The number of water molecules in the 
inner-coordination sphere (q) was indirectly determined by measuring the fluorescent lifetimes 
of 5 in H2O and D2O.   
 
In general, the OH oscillators present on the coordinated water molecule are efficient quenchers 
of the excited state.  Although quenching by OH oscillators may be minimized by using octa- or 
nonadentate ligands, amide and amine NH oscillators are more prone to quenching in these 
systems.293 However O-D oscillators are largely ineffective at quenching fluorescence, therefore 
it is possible to indirectly determine the number of water molecules in both coordination spheres 
by comparing the fluorescence lifetimes in H2O and D2O.220  The intensity and lifetime of 
lanthanide emissions were investigated, and has been found to be sensitive to the local ionic or 
chiral environment by the perturbation of the singlet, triplet, or lanthanide excited states.   
 
Nearby water molecules in the outer coordination sphere also quench the excited state, albeit to a 
lesser extent because of their relative distance from the metal center. The effect of distance on 
the efficiency of vibrational deactivation follows an approximate r-6 dependence.  For an OH 
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oscillator that is 2.9 Å from a Ln3+ ion, the effect can be assumed to be 100% efficient (i.e., a 
typical Ln water proton distance from crystallographic analyses of aqua species.  Then at a 
distance of 3.6 Å, the process may be calculated to be 25% efficient and 8% at 4.5 Å.8  These 
distances approximate to second- and outer-sphere hydration values and highlight the quenching 
effect of unbound water molecules.  As a consequence, an improved method for assessing the 
hydration states of Eu, Yb, and Tb complexes has emerged, accounting for the effect of 
exchangeable XH oscillators and of closely diffusing waters,222,8  This relationship between the 
fluorescent lifetimes was modeled in Equation 3.1 and 3.2.222,224,268 
 
Furthermore, the relaxation through O-D oscillators is less efficient because only the higher 
harmonics overlap with the metal excited state, and the Frank-Condon overlap factor is less 
favorable. There is also an additional contribution of solvent based quenching from the second-
sphere as mentioned by Sudnick et al.,268 as the quenching effect is still observable in complexes 
without coordinated solvent molecules.  The coordination of lanthanide complex is a largely 
ionic interaction and hence the solution hydration states of Eu3+ will provide results close to that 
of Gd3+. 
 
Equations under consideration: 
 
q = A[τ-1H2O - τ
-1
D2O]………......................Equation 1.1 
q = A[τ-1H2O - τ-1D2O - kXH] ……………….Equation 1.2 
where kXH = α + βnOH + λnNH + δnO=CNH 
 
 
 
 
 
 
 
 
 
       q = 1.11(kH2O-kD2O-0.985) ………………….Equation 3.1224,268 
   q = 1.11(kH2O-kD2O-0.965) ………………….Equation 3.2222 
kXH given α β γ δ 
0.985  0.31 0.45 0.99 0.075 
   
 
n=1 n=0 n=3 
      
0.965  0.31 0.44 0.99 0.075 
   n=1 n=0 n=3 
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As mentioned earlier the reason for non-integral and larger than expected q-values is that water 
molecules in the second coordination sphere of the Eu3+ ion, also called ‘closely diffusing water 
molecules’ are known to shorten luminescence lifetimes to a small extent.222,223  Equation 1.1 is 
easily modified to account for the effects of X–H oscillators and water molecules beyond the 
first coordination sphere yielding Equation 1.2.222,224 
 
q = A[τ-1H2O - τ
-1
D2O - kXH] ………Equation 1.2 
where kXH = α + βnOH + λnNH + δnO=CNH 
 
where nOH is the number of alcoholic O–H oscillators in the first coordination sphere of Eu3+, 
nNH is the number of secondary amine N–H oscillators in the first coordination sphere of Eu3+, 
and nO=CNH is the number of amide N–H oscillators in which the amide carbonyl oxygen is in the 
first coordination sphere of Eu3+.  The respective contributions of these X–H oscillators to the 
quenching of the 5D0 state of Eu3+ are β =  0.44 ms-1, γ  = 0.99 ms-1 (calculated as the average of 
0.759,225 1.0,225 and 1.2222), and δ222,223  = 0.075 ms-1.   The contribution to the q-value of a single 
O–H oscillator in the first coordination sphere of Eu3+ is calculated as half the contribution of a 
water molecule, i.e. β = 1/(2A).  The value α is the quenching of the excited state of Eu3+ by 
second coordination sphere water molecules. 
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3.3.2.1  Europium-1,4,7-tris[N-methylcarbomylmethyl]-10-2(hydroxycyclohexyl)-1,4,7,10-  
              tetraazacyclododecane (5) in MCB with KHP   
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.46:  Eu3+ 7F0     5D0 excitation and emission spectra of complex 5 containing 1 mM  
                       KHP in MCB at 25 ºC. 
 
Table 3.6:  Eu3+ Excited State Lifetimes of 5 in MCB with KHP. 
 
pH kH2O τH2O / ms kD2O τD2O/ ms 
4.710 3.149 0.3176 0.569 1.758 
5.32 3.12 0.3205 0.568 1.761 
7.423 2.849 0.3510 0.601 1.664 
8.172 2.592 0.3858 0.637 1.570 
8.71 2.799 0.3573 0.808 1.238 
9.382 2.953 0.3386 0.971 1.030 
9.484 2.727 0.3667 1.115 0.900 
 
From the emission spectrum shown in Figure 3.46 it was possible to determine the appropriate 
wavelength of excitation (240 nm).  Table 3.6 shows the Eu3+ Excited State Lifetimes of 5 in 
Wavelength / nm 
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MCB with KHP which are the parameters used for the estimation.  The hydration number (q) 
obtained for 5 shown in Table 3.7 in water and deuterated water in MCB with KHP decreases 
from pH 4.710 to pH 9.484 and range from 1.77 to 0.70 using Equation 3.1224,268 and from 1.79 
to 0.72 using Equation 3.2222, respectively.  The pH points selected were taken before and after 
the respective pKas determined using luminescence spectroscopy. 
 
Table 3.7:  q values determined at 580 nm for 5 in MCB with KHP. 
 
pH q values Eq. 3.1 q values Eq. 3.2 
4.710 1.77 1.79 
5.32 1.74 1.76 
7.423 1.40 1.42 
8.172 1.08 1.10 
8.71 1.12 1.14 
9.382 1.11 1.13 
9.484 0.70 0.72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.47:  Change in q value for 5 across the pH range 4.710 to 9.484. 
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3.3.2.2  Europium-1,4,7-tris[N-methylcarbomylmethyl]-10-2(hydroxycyclohexyl)-1,4,7,10-  
             tetraazacyclododecane (5) in Water 
 
Table 3.8:  Eu3+ Excited State Lifetimes of 5 in water. 
 
 
Table 3.8 shows the Eu3+ Excited State Lifetimes of molecule 5 in water.  The hydration number 
(q) obtained for 5 shown in Table 3.9 in water and deuterated water from pH 4.375 and 8.645 
range from 0.94 to 0.55 using Equation 3.1224,268 and from 0.95 to 0.56 using Equation 3.2222, 
respectively.  Again, the pH points selected were taken before and after the pKa for the 
hydrolysis of water coordinated to the metal center determined using luminescence spectroscopy.   
 
 
Table 3.9:  q values determined at 580 nm for 5 in water. 
 
 
 
 
 
 
 
 
 
 
 
Of particular significance is that a single water molecule is coordinated to the metal center 
corroborating the results obtained from solid state analyses.  It is an important feature when 
designing a potential MRI-CAs as it increases the difference in contrast between normal and 
diseased tissue. 
 
pH kH2O τH2O / ms kD2O τD2O/ ms 
 4.375 2.374 0.4212 0.556 1.800 
4.795 2.331 0.4290 0.559 1.789 
8.275 2.453 0.4077 0.987 1.013 
8.645 2.392 0.4181 0.924 1.082 
pH q values Eq. 3.1 q values Eq. 3.2 
 4.375 0.94 0.95 
4.795 0.88 0.90 
8.275 0.55 0.56 
8.645 0.55 0.56 
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Figure 3.48:  Change in q value for 5 across the pH range 4.375 to 8.645. 
 
R2 = 0.99
q according to Eq. 3.1 
q according to Eq. 3.2 
Linear (Eq. 3.1) 
Linear (Eq. 3.2) 
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3.4 Cyclic Voltammetry of Eu-complexes across pH Range 
 
 
In a typical cyclovoltammetric experiment a stationary working electrode is dipped into an 
electrolyte solution.  In order to minimize the ohmic resistance a three electrode arrangement is 
preferable.  In this methodology, the current passes between the working electrode and a counter 
electrode.  The potential of the working electrode relative to the reference electrode is varied 
linearly with time with sweeps between 100 mV.s-1 to 1000 mV.s-1.  The current is recorded as a 
function of potential shown in Figure 3.49.  Cyclic voltammetry was performed in order to 
determine the reduction potentials of the 5 and 9 complexes at selected points across the pH 
range 2 to 12.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.49: Cyclic voltammograms of 5 (top) and 9 (bottom) at pH 6.294 and pH 6.212,   
                       when scanned from (100-1000mV). 
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Provided the rate of electron transfer at the electrode is very fast (which corresponds to an 
absence of an inhibition), the concentration of the oxidised and reduced species at the electrode 
surface is dictated by the Nernst equation.  Under these circumstances the electrode reaction is 
said to be reversible.   
 
The cyclic voltammograms (CV) of 5 and 9 were investigated at different scan rates between pH 
3 and 11.  Figure 3.50 illustrates cyclic voltograms of 5 (red) and 9 (blue) at pH 6.294 and 6.212, 
respectively.  The plot of E1/2 versus pH shown in Figure 3.51 illustrates the change in the 
midpoint potential across the pH range.  At low pH between the pH 3 to 6.5, both complexes 
have an E1/2 = -0.83 V however at about pH 8.8 complex 5 has an E1/2 = -0.83 V while complex 9 
has an E1/2 = -0.79 V.   At high pH > 10, different electrochemical behavior for both complexes 
are observed where 5 has an E1/2 = -1.01 V and 9 has E1/2 = -1.00 V (versus Ag/AgCl), 
respectively.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.50:  Cyclic voltammograms of 5 (in red) and 9 (in blue) at pH 6.294 and 6.212,      
respectively.
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Figure 3.51: Showing E1/2 (top) and Peak separation (bottom) versus pH for 5 (red) and 9 (blue).   
 
The peak separation for both complexes behave differently.  For a fully-reversible, diffusion-
controlled, one-electron reduction, the separation between the cathodic and anodic waves should 
be 57 mV at 298 K and independant of the scan rate.270  However, if it is below 57 mV  its shows 
quasi reversible behavior.  From Figure 3.52 it is deduced that the electrode reactions in both 
complexes are quasi reversible at low pH between 3 and 8.8.  However at high pH > 10, 
complexes 5 and 9 have peak separation of 63 mV and 36 mV, respectively.  At high pH >  11.5, 
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the lanthanide ion in complex 5 protrudes out of the macrocyclic cavity, whereas in complex 9 at 
about pH 10.9 it is still within the cavity of the macrocycle.  In the oxidative sweep and reductive 
sweep, only a distinct wave for both complexes are observed.  Usually a well defined 
symmetrical voltammogram arises from a single electrochemically active species.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.52:  Change in potential observed of selected pH points in 5 (top) and 9 (bottom) at   
                      constant current versus Ag/AgCl. 
 
The above voltammograms show that the metal is encapsulated within the complexes between 
pH 3 to 10, however above pH 11 the complex is demetalated and results in the change in 
potential as shown in Figure 3.52.  This result shows that there exists a quasi reversible system 
for both complexes which is highly dependant on the pH of the system.   
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Reduction: [EuL]3+ + e-      [EuL]2+  
Oxidation: [EuL]2+          [EuL]3+ + e- 
 
Nicholson et. al.270 have extended the theory of cyclic voltammetry to include electron transfer 
reactions which is described by the absolute rate equation not shown here.  The results of his 
theoretical calculations have made it possible to use cyclic voltammetry to measure standard rate 
constants for electron transfer.  Thus a system that appears reversible at one scan rate may be 
made to exhibit kinetic behavior at other scan rates, as indicated by increased separation of 
cathodic and anodic peak potentials.  The standard rate constant is determined for electron 
transfer by plotting the log of the peak cathodic current, log icp, against the log of the scan rate, 
log v.  The slope is used to determine whether the electrochemical reduction is under diffusion 
control (slope close to 0.5) or is adsorbed on the electrode (slope close to1.0).  As shown in 
Figure 3.53 complex 5 and 9 show a slope close to 1.0 ± 0.09 and 0.93 ± 0.086, respectively, 
which means the reduction in complexes are not diffusion controlled but the redox active species 
are adsorbed on the electrode surface.   
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Figure 3.53:  Plots obtained using Nicholson Method to determine whether electrochemical   
                       reaction is diffusion controlled for 5 and 9. 
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3.5 Discussion 
 
Synthetic Aspects 
 
 
A complete summary of precursors, intermediates, ligands and lanthanide complexes used in this 
study is provided in Figure 3.54.  The two target precursor chloroacetamides were easily 
synthesized in reasonable yield with no mixtures being formed.263  These molecules were 
characterized using conventional methods (see appendices A, B and C) which confirmed their 
chemical identity and purity.  The yields obtained compare well with literature.263  The ring 
opening reaction of cyclohexeneoxide with cyclen was harnessed to introduce the cyclohexyl 
group.264 The synthesis of the β-amino alcohol intermediate, [1-(2-Hydoxycyclohexyl)-1,4,7,10-
tetraazacyclodecane or molecule 1], was synthesized in lower yield as previously reported by de 
Sousa et. al.264 using the direct alkylation strategy.  The reason for this decrease can be attributed 
to the number of recrystallizations it underwent to achieve a pure crystalline product with no 
traces of starting material or mixtures of bis or tri-substituted cyclen.   Molecule 1 was 
characterized using NMR (1H/13C, COSY, C-H correlation – see appendix A), ESI-MS (see 
appendix B) and FTIR (see appendix C) which confirmed its chemical identity unequivocally.  
Furthermore, purity was confirmed using its melting point of 145 ºC to make certain all samples 
were pure and homogenous.  Two new octadentate macrocyclic ligands were prepared using the 
mono substituted 2-hydroxy-cyclohexyl-cyclen with amidic arms introduced by N-alkylation at 
the three available positions on the cyclen backbone.  The choice of pendant groups originated 
from the fact that hydroxyalkyl pendant groups are activated by metal ion coordination to 
become potent nucleophiles294-297 while amide groups slow down demetalation of 
complexes.298,299  The amide ligand 2, 1,4,7-tris[N-methylcarbamylmethyl]-10-(2-
hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane,68 the N,N-dimethyl analogue 3, 1,4,7-
tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-tetraazacyclododecane68 
and the secondary amide 4, 1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-
tetraazacyclodecane also commonly known as DTMA146,265 were prepared using established 
procedures involving the alkylation of molecule 1 with the appropriate α-haloamide derivative.  
Although two different methodologies were used toward the synthesis the ligands 2 and 3, 
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Tsukube and co-workers68 method was found to be most useful for high yields (< 95 %) and 
reproducible preparations.  All N-substituted cyclen based ligands were characterized using 
conventional methods as described earlier.  The lanthanide complexes were prepared in 
anhydrous acetonitrile by reaction with the lanthanide trifluoromethanesulfonate (triflate) salt, 
and purified by recrystallization.  Complexation reactions with Eu3+ and Gd3+ were successfully 
achieved using the method developed by Parker and co-workers265 and resulted in high yields of 
complex being isolated.  All target molecules were characterized using conventional methods 
(see appendices A, B and C) and X-ray crystallography was utilized when possible.  The 1H 
NMR spectra for Eu3+ complexes are understandably complex as the ligands in question lack C4 
symmetry and give rise to 16 possible isomers.  However, other useful information can be 
deduced concerning the coordination geometry of these Eu3+ complexes.  Many studies on 
related lanthanide complexes of carboxylate or amidic origin have revealed that two major 
diastereomers are present in solution namely the capped square antiprism and the twisted-square 
antiprism structure.136,152  Both asymmetrical complexes 5 and 7 gave rise to four non-equivalent 
axial ring resonances that shifted to higher frequency compared to other resonances (see 
appendices A18 and A22).  The presence of resonances in the 10 to 25 ppm range suggested that 
there was a mixture of two major isomers present.300  In general, the syntheses of Ln-based 
polyazamacrocycles are very feasible and can be prepared quantitatively.  The reproducibility 
and high yields achieved in this work makes these newly synthesized complexes commercially 
viable as the reactions are atom economical. 
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Figure 3.54:  Target molecules in the study. 
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Supramolecular Chemistry 
 
Molecule 2 was isolated as a free base whereas molecule 3 was isolated as a sodium complex. 
They both formed in the monoclinic crystal system and found to be in the P21/c and P21/n space 
group, respectively (see Figure 3.4, 3.6 and Table 3.1).  Both crystals are stabilized by multiple 
and cooperative intramolecular N―H⋅⋅⋅O and O―H⋅⋅⋅O hydrogen bonding interactions.  The 
average torsion angles N―C―C―N in the cyclen ring for molecule 2 and 3 were 62.45 º and 
60.76 º, respectively.  The use of Na+ as a substitute for lanthanide ions in X-ray crystallography 
has been previously demonstrated by other work performed by Govenlock and co-workers, as the 
ion is of similar size and thereby a similar coordination requirement.301  The decrease in average 
torsion angles for molecule 3 can be attributed to the presence of sodium in the macrocyclic 
cavity which through electrostatic interactions draws the donor atoms closer to the metal center.  
The average Na―N (2.595 Å) and Na―O (2.563 Å) bond lengths for molecule 3 confirm this 
argument.  Comparing the average metal to donor distances in the sodium complex with the 
complexes 5 and 6, where Eu―N (2.661 Å), Eu―O (2.381 Å) and Gd―N (2.659 Å), Gd―O 
(2.376 Å), respectively, and found them to very close to eachother and to the sodium-donor 
distances in 3. 
 
Three lanthanide complexes are reported where each adopts a capped square anitiprismatic 
geometry.143  Molecule 2 formed crystals with both europium and gadolinium to give molecule 5 
and 6, respectively.  They both formed in the triclinic and orthorhombic crystal system and found 
to be in the P-1 and Pcca space groups, respectively.  The central lanthanide ion coordinates to the 
four nitrogens of the cyclen ring, the three amide oxygens and the hydroxyl group oxygen of the 
pendant cyclohexyl ring giving rise to an octadentate system which further coordinates to either 
water302 as in the case of molecule 5 or a triflate as in the case of molecule 6 to form a nine 
coordinate polyhedron.  For molecule 5, the average Eu―N and Eu―O bond distances within 
the cyclen ring were 2.661 Å and 2.381 Å, respectively.  In addition the bond distance between 
the oxygen from the triflate in the capping position and the central europium metal, Eu―O TfO-, 
was 2.443 Å.  However, for molecule 6, the average Gd―N and Gd―O bond distances within 
the cyclen ring were 2.659 Å and 2.376 Å, respectively.  In addition, the bond distance between 
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the oxygen from the water in the capping position and the central gadolinium metal, Gd―OW, 
was 2.442 Å.  The closeness of the geometrical parameters between molecule 5 and 6 further 
demonstrate that Eu3+ can be used as a structural probe for corresponding Gd3+ analogues.  The 
geometry about the lanthanide ions for molecules 5 and 6 is a distorted capped square 
antiprism.143 
 
Similarly, molecule 4 formed a crystal with europium to give molecule 9, which is formed in the 
triclinic crystal system and found in the P-1 space group.  Molecule 9 also has a nine coordinate 
environment which arises from coordination to four nitrogens of the cyclen ring, the four oxygen 
donors on the carboxylic amides and an additional water molecule which caps the macrocycle.  It 
thus assumes a similar distorted capped square anitiprism geometry.  For molecule 9, the average 
Eu―N and Eu―O bond distances within the cyclen ring were 2.650 Å and 2.388 Å, 
respectively.  In addition, the bond distance between the oxygen from the water in the capping 
position and the central europium metal, Eu―OW, was 2.437.   
 
Although the study of the solid-state structure gives the exact information about conformation, 
bond distances and bond angles potentially important interactions between the complex and its 
environment is given more accurately from the study of solution structure and specifically the 
interaction with solvent water molecules and buffering agents which better mimic conditions 
within the human body.   
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Table 3.10:  Summary of Spectroscopic pKa Determination. 
 
Table 3.10 provides a summary of the spectroscopic results obtained using luminescence and 
UV-vis spectroscopy.  The proposed protonation equilibrium of 5 and 9 in MCB with KHP is 
depicted Figure 3.25 and Figure 3.30, respectively.  The non-linear least squares fit results 
clearly illustrate the profound effect that KHP has on the overall outcome of each experiment.  
The phthalate moiety clearly behaves as an antenna for both 5 and 9, which results in enhanced 
                                                 
 
* invalid pKa caused by precipitation of europium ions at high pH 
Compound Name pKas in Water 
Mean 
pKas in MCB without 
KHP 
 
pKas in MCB with 
KHP 
 
pK1 = 8.69 ± 0.07 
UV-vis 
  pK1 = 8.70 ± 0.08 
pK1 = 9.04 ± 0.07 
UV-vis 
  pK1 = 9.02 ± 0.10 
pK1 = 4.67 ± 0.06 
pK2 = 8.69 ± 0.06  
UV-vis  
pK1 = 2.84 ± 0.24 
pK2 = 5.11 ± 0.10 
pK3 = 11.12 ± 0.62* 
 
 
 
 
  
pK1 = 8.22 ± 0.07 
UV-vis  
*2pKas could not be 
verified. 
 
 
  
pK1 = 4.99 ± 0.63 
pK2 = 7.30 ± 0.11  
UV-vis  
pK1 = 2.55 ± 0.16 
pK2 = 4.97 ± 0.02 
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emission in the acidic region and decreases after pH 7, which can be attributed to the 
displacement of pthlalate as the cyclohexyl moiety or amidic oxygen re-coordinates to the metal 
center, thus modulating the emission of europium complexes across the pH range for both 
complex 5 and 9.  Comparing the pKa for the deprotonation of water in 5 and 9 in MCB with 
KHP, the pKa for 5 was observed to be larger.  This increase can be attributed to the hydrophobic 
nature of the bulky cyclohexyl pendant.  For 5 and 9, the Eu―O bond length for the coordination 
of the cyclohexyl oxygen donor is 2.409 Å and 2.389 Å, respectively.  From this it could be 
deduced that there is not a major difference in coordination environment in 5 and 9.  The 
cyclohexyl group is merely a substitute for the weakest amidic oxygen interaction as can be seen 
from the bond distances.  Although it could be pointed out that the average Eu―O bond length 
of amidic oxygen donors in 9 is 2.372 Å compared to 2.381 for 5.  This small change is 
negligible in the bigger scheme of things.  Thus by incorporating the cyclohexyl moiety into the 
ligand architecture the coordination polyhedron was not changed to any great extent.  It could be 
argued that the cyclohexyl group elicits compression on the metal center effectively making the 
metal smaller which increases the pKa of the metal bound water molecule by increasing its bond 
length as illustrated in Figure 3.55.   The fact is that cyclohexyl moiety in 5 binds more strongly 
to the metal center than the acetamide counterparts in 9 causing an increase in pKa.  In addition, 
it is proposed that the bulky hydrophobic nature of the cyclohexyl moiety that plays a certain role 
in causing an increase in pKa of the metal bound water molecule.  In general for 5, it can be 
observed that it is the hydrophobic nature of cyclohexyl group and ionic like character of the 
tautomeric amidic arms that leads to a higher pKa value for the hydrolysis of water coordinated 
to the metal center being observed.  This result agrees well with the hypothesis and this could 
facilitate fast water exchange when applied to MRI.   
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Figure 3.55: Metal compression induced by cyclohexyl moiety causes an increase in pKa value c      
                      of water molecule attached to europium metal center. 
 
The proposed protonation equilibrium of 5 and 7 in MCB excluding KHP is depicted Figure 3.35 
and Figure 3.40, respectively.  Comparing the pKa for the hydrolysis of water in 5 and 7 in MCB 
excluding KHP, again it was observed that the pKa for 5 is larger.  This is possibly due to the 
weaker inductive effect of 7 and stronger tautomeric effect of 5.  The mere fact that the 
deprotonation of 7 is not possible and only relies on weaker inductive interaction brought about 
by the methyl groups on C=O―Eu bond making the Eu―O(W) bond much stronger as illustrated 
in Figure 3.56.  However, for 5 which can be deprotonated it is proposed that the tautomers of 
the amidic pendant arms form a much stronger C=O―Eu interaction and the presence of a 
methyl group also contributes with a weaker inductive effect.  The net effect results in an 
increased pKa of the coordinated water molecule. 
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Figure 3.56: Inductive effects can cause a decrease in pKa value of water molecule   
                    attached to lanthanide metal center. 
 
Examining the proposed protonation equilibrium of 5 in water only, depicted in Figure 3.45, it is 
evident that the other biological buffers do not change the pKa corresponding to the 
deprotonation of water from the central metal significantly, taking experimental error into 
account.  The modulation of luminescence and absorbance spectra of 5 in water compared to 5 in 
MCB without KHP across the pH range was very similar.  Their respective weighted pKa values 
were found to be pK1 = 8.69 ± 0.07 and pK1 = 9.04 ± 0.07, and confirms that although Goods 
buffers do not coordinate to the metal center, its presence in solution has negligible effects in 
terms of the actual pKa values obtained.   
 
Overall the results obtained spectroscopically show that these newly developed complexes do 
show potential as MRI-CAs since their intensity is highest within the physiological pH range.  
However, incorporating the cyclohexyl moiety onto the cyclen backbone or using the di-
methylated acetamide arms instead of the N-methylated had a negligible influence on the overall 
hydrolysis of the metal-bound water molecule.  In addition, the phthalate moiety clearly behaves 
as an antenna and is modulated by the change in pH.  Designing a system which incorporates the    
phthalate moiety into the ligand structure as a potential MRI-CA would be the next step in the 
right direction. 
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q Values 
 
The presence of the metal-bound water molecules coordinated to complex 5 in MCB with KHP 
and water only were observed by evaluating the hydration number (q) using the luminescence 
methods described earlier, where the rate constant for radiative decay (k) of the 5D0 excited state 
of Eu3+ are measured in H2O and D2O.216-224,268  The details of which are tabulated in Table 3.7 
and Table 3.9.  From these results it can be seen that whether in water or in MCB with KHP the 
central metal has single water molecule coordinated to the metal center a very important feature 
inherent to MRI-CAs.  Considering the chemical environment in samples containing the 
phthalate moiety it is understandable why there is a q value that tends to 2 at low pH < 4.9.  
Unidentate coordination of phthalate, as illustrated in Figure 3.58, at low pH permits formation 
of hydrogen bonds with water molecules in the outer coordination sphere, the hydrogen of the 
outer sphere water molecule then hydrogen bonds to the oxygen of the cyclohexyl moiety.  The 
outer sphere water molecule could also bond to other water molecules that are in close proximity.  
At higher pH > 7 further phthalate deprotonation alters the hydrogen bonding array to 
accommodate hydrogen bonded outer-sphere water.  The q values obtained show a decrease as 
pH is increased.  It is the above mentioned phenomena which result in an overall decrease in OH 
oscillators in the coordination polyhedron.  From the results obtained it is clear that phthalate 
moiety coordinates with the central Eu3+ ion in a unidentate fashion and the central metal indeed 
maintains a coordination number of nine.   
 
The q values corroborate well with luminescence spectroscopic data which shows two valid 
spectroscopic pKas, corresponding to the phthalate deprotonation followed by the deprotonation 
of the metal-bound water molecule and where the mean pKa value was found to be pK1 = 4.67 ± 
0.06 and pK2 = 8.69 ± 0.12, respectively.   
 
 
 
 
 | P a g e  
 
 
180
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.57:  The proposed coordination environment of 5 in the presence of KHP. 
 
It is proposed that if phthalate were to bind in a bidentate fashion it will result in the formation of 
a 7-membered ring chelate, which is highly unstable and will immediately result in the 
displacement of the metal-bound water molecule.  At low pH < 4.9, the negatively charged 
oxygen atom of the phthalate moiety has a much stronger ionic interaction as compared to the 
neutral cyclohexyl group and initially causes the cyclohexyl moiety to be displaced.  At high pH 
>7, it is proposed that the opposite occurs where the cyclohexyl group displaces the phthalate 
resulting in a decrease in emission intensity as observed in the luminescence studies.  The slight 
increase in q is attributed to the hydrogen bonding elicited by the cyclohexyl moiety which 
interacts with outer sphere water molecules.  There exists a closely linear relationship between q 
values and the number of protons lost during hydrolysis due to an increase in pH.  Figure 3.57 
illustrates how the europium metal center maintains its coordination number of nine.  Overall, 
the slight increase in q at high pH which should be close to 0.5, is brought about by outer sphere 
hydrogen bonding between the phthalate and cyclohexyl moiety with outer sphere water 
molecules.    
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Figure 3.58:  The proposed coordination environment of 5 in water remains unchanged. 
 
The presence of the metal-bound water molecules coordinated to complex 5 in water was 
evaluated.  At low pH the q value is close to one since there is a water molecule coordinated to 
the metal center.  As the pH is increased and this water molecule is deprotonated the value of q 
tends to 0.5.  The decrease in q is attributed to the deprotonation the metal-bound water 
molecule.   Figure 3.58 shown above illustrates the proposition and the plot of q value versus pH 
shown in Figure 3.48 shows there exists a linear relationship between q and the number of 
protons lost during hydrolysis.  For the non-linear least square fit of this relationship the R2 was 
found to be 0.99.  In summary the results obtained suggests the presence of a single water 
molecule and the unidentate coordination of phthalate in solution. 
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Cyclic Voltammetry 
 
Finally, the electrochemical behavior of complex 5 and 9 across the pH range were investigated 
using cyclic voltammetry (CV).  The mid-point reduction potential E1/2 of a Eu3+L/Eu2+L redox 
couple gives direct information on the redox stability of the Eu2+ state: a less negative E1/2 
indicates higher resistance of the E2+L to oxidation.303  A well defined symmetrical 
voltammogram is observed for both complexes and it is deduced that there can only be a single 
electrochemically active species.  The results for 5 show that the metal is encapsulated between 
pH 3 to 10 (E1/2 = -0.83 V), however above pH 11 the complex is demetalated (E1/2 = -1.01 V).  
The results for 9 show that the metal is encapsulated between pH 3 to 10 (-0.83 V), however 
above pH 10.5 the complex is also demetalated (-1.0 V).   
 
The midpoint potential is related to the ratio of the thermodynamic stabilities of the E3+L and 
Eu2+L given by Equation 3.3 below.304 
 
                                                            RT       KEu2+ 
         F        KEu3+      
 
The peak separations for both complexes are different.  At low pH, between 3 and 8.8 both 
complexes are quasi reversible and show a peak separation of < 57 mV.  However at high pH > 
10, complex 5 and 9 have peak separations of 63 mV and 36 mV, respectively.  It is proposed 
that at high pH > 11.5 that the lanthanide ion in complex 5 protrudes out of the macrocyclic 
cavity, whereas in complex 9 at about pH 10.9 it is still within the cavity of the macrocycle.  This 
is a major difference and is attributed to the increased resistance of 9 to be demetalated due to the 
four amidic arms which become deprotonated and hold onto the metal more tightly.  In the case 
of 5, the weaker interaction of the cyclohexyl group allows less resistance to demetalation.  From 
the study of E1/2 across the pH range it is clear that the hydrolysis of the metal-bound water 
molecule, the coordination and displacement of the phthalate moiety does not significantly affect 
the electrochemistry of the metal center. 
 
ln ……………..Equation 3.3 ΔE1/2 = E1/2,complexed - E1/2,uncomplexed = 
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At high pH, the slightly less negative value of 9 (E1/2 = -1.0 ) compared to 5 (E1/2 = -1.01 ) shows 
that 9 is not readily oxidized.  This result shows that complex 5 is less resistant to oxidation as 
compared to complex 9, meaning that incorporating the cyclohexyl moiety into the macrocyclic 
backbone shows no major contribution in terms of complex stability.   
 
The standard rate constant is determined for electron transfer by plotting the log of the peak 
cathodic current, log icp, against the log of the scan rate, log v.  The slope is close to 1.0 for both 
complexes investigated, which means the reductions in both complexes are not diffusion 
controlled but the redox active species are adsorbed on the electrode surface.  The 
electrochemical results shows that the metal remains encapsulated for most of the pH range and 
only becomes toxic free metal above pH 11, which is why molecule 5 could be an ideal 
candidate for MRI-CA development.   
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Chapter Four Conclusions and Future work 
4.1  Concluding Remarks 
 
 
In this focused study the spectroscopic and electrochemical properties of paramagnetic 
lanthanide polyazamacrocyclic complexes in solution were studied across the pH range.  
Systematic research in the field of MRI contrast media focuses on the development of complexes 
with higher efficiency (relaxivity) and new functionalities which target specific organs and 
diseases.  In this work some of these interaction parameters are assessed and used to understand 
their structure-property relations that exist in solid and solution state.  So far, there are no studies 
that report interactions of lanthanide complexes in which a β-amino alcohol pendants are 
involved.  This study is a first of its kind and the results obtained agree with theory for the most 
part.  Firstly, the mono-substituted β-amino alcohol cyclen intermediate was successfully 
isolated, followed by N-alkylation with the appropriate α-haloamide derivative to produce 2 and 
3 in high yields and reproducibility.  Ligand 4 was successfully synthesized for comparative 
purposes.  Complexation of these ligands afforded us the target complexes shown in Figure 3.54.   
 
Three lanthanide crystal structures are reported with each adopting a nona-coordinated 
polyhedron with a capped square anitiprismatic geometry.  It is observed that the mean Ln―O 
bond distances for amidic oxygen donors decrease in length when going from complex 9 to the 
newly synthesized asymmetric hydroxy-cyclen-based complexes.  The complexes showed almost 
no disorder using crystallization by slow evaporation techniques.  Although the differences in 
bond length is very small this result confirms that the metal compression induced by the 
cyclohexyl moiety induces stronger bonding to the oxygen donors of the acetamide arms which 
translates into the oxygen donor in the capping positions having a longer Ln―O bond length.  
The longer Ln―O bond observed in the capping position promotes the hydrolysis of the metal 
bound water molecule which facilitates fast water exchange when applied to MRI.  In addition 
similarity of geometrical parameters between molecule 5 and 6 further demonstrate that Eu3+ can 
be used as a structural probe for corresponding Gd3+ analogues.   
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The spectroscopic behavior of the Eu-complexes in MCB with KHP were investigated across the 
pH range and found that the phthalate moiety clearly behaves as an antenna and modulates the 
emission.   Comparing the pKa for the metal-bound water molecule in 5 and 9 in MCB with 
KHP, it was observed that the pKa for 5 was larger.  This increase can be attributed to the 
hydrophobic nature of the bulky cyclohexyl moiety.  In general for 5, it can be observed that it is 
both compression induced by cyclohexyl moiety and ionic like character of tautomeric arms that 
leads to a higher pKa value for the hydrolysis of water coordinated to the metal center being 
observed.  At low pH < 4.9, the phthalate behaves like an antenna and transfers energy from the 
S1 and T1 energy level to the lanthanide triplet state resulting in an enhanced emission.  At high 
pH > 7, the phthalate is displaced by either the cyclohexyl group in the case of 5 or one of the 
amidic arms in the case of 9 as the pH is increased further.   The spectroscopic behavior of 5 and 
7 in MCB excluding KHP showed that the pKa for 5 was again larger.  This is possibly due to the 
weaker inductive effect of 7 and stronger tautomeric effect of 5.  Examining the spectroscopic 
behavior of 5 in water only showed that that the other biological buffers do not interact with the 
metal center.  The results show that these Goods buffers namely; CHES, MES, MOPS and Tris 
do not coordinate to the metal directly and the minute difference in pKa observed could be due 
experimental error or conditions.    
 
The hydration number (q) for complex 5 in MCB with KHP and aqueous solution were 
evaluated.  For the former investigation with KHP, at low pH it was found that the q value that 
tends to 2 and at high pH tends to 0.5.  It is proposed that at low pH the phthalate anion 
coordinates in a unidentate fashion and displaces the cyclohexyl moiety.  This coordination 
permits hydrogen bonding between the phthalate and cyclohexyl moiety with outer sphere water 
molecules.  It is this specific interaction that causes q to increase since the number of OH 
oscillators around the polyhedron increases.   
 
At higher pH > 7, the phthalate is further hydrolyzed, and again hydrogen bonds to neighboring 
water molecules where q now tends to 1.4.  This is followed by the hydrolysis of the metal-
bound water molecule which decreases the q value substantially.  The q values obtained agreed 
well with the proposition that the phthalate moiety coordinates with the central Eu3+ ion in a 
unidentate fashion.   It is proposed that if phthalate were to bind in a bidentate fashion it will 
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result in the formation of a 7-membered ring chelate which is highly unstable and will 
immediately result in the displacement of the metal-bound water molecule as mentioned earlier.  
Following from the argument used in the luminescence study, it is proposed that at high pH the 
cyclohexyl group displaces the phthalate.  In the latter study in aqueous solution, complex 5 
behaves as predicted.  At low pH the q value is close to one since there is a water molecule 
coordinated to the metal center.  As the pH is increased and this water molecule is deprotonated, 
the value of q tends to 0.5.   
 
Finally, the electrochemical behavior of complex 5 and 9 across the pH range were investigated 
using cyclic voltammetry (CV).  The results show that there is only one electrochemical species 
in solution and that the metal is encapsulated within the complexes between pH 3 to 10, however 
above pH 10.5 the complex is demetalated.  It was determined that the reductions in both 
complexes are not diffusion controlled but the electrochemically active species are adsorbed on 
the electrode surface.  In addition, the E1/2 for both complexes across the pH range was 
determined, which showed that 9 is more resistant to demetalation than 5.  It was demonstrated 
that incorporating the cyclohexyl group into the macrocyclic backbone does not really increase 
complex stability.  The hypothesis that by incorporating the bulkier backbone of the cyclohexyl 
ring onto cyclen, causes a decrease in the activation energy required to reach the eight coordinate 
transition state thereby increasing the rate of exchange with the bulk solution cannot be 
disproved.  However, the increase in the Ln―O bond length is not due to the steric effects of 
cyclohexyl moiety instead it’s the hydrophobic nature of the cyclohexyl group which is possibly 
causing this increase in pKa of the metal bound water molecule.  Overall the findings for all 
investigation sheds does some light into this subject matter and explains the behavior of these 
types of systems in solution which can be corroborated using supramolecular chemistry.   
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4.2  Futurework 
 
Clearly more work will be required if the complete relationship between spectroscopic, 
electrochemical and coordination environment is to be elucidated.  Nonetheless, the work 
presented herein lays the foundation for future projects.  Starting with the ligand architecture, 
where the size of the ring and number the β-amino cyclic moieties can be altered and optimized 
to get the best possible metal encapsulation.  Furthermore, the type of pendant arms could also be 
changed to hydroxymates which have been shown to have better relaxivity than their amidic 
counterparts.  The solution chemistry can be further investigated using a plethora of anionic 
chromophores including lactate, citrate, malonate and salicylic acid derivatives.  Generally, in 
scientific research it is clear that an answer to a question gives birth to new questions.  The next 
step towards powerful imaging involves specific recognition between the Gd3+ complex and a 
target of interest.  A more holistic view on the current subject matter, namely the development of 
MRI contrast agents, would be incomplete without relaxometric investigations of these types of 
systems with gadolinium, to access its feasibility and practicality in its application in early 
diagnosis. 
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Appendices 
A  NMR 
A1:  N-Me-chloroacetamide – 1H 
O
Cl NHCH3
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A3:  N-Me-chloroacetamide – C-H correlation 
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A4:  Di-Me-chloroacetamide – 1H 
  O
Cl N(CH3)2
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A5:  Di-Me-chloroacetamide – 13C 
  O
Cl N(CH3)2
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A6:  1-(2-Hydroxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1) – 1H 
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A8:  1-(2-Hydroxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1) – COSY 
NH N
HNNH
OH
1
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A10:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
          tetraazacyclododecane (2) -1H 
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A11:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
          tetraazacyclododecane (2) 13C 
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A12:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
           tetraazacyclododecane– C-H correlation 
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A13:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
           tetraazacyclododecane (2) – COSY in D2O 
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A14:  1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
           teraazacyclododecan (3) – 1H 
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A15:  1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
           teraazacyclododecan (3) – C-H correlation 
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A16:  1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (4) – 1H 
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A17:  1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (4) – 13C 
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A17:  Eu-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
           tetraazacyclododecane (5) – 1H 
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A18:  Eu-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
          tetraazacyclododecane (5) – COSY 
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A19:  Eu-1-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
          tetraazacyclododecane (5) – 3D COSY 
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A20:  Eu-1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-  
          1,4,7,10-tetraazacyclododecane (7) – 1H 
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A21:  Eu-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (9) – 1H 
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DS-Cy-cyclen I5_17 Oct 2011 #49-94 RT: 1.05-1.94 AV: 46 NL: 1.01E7
T: ITMS + c ESI Full ms [150.00-1000.00]
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B – ESI-MS 
B1:  1-(2-Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1) 
NH N
HNNH
OH
1Mw = 270.41 g.mol-1
[M + H]+ = m/z (271) 
[M + Na]+ = m/z (293) 
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B2:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
       tetraazacyclododecane (2) 
DS-N-Me-Ac3-Cy-cyclen C1_07 Sep 2011 #9-29 RT: 0.17-0.56 AV: 21 NL: 8.42E6
T: ITMS + c ESI Full ms [150.00-1000.00]
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2
Mw = 483.65 g.mol-1
[M + H]+ = m/z (484)  
[M + Na]+ = m/z (507) 
[M + K]+ = m/z (522) 
[M + Cs]+ = m/z (616)   
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B3:  1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
       tetraazacyclododecane (3) 
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Mw = 525.73 g.mol-1 
[M + H]+ = m/z (527)  
[M + Na]+ = m/z (549) 
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Comparison betw een "C:\MASPEC\Data\DS 012 LRFAB.ms2" and "C:\MASPEC\Data\NBA 01082006 LRFAB.ms2"
Scan 5#0:28 - 7#0:39. Entries=911. Base M/z=154. 100% Int.=2.84587. FAB. POS. 
Scan 9#0:55. Entries=1273. Base M/z=154. 100% Int.=1.79712. FAB. POS. 
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SCAN GRAPH. Flagging=Low  Resolution M/z. 
Scan 5#0:28 - 7#0:39. Entries=911. Base M/z=154. 100% Int.=2.84587. FAB. POS. 
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B4:  1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (4) 
 
 
N
N
N
N
O
MeHN
O
MeHN
O NHMe
NHMe
O
4
Mw = 456.58 g.mol-1
[M + H] = m/z (480) 
  [M + Na+] = m/z (480) 
[M + Ca2+] = m/z (495) 
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DS Eu(III)-N-Me-Ac3-Cy-cyclen A_27 Oct 2011 #62-206 RT: 1.94-6.52 AV: 145 SB: 62 0.00-1.94 NL: 2.62E5
T: ITMS + c ESI Full ms [150.00-2000.00]
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B5:  Eu-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
        tetraazacyclododecane (5) 
DS Eu(III)-N-Me-Ac3-Cy-cyclen A_27 Oct 2011 #96 RT: 3.01 AV: 1 NL: 2.98E5
T: ITMS + c ESI Full ms [150.00-2000.00]
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Mw = 635.61 g.mol-1
[M + 2H]2+ = m/z (318) 
  [M + 1TfO]2+ = m/z (393) 
[M + 1TfO]+ = m/z (784) 
[M + 2TfO]+ = m/z (934) 
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B6:  Eu-1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
       tetraazacyclododecane (7) 
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Mw = 677.69 g.mol-1
[M + 2H]2+ = m/z (414) 
 [M + 2TfO]+ = m/z (976) 
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B7:  Eu-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (9) 
9
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OEu
Mw = 608.55 g.mol-1
[M - H]+ = m/z (607) 
 [M + 1TfO]+ = m/z (757) 
  [M + 2TfO]+ = m/z (907)   
 | P a g e  
 
 
234
B8:  Gd-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
        tetraazacyclododecane (6) 
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Mw = 640.90 g.mol-1
[M + 2H]2+ = m/z (395) 
 [M + 1TfO]+ = m/z (789) 
  [M + 2TfO]+ = m/z (939) 
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B9:  Gd-1,4,7-tris[N,N-dimethylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10- 
        tetraazacyclododecane (8) 
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Mw = 682.98 g.mol-1
[M + 2TfO]+ = m/z (982). 
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C- FTIR 
C1:  N-Me-chloroacetamide 
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C2:  Di-Me-chloroacetamide 
34
37
.9
5
29
43
.4
7
16
38
.9
6
15
00
.2
9
14
01
.0
8
12
56
.7
3
11
20
.5
4
10
61
.2
7
97
9.
57
92
9.
88
79
3.
39
74
9.
86
65
6.
07
56
5.
38
5001000150020002500300035004000
Wavenumber cm-1
20
40
60
80
10
0
12
0
14
0
Tr
an
sm
itt
an
ce
 [%
]
 
 
  O
Cl N(CH3)2
 | P a g e  
 
 
238
C3:  1-(2-Hydoxycyclohexyl)-1,4,7,10-tetraazacyclodecane (1) 
 
32
83
.9
9
27
99
.1
0
14
46
.4
9
13
37
.3
3
12
84
.2
4
12
40
.0
6
12
13
.4
7
11
13
.5
0
10
78
.7
7
10
40
.1
0
94
5.
46
91
8.
13
85
7.
78
81
1.
09
75
1.
14
61
7.
71
5001000150020002500300035004000
Wavenumber cm-1
20
40
60
80
10
0
12
0
14
0
Tr
an
sm
itt
an
ce
 [%
] NH N
HNNH
OH
1
 | P a g e  
 
 
239
C4:  1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
        tetraazacyclododecane (2) 
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C5:  1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (4) 
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C6:  Eu-1,4,7-tris[N-methylcarbamylmethyl]-10-(2-hydroxycyclohexyl)-1,4,7,10-  
        tetraazacyclododecane (5) 
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C7:  Eu-1,4,7,10-Tetrakis(methylcarbamylmethyl)-1,4,7,10-tetraazacyclodecane (9) 
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D:  Some Important Calculations and Electrode Standardization 
0.05 M KHP standard solution: 
 
mKHP required    = CVM 
     = 0.05 mol/L x 0.250 L x 204.2231 g/mol 
     = 2.553 g 
mKHP measured   = 2.555 g 
CKHP     = (2.555 g) ÷ (204.2231 g/mol x 0.250 L) 
     = 0.050043 mol/L 
 
0.1 M NaNO3 standard solution: 
 
mNaNO3 required   = CVM 
     = 0.1 mol/L x 0.250 L x 84.9949 g/mol 
     = 2.1249 g 
mNaNO3 measured   = 2.1249 g 
CNaNO3     = (2.1249 g) ÷ (84.9949 g/mol x 0.250 L) 
     = 0.1000013 mol/L 
 
0.05 M NaOH / 0.05 M NaNO3 standard solution: 
 
VNaOH of 0.1 M HNO3 used  = 0.500 L 
mNaNO3 required   = CVM 
     = 0.05 mol/L x 1.0 L x 84.9949 g/mol 
     = 4.2497 g 
mNaNO3 measured   = 4.2498 g 
CNaNO3     = (4.2498 g) ÷ (84.9949 g/mol x 1.0 L) 
     = 0.0500006 mol/L 
 
Titration with 0.05 M KHP 
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VKHP used    = 5.00 mL 
nKHP     = 0.050043 mol/L x 0.005 L 
     = 2.50215 x 10-4 mol 
 
Table D1: Titration of 0.05 M KHP with 0.05 M NaOH / 0.05 M NaNO3. 
Titration Vini (mL) Vfin (mL) VTotal (mL) 
1 0.08 5.12 5.04* 
2 0.00 5.06 5.06 
3 0.10 5.28 5.18 
4 0.00 5.14 5.14 
 
Average volume used titrated  = 5.105 mL 
 
 
Since KHP reacts with NaOH in a 1:1 ratio, 
CNaOH     = 2.50215 x 10-4 mol ÷ 0.005105 L 
     = 0.0490137 mol/L 
 
Thus, the actual concentration of 0.05 M NaOH / 0.05 M NaNO3 solution is 0.049013 M 
NaOH / 0.0500006 M NaNO3. 
 
0.05 M HNO3 / 0.05 M NaNO3 standard solution: 
 
VHNO3 of 0.1 M HNO3 used  = 0.500 L 
mNaNO3 required   = CVM 
     = 0.05 mol/L x 1.0 L x 84.9949 g/mol 
     = 4.2497 g 
mNaNO3 measured   = 4.2502 g 
CNaNO3     = (4.2502 g) ÷ (84.9949 g/mol x 1.0 L) 
     = 0.050005 mol/L 
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Titration with 0.049013 M NaOH / 0.0500006 M NaNO3 
 
V HNO3 used    = 5.00 mL 
nNaOH     = 0.050005 mol/L x 0.005 L 
     = 2.50026 x 10-4 mol 
 
Table D2:  Titration of 0.05 M HNO3 / 0.05 M NaNO3 with 0.05 M NaOH / 0.05 M NaNO3. 
Titration Vini (mL) Vfin (mL) VTotal (mL) 
1 0.12 5.14 5.02 
2 0.00 5.06 5.06 
3 0.00 5.02 5.02 
4 0.04 5.08 5.04* 
 
Average volume used  = 5.035 mL 
 
Since HNO3 reacts with NaOH in a 1:1 ratio, 
CHNO3     = 2.50026 x 10-4 mol ÷ 0.005035 L 
     = 0.0496576 mol/L 
 
Thus, the actual concentration of 0.05 M HNO3 / 0.05 M NaNO3 solution is 0.0496576 M 
HNO3 /0.050005  M NaNO3. 
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Standardization of Electrodes 
 
The titration data obtained for two different electrodes is tabulated below. 
Table D3: Electrode standardization raw data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The electrode standardization was performed on a solution consisting of 5 mL of the 0.0496576 
M HNO3 / 0.050005 M NaNO3 standard solution and 15 mL of the 0.1 M NaNO3 standard 
solution. This 20 mL solution was titrated with 10 mL of the 0.049013 M NaOH / 0.0500006 M 
NaNO3 standard solution, which was dispensed in 0.5 mL increments. Voltage readings were 
measured upon each increment addition via the glass electrode over a 3 minute period, with a 0.1 
mV drift constraint allowed for each reading. 
 
 
VNaOH added 
(mL) 
E (mV) 
Electrode 1 
E (mV) 
Electrode 2 
0.00 297.3 296.2 
0.50 289.1 293.3 
1.00 283.5 288.5 
1.50 278.1 281.9 
2.00 276.3 278 
2.50 272.3 272 
3.00 269.1 265.8 
3.50 263 257.7 
4.00 254.4 245.6 
4.50 239.8 227.3 
5.00 213.8 217.8 
5.50 -83.7 -222.9 
6.00 -162.2 -241.7 
6.50 -234.2 -255.8 
7.00 -239.7 -262.2 
7.50 -252.4 -268.2 
8.00 -260.5 -273 
8.50 -266.8 -276.9 
9.00 -270.5 -279.5 
9.50 -274.4 -282.7 
10.00 -277.6 -284.5 
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Eo = pH(slope) + E 
 
 
The value for Eo determined for the particular cell plus glass electrode plus reference electrode 
used in this study ranged from 402.8 to 405.6 mV, accompanied by a small deviation of the 
Nernstian slope from the accepted 59.16 mV. Determined values of the Nernstian slope obtained 
here ranged from 56.49 to 57.87 mV/decade. It is normal for the Eo and Nernstian slope to 
change for a given glass electrode, which is thought to be caused by changes in the surface 
structure of the glass with time. This deviation in the Nernstian slope, as well as changes in Eº 
for the cell, are the reasons that daily determinations of these cell constants were necessary. 
Nernstian slopes in the range 56-61 mV are considered acceptable. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Electrode 2 was only used in experiments as it showed comparably better fit to the   
          Nernstian Equation than Electrode 
 
y = -56.49x + 402.8
R² = 0.999
y = -57.87x + 405.6
R² = 1
-400
-200
0
200
400
0 2 4 6 8 10 12
Vo
lta
ge
 / 
m
V
pH
Electode 1
Electrode 2
Linear (Electode 1)
Linear (Electrode 2)
Shows linear least square fits of electrodes tested. 
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E:  Spectroscopic Data 
Luminescence Data  
Table E1:  Complex 5 in MCB with KHP 
pH 
 
580 nm 
 
593 nm 
 
616 nm 
 
653 nm 
 
686 nm 
 
700 nm 
 
1.98 28.01032 127.3811 104.3255 8.885786 47.70411 84.57339 
2.197 28.25131 126.5988 106.4739 8.863433 48.96783 84.38441 
2.469 28.19157 127.5536 104.306 9.604146 48.14294 84.36037 
2.503 28.83414 132.5533 108.333 9.040313 49.83659 88.45561 
2.651 26.2006 132.8248 105.8429 9.328521 47.20216 84.62986 
2.796 27.25687 141.8221 112.3092 8.903292 48.43601 91.58847 
2.93 33.71307 177.5957 147.1038 11.54678 58.86669 109.2576 
3.47 37.21442 198.2178 182.3395 12.26604 65.96891 122.9627 
3.885 40.20565 207.7741 207.1436 12.36586 67.12573 126.339 
3.95 43.82184 230.1279 251.4288 14.3421 74.88898 140.2473 
4.32 47.81548 242.0879 289.2793 15.67754 77.13499 146.6583 
4.47 54.7904 282.0136 363.1475 18.16419 95.54459 169.0585 
4.71 52.59426 267.2501 361.5172 16.66641 90.25335 163.8173 
4.9 66.87595 337.2163 478.7227 21.96202 112.3049 205.471 
4.959 67.34241 335.9375 474.9282 21.17924 113.4241 201.5364 
5.32 77.36083 391.5547 563.3078 25.14756 131.2099 235.3411 
6.101 88.94524 421.7938 618.9667 27.6757 152.0579 263.3185 
6.642 89.86274 432.255 636.149 29.19111 152.957 267.0365 
6.978 93.78536 442.3407 661.9435 30.3271 158.3971 268.1409 
7.171 93.34807 430.2551 615.4591 27.76355 153.5212 263.5741 
7.224 94.18813 406.1693 597.4482 28.48067 150.644 262.0091 
7.423 92.64413 376.8264 543.4401 27.43141 145.4159 250.0646 
8.204 85.42323 287.451 363.8146 23.33539 120.7403 200.3198 
8.172 82.62257 271.0667 346.9864 21.90217 115.9694 190.1282 
8.381 85.48022 249.6682 310.1425 20.86946 109.225 179.2365 
8.47 85.85754 230.5284 298.3781 18.96434 101.5758 169.7413 
8.675 86.46285 210.3616 282.8134 19.2936 97.28004 159.3553 
8.71 87.02991 164.2497 229.9756 15.39571 79.85363 131.5029 
9.382 76.53088 98.19234 147.0627 10.55114 54.58936 87.30116 
9.484 81.04065 114.598 170.1228 11.71361 63.02435 99.92001 
9.495 75.96996 72.68029 113.7259 8.725314 44.79044 70.72247 
9.705 71.84787 73.87054 115.4299 9.125332 46.0648 71.13033 
9.889 66.14352 49.75606 86.32747 6.57108 35.5578 53.63659 
10.048 63.36357 44.59178 78.5749 6.528862 34.90343 51.61696 
10.395 65.049 43.48596 74.03234 6.494727 33.18026 50.02839 
10.501 62.77079 38.31433 71.92744 6.088898 31.80132 46.11047 
10.91 58.58298 33.42497 62.33338 4.979872 27.73181 40.74892 
11.505 58.75228 31.75255 60.6249 5.783909 26.95882 41.18166 
12.555 55.31254 33.87047 70.04906 5.677895 25.58411 40.99745 
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pKa Fit Data 
Nonlinear Regression   Friday, March 09, 2012, 09:17:25 AM 
 
Data Source: Data 2 in Eu(III) complex 5 in MCB with KHP 580 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.99118461 0.98244693 0.98038187  3.17258473  
 
  Coefficient Std. Error t P  
 
A0 29.548236311.11777524 26.43486396 <0.00000001  
A1 90.373478011.04172690 86.75352221 <0.00000001  
A2 57.603660581.68079443 34.27168694 <0.00000001  
pK1 4.712167620.04959484 95.01326067 <0.00000001  
pK2 9.583540680.10150577 94.41375533 <0.00000001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression5 178066.2957358535613.25914717  
Residual34 342.21999153 10.06529387  
Total 39 178408.515727384574.57732634  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 19154.086342214788.52158555475.74582999 <0.00000001  
Residual34 342.21999153 10.06529387  
Total 38 19496.30633373 513.06069299  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.89587277) 
 
K-S Statistic = 0.09004608 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.93681075) 
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Fit Equation Description: 
[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 29.5482}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 90.3735}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 57.6037}} 
pK1 = 4.5 ' {{previous: 4.71217}} 
pK2 = 9 ' {{previous: 9.58354}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
 
Number of Iterations Performed = 10 
 
Nonlinear Regression   Friday, March 09, 2012, 09:53:05 AM 
 
Data Source: Data 1 in Eu(III) complex 5 in MCB with KHP 592 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.99084592 0.98177563 0.97963159  18.70274773  
 
  Coefficient Std. Error t P  
 
A0 143.221627496.78055026 21.12241955 <0.00000001  
A1 433.161474908.58164966 50.47531559 <0.00000001  
A2 42.681381476.35195333 6.71941043 0.00000010  
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pK1 4.586283480.06625694 69.21966596 <0.00000001  
pK2 8.438403370.04770984176.86925007 <0.00000001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression5 2288293.59826116457658.71965223  
Residual34 11892.95426487 349.79277250  
Total 39 2300186.5525260258979.14237246  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 640692.23799796160173.05949949457.90843063<0.00000001  
Residual34 11892.95426487 349.79277250  
Total 38 652585.1922628317173.29453323  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.17363925) 
 
K-S Statistic = 0.17316973 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.92410903) 
Fit Equation Description: 
[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 143.222}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 433.161}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 42.6814}} 
pK1 = 4.5 ' {{previous: 4.58628}} 
pK2 = 9 ' {{previous: 8.4384}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
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Number of Iterations Performed = 14 
 
Nonlinear Regression   Friday, March 09, 2012, 10:00:44 AM 
 
Data Source: Data 1 in Eu(III) complex 5 in MCB with KHP 616 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.99283200 0.98571538 0.98403483  24.71385710  
 
  Coefficient Std. Error t P  
 
A0 115.125938548.92294059 12.90224197 <0.00000001  
A1 649.1732987012.1495064353.43207169 <0.00000001  
A2 82.717943628.06825219 10.25227542 <0.00000001  
pK1 4.607445700.04831307 95.36643592 <0.00000001  
pK2 8.238542940.04504467182.89718988 <0.00000001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression5 4268661.17792443853732.23558489  
Residual34 20766.34090667 610.77473255  
Total 39 4289427.51883110109985.32099567  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 1432988.46056933358247.11514233586.54540873<0.00000001  
Residual34 20766.34090667 610.77473255  
Total 38 1453754.8014760038256.70530200  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.21347919) 
 
K-S Statistic = 0.16566708 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.35992142) 
 | P a g e  
 
 
253
Fit Equation Description: 
[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 115.126}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 649.173}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 82.7179}} 
pK1 = 4.5 ' {{previous: 4.60745}} 
pK2 = 9 ' {{previous: 8.23854}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
 
Number of Iterations Performed = 12 
Nonlinear Regression   Friday, March 09, 2012, 10:10:34 AM 
 
Data Source: Data 1 in Eu(III) complex in MCB with KHP 653 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.98999515 0.98009039 0.97774809  1.18261577  
 
  Coefficient Std. Error t P  
 
A0 9.715700430.41718093 23.28893694 <0.00000001  
A1 29.002068160.52358828 55.39098045 <0.00000001  
A2 6.047694410.42764396 14.14189144 <0.00000001  
pK1 4.713059680.06171309 76.37050454 <0.00000001  
pK2 8.662829650.05348310161.97321247 <0.00000001  
 | P a g e  
 
 
254
Analysis of Variance:  
 DF SS MS  
Regression5 11473.829618072294.76592361  
Residual34 47.55172241 1.39858007  
Total 39 11521.38134048 295.42003437  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 2340.82921707 585.20730427 418.42960336 <0.00000001  
Residual34 47.55172241 1.39858007  
Total 38 2388.38093947 62.85212999  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.38087336) 
 
K-S Statistic = 0.14236628 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.68250855) 
 
Fit Equation Description: 
[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 9.7157}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 29.0021}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 6.04769}} 
pK1 = 4.5 ' {{previous: 4.71306}} 
pK2 = 9 ' {{previous: 8.66283}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
 
Number of Iterations Performed = 12 
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Nonlinear Regression   Friday, March 09, 2012, 10:17:02 AM 
 
Data Source: Data 1 in Eu(III) complex 5 in MCB with KHP 685 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.99164441 0.98335864 0.98140083  5.77890585  
 
  Coefficient Std. Error t P  
 
A0 51.589455062.02181241 25.51643996 <0.00000001  
A1 155.290841402.59874710 59.75604214 <0.00000001  
A2 31.247589882.06662051 15.12013926 <0.00000001  
pK1 4.754228640.05624307 84.53003178 <0.00000001  
pK2 8.628604290.04803191179.64315537 <0.00000001  
 
Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression5 319718.2444172563943.64888345  
Residual34 1135.45559748 33.39575287  
Total 39 320853.700014728227.01794910  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 67095.4809956016773.87024890502.27555329 <0.00000001  
Residual34 1135.45559748 33.39575287  
Total 38 68230.936593081795.55096298  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.21798242) 
 
K-S Statistic = 0.16488904 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.41167554) 
 
Fit Equation Description: 
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[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 51.5895}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 155.291}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 31.2476}} 
pK1 = 4.5 ' {{previous: 4.75423}} 
pK2 = 9 ' {{previous: 8.6286}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
 
Number of Iterations Performed = 13 
 
Nonlinear Regression   Friday, March 09, 2012, 10:21:16 AM 
 
Data Source: Data 1 in Eu(III) complex 5 in MCB with KHP 700 nm 2 pKa.JNB 
Equation: User-Defined, pK2 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
 
 
R  Rsqr  Adj Rsqr  Standard Error of Estimate 
 
0.99111280 0.98230457 0.98022276  10.50033038  
 
  Coefficient Std. Error t P  
 
A0 92.996998183.74204722 24.85190396 <0.00000001  
A1 267.737682754.70772983 56.87193031 <0.00000001  
A2 47.696393213.70120509 12.88671987 <0.00000001  
pK1 4.664557120.06083012 76.68170148 <0.00000001  
pK2 8.581902090.04845446177.11274706 <0.00000001  
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Analysis of Variance:  
 
Analysis of Variance:  
  DF SS MS  
Regression5 954823.27214550190964.65442910  
Residual34 3748.73589620 110.25693812  
Total 39 958572.0080417024578.76943697  
 
Corrected for the mean of the observations: 
  DF SS MS F P  
Regression4 208098.9869748952024.74674372471.85009514 <0.00000001  
Residual34 3748.73589620 110.25693812  
Total 38 211847.722871095574.94007556  
 
Statistical Tests: 
 
Normality Test (Kolmogorov-Smirnov)   Passed (P = 0.38013180) 
 
K-S Statistic = 0.14245209 Significance Level = 0.05000000 
 
Constant Variance Test  Passed (P = 0.25298603) 
 
Fit Equation Description: 
[Variables] 
x = col(1) ' {{prevmin: 0.000000}} {{prevmax: 0.160000}} {{intervals: 100}} 
y = col(2) 
[Parameters] 
A0 = col(2,1) ' {{previous: 92.997}} {{MinRange: 0}} {{MaxRange: 2}} 
A1 = col(2,18) ' {{previous: 267.738}} {{MinRange: 0}} {{MaxRange: 2}} 
A2 = col(2,39) ' {{previous: 47.6964}} 
pK1 = 4.5 ' {{previous: 4.66456}} 
pK2 = 9 ' {{previous: 8.5819}} 
[Equation] 
H = 10^(-x); 
K1 = 10^(-pK1) 
K2 = 10^(-pK2) 
Den = H^2 + K1*H + K1*K2 
f = (H^2*A0 + K1*H*A1 + K1*K2*A2)/Den 
fit f to y 
[Constraints] 
[Options] 
tolerance=1e-018 
stepsize=1 
iterations=20000 
 
Number of Iterations Performed = 13 
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Table E2:  Complex 9 in MCB with KHP 
pH 
 
580 nm 
 
593 nm 
 
616 nm 
 
689 nm 
 
701 nm 
 
1.961 0.204783 0.631532 0.340893 0.349372 0.741085 
2.023 0.295675 0.768908 0.474859 0.376314 0.583287 
2.268 0.241227 0.856929 0.573369 0.261365 0.479148 
2.49 0.133618 0.803263 0.500406 0.200911 0.475694 
2.79 0.231633 1.062729 0.56261 0.249887 0.579279 
3.141 0.144799 1.030295 0.680548 0.315253 0.708654 
3.372 0.142896 0.94125 0.517955 0.287906 0.706798 
3.81 0.336072 1.450299 0.957379 0.359747 0.725373 
4.016 0.30553 1.593919 1.322851 0.466916 0.926587 
4.4 0.340503 2.023919 1.753657 0.599736 0.88706 
4.527 0.404996 1.946747 2.074503 0.520649 1.024189 
4.881 0.298564 2.368854 2.743002 0.647384 1.088336 
5.1 0.345302 2.730675 3.417781 0.600792 1.311448 
5.297 0.495988 3.041573 3.859563 0.839496 1.516452 
5.6752 0.611688 3.413275 5.032158 0.876234 1.680039 
6.056 0.60071 3.398914 5.16177 0.909239 1.646256 
6.258 0.573846 3.647827 5.671446 0.926245 1.819632 
6.441 0.546256 3.500638 5.139294 0.93182 1.626458 
6.718 0.636532 3.407398 4.982592 1.00575 1.480337 
6.95 0.544174 3.260687 4.699016 0.882541 1.500034 
7.235 0.589984 2.684019 3.895092 0.872145 1.326272 
7.332 0.62496 2.133726 2.927234 0.730765 1.206475 
7.706 0.478192 0.955471 1.083364 0.464467 0.847198 
7.834 0.320701 0.902709 0.967943 0.484704 0.926159 
8.176 0.457485 0.795722 0.769802 0.491164 0.815666 
8.38 0.241813 0.942017 0.752844 0.323091 0.787998 
8.055 0.341572 0.890042 0.800654 0.403228 0.843556 
8.612 0.39422 0.778287 0.756912 0.395388 0.859946 
8.8 0.421617 0.870871 0.678344 0.427854 0.821415 
8.855 0.304403 0.894666 0.682092 0.412508 0.938606 
9.065 0.261968 0.869852 0.866752 0.4788 0.761776 
9.221 0.296462 0.862196 0.63652 0.520069 0.836281 
9.467 0.378276 0.911486 0.702472 0.397924 0.727511 
9.287 0.271439 0.891613 0.729263 0.269471 0.814573 
9.687 0.23371 0.83443 0.640605 0.441187 0.817757 
9.458 0.287311 1.067662 0.802589 0.392357 0.772455 
9.722 0.294482 0.885272 0.763219 0.439985 0.886162 
9.785 0.199106 0.819162 0.515089 0.398684 0.846531 
11.758 0.277984 0.72905 0.826579 0.242345 0.675763 
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Eu(III)complex 9 in MCB with KHP 
Results for nonlinear 2 pKa fit 580 nm 
 
[Initial paramater estimates] 
PK1 = 5.106645 
PK2 = 7.71641 
A0 = 0.2226436 
A1 = 0.6412079 
A2 = 0.2806649 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 1.58288917727186E-001 
Estimated standard deviation : 6.82316378503460E-002 
Mean of residuals            : -1.28963763412973E-016 
Number of Iterations         : 9 
R-squared                    : 0.80073 
Adjusted R-squared           : 0.77729 
F-Statistic                  : 34.15616 
 
Parameter Coefficient  Varied Standard error 
PK1  5.106645415224E+000 Yes 0.203066 
PK2  7.716409838355E+000 Yes 0.224966 
A0  2.226435903625E-001 Yes 0.0237125 
A1  6.412078642981E-001 Yes 0.0432441 
A2  2.806649458486E-001 Yes 0.0223356 
 
 
[Correlation matrix] 
   1    2    3    4    5   
 
1 1.0000  -0.4153 0.4469  0.6424  0.1127   
2 -0.4153 1.0000  -0.0844 -0.6799 -0.5174   
3 0.4469  -0.0844 1.0000  0.1369  0.0219   
4 0.6424  -0.6799 0.1369  1.0000  0.1922   
5 0.1127  -0.5174 0.0219  0.1922  1.0000   
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Eu(III)complex 9 in MCB with KHP  
Results for nonlinear 2 pKa fit 616.02 nm 
 
[Initial paramater estimates] 
PK1 = 5.113378 
PK2 = 7.159546 
A0 = 0.5799183 
A1 = 6.465935 
A2 = 0.5469474 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 2.85529289881319E+000 
Estimated standard deviation : 2.89791654307487E-001 
Mean of residuals            : -1.15183665000905E-014 
Number of Iterations         : 9 
R-squared                    : 0.97425 
Adjusted R-squared           : 0.97122 
F-Statistic                  : 321.63198 
 
Parameter Coefficient  Varied Standard error 
PK1  5.113377815536E+000 Yes 0.0717764 
PK2  7.159545756549E+000 Yes 0.0698058 
A0  5.799182973000E-001 Yes 0.10116 
A1  6.465934700326E+000 Yes 0.279012 
A2  5.469474438731E-001 Yes 0.0820204 
 
 
[Correlation matrix] 
   1    2    3    4    5   
 
1 1.0000  -0.5486 0.4332  0.7443  0.1301   
2 -0.5486 1.0000  -0.1114 -0.7830 -0.4338   
3 0.4332  -0.1114 1.0000  0.1613  0.0244   
4 0.7443  -0.7830 0.1613  1.0000  0.1965   
5 0.1301  -0.4338 0.0244  0.1965  1.0000   
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Eu(III)complex 9 in MCB with KHP  
Results for nonlinear 2 pKa fit 592.94 nm 
 
[Initial paramater estimates] 
PK1 = 4.847834 
PK2 = 7.202269 
A0 = 0.9189541 
A1 = 4.003031 
A2 = 0.754775 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 1.76440150494909E+000 
Estimated standard deviation : 2.27802901452697E-001 
Mean of residuals            : -1.27094445967302E-014 
Number of Iterations         : 9 
R-squared                    : 0.95467 
Adjusted R-squared           : 0.94934 
F-Statistic                  : 179.00993 
 
Parameter Coefficient  Varied Standard error 
PK1  4.847834155072E+000 Yes 0.100116 
PK2  7.202269498785E+000 Yes 0.0913513 
A0  9.189541165088E-001 Yes 0.0838126 
A1  4.003031038145E+000 Yes 0.179371 
A2  7.547750198405E-001 Yes 0.0648304 
 
 
[Correlation matrix] 
   1    2    3    4    5   
 
1 1.0000  -0.4988 0.4494  0.7075  0.1185   
2 -0.4988 1.0000  -0.1053 -0.7405 -0.4414   
3 0.4494  -0.1053 1.0000  0.1565  0.0238   
4 0.7075  -0.7405 0.1565  1.0000  0.1835   
5 0.1185  -0.4414 0.0238  0.1835  1.0000 
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Eu(III)complex 9 in MCB with KHP  
Results for nonlinear 2 pKa fit 688.98 nm 
 
[Initial paramater estimates] 
PK1 = 4.934115 
PK2 = 7.371128 
A0 = 0.3053049 
A1 = 1.029949 
A2 = 0.3745963 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 2.03419053252437E-001 
Estimated standard deviation : 7.73492943145187E-002 
Mean of residuals            : 1.08303908765496E-015 
Number of Iterations         : 9 
R-squared                    : 0.89772 
Adjusted R-squared           : 0.88568 
F-Statistic                  : 74.60329 
 
Parameter Coefficient  Varied Standard error 
PK1  4.934115368667E+000 Yes 0.139707 
PK2  7.371128343365E+000 Yes 0.148985 
A0  3.053048679115E-001 Yes 0.0278965 
A1  1.029948655682E+000 Yes 0.056425 
A2  3.745962721908E-001 Yes 0.0229343 
 
 
[Correlation matrix] 
   1    2    3    4    5   
 
1 1.0000  -0.4687 0.4481  0.6847  0.1167   
2 -0.4687 1.0000  -0.0966 -0.7199 -0.4656   
3 0.4481  -0.0966 1.0000  0.1483  0.0229   
4 0.6847  -0.7199 0.1483  1.0000  0.1869   
5 0.1167  -0.4656 0.0229  0.1869  1.0000   
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Eu(III)complex 9 in MCB with KHP  
Results for nonlinear 2 pKa fit 701 nm 
 
[Initial paramater estimates] 
PK1 = 4.96978 
PK2 = 7.074696 
A0 = 0.622348 
A1 = 1.902426 
A2 = 0.786448 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 2.43509474426068E-001 
Estimated standard deviation : 8.46288565766583E-002 
Mean of residuals            : 1.67979056590421E-015 
Number of Iterations         : 9 
R-squared                    : 0.94880 
Adjusted R-squared           : 0.94278 
F-Statistic                  : 157.52011 
 
Parameter Coefficient  Varied Standard error 
PK1  4.969780394440E+000 Yes 0.095994 
PK2  7.074695735741E+000 Yes 0.107127 
A0  6.223480235731E-001 Yes 0.0304147 
A1  1.902425633513E+000 Yes 0.0798969 
A2  7.864479690511E-001 Yes 0.0234876 
 
 
[Correlation matrix] 
   1    2    3    4    5   
 
1 1.0000  -0.5520 0.4384  0.7477  0.1277   
2 -0.5520 1.0000  -0.1152 -0.7794 -0.4235   
3 0.4384  -0.1152 1.0000  0.1656  0.0250   
4 0.7477  -0.7794 0.1656  1.0000  0.1893   
5 0.1277  -0.4235 0.0250  0.1893  1.0000   
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Table E3:  Complex 5 in MCB without KHP 
pH 
 
580 nm 
 
593 nm 
 
616 nm 
 
653 nm 
 
686 nm 
 
700 nm 
 
1.778 195.2846 810.663 699.5883 64.13406 325.653 547.6007 
2.245 206.6097 845.0241 734.0364 65.40521 336.4706 576.0251 
2.333 203.4903 835.7556 728.243 65.16405 333.8904 569.744 
2.697 202.9864 853.6873 743.613 65.82397 340.9203 579.3045 
2.821 203.5594 838.5414 736.3145 64.75481 337.0712 575.2002 
3.145 201.9683 842.98 735.3362 65.40688 338.1154 574.9512 
3.358 204.2976 845.9576 738.0281 65.6218 340.7464 569.0624 
3.778 202.6357 843.7213 724.5893 63.79672 335.541 568.5742 
4.239 202.2702 843.5906 732.3077 65.20831 335.3627 569.0453 
4.495 207.3555 840.9897 725.4742 64.35615 341.4245 564.0582 
4.9 205.6532 845.7675 728.3318 65.33652 337.0086 565.8182 
5.409 202.9387 838.149 724.5651 64.07048 337.6984 564.1691 
5.697 202.9371 837.6331 721.7948 65.38525 335.5614 561.1257 
5.97 204.9446 841.0306 722.8145 65.35878 339.696 569.0973 
6.239 204.3648 840.8464 730.3334 66.22919 337.7013 561.3988 
6.33 202.8883 837.8123 726.6285 63.84427 338.7542 565.0295 
5.964 205.9308 843.0583 725.1833 62.87744 337.0363 563.5749 
6.67 206.1183 841.9871 728.2561 65.20667 341.2728 568.7681 
6.15 205.2491 834.825 725.2226 63.95226 336.8221 566.7371 
7.298 210.6601 829.8077 723.9879 64.33308 337.0156 566.7156 
6.414 210.6279 831.3297 721.8156 64.26594 334.0952 560.9182 
6.385 196.2729 772.6138 671.6031 59.13851 314.1742 526.8398 
7.096 204.7534 803.772 701.5762 61.27945 325.9899 549.3306 
7.498 210.184 775.3029 685.27 60.6262 318.1284 527.0948 
7.211 209.8074 771.4942 684.5627 60.62157 316.5522 523.8483 
7.993 220.8056 733.2023 663.5981 59.96705 306.6989 513.9951 
7.649 234.4881 698.0406 646.1179 56.46826 296.9293 494.1169 
8.453 252.9506 619.8992 607.0824 52.35078 272.0445 453.1989 
8.785 238.1107 668.6689 639.8068 54.44976 284.4984 474.4576 
8.95 274.2381 527.8185 563.2554 48.10026 252.3819 408.7452 
8.88 251.0165 622.4475 629.0097 53.29805 277.5058 453.5626 
9.089 284.7923 480.8141 553.1343 46.31601 239.1019 383.5215 
9.496 309.7236 349.2112 481.7581 38.87819 202.2949 314.4131 
10.039 314.8727 341.789 494.6658 39.1232 206.8369 316.2446 
10.352 327.0158 245.4566 418.5801 33.73812 175.2239 258.0613 
10.467 327.1991 175.9459 326.9938 29.55535 146.103 219.5225 
11.501 323.5064 179.4825 334.7118 29.6229 146.7617 220.0659 
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 580 nm 
[Initial paramater estimates] 
PK1 = 8.90725 
A0 = 204.9185 
A1 = 327.8579 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.80425864149277E+003 
Estimated standard deviation : 7.28467093506222E+000 
Mean of residuals            : 5.72377925836756E-011 
Number of Iterations         : 9 
R-squared                    : 0.97170 
Adjusted R-squared           : 0.97003 
F-Statistic                  : 583.64012 
 
Parameter Coefficient  Varied Standard error 
PK1  8.907250008608E+000 Yes 0.0591514 
A0  2.049184634586E+002 Yes 1.44553 
A1  3.278579018656E+002 Yes 3.91802 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  0.2759  0.6009   
2 0.2759  1.0000  0.0591   
3 0.6009  0.0591  1.0000  
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 592.94 nm 
[Initial paramater estimates] 
PK1 = 9.036708 
A0 = 826.3804 
A1 = 204.6111 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 4.79121469328806E+004 
Estimated standard deviation : 3.75390568893725E+001 
Mean of residuals            : -2.27501052681119E-009 
Number of Iterations         : 10 
R-squared                    : 0.96857 
Adjusted R-squared           : 0.96672 
F-Statistic                  : 523.89271 
 
Parameter Coefficient  Varied Standard error 
PK1  9.036707872803E+000 Yes 0.0609308 
A0  8.263803699150E+002 Yes 7.39241 
A1  2.046111322649E+002 Yes 21.0156 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.2818 -0.5956   
2 -0.2818 1.0000  0.0594   
3 -0.5956 0.0594  1.0000   
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 616.02 nm 
 
[Initial paramater estimates] 
PK1 = 9.174554 
A0 = 717.3284 
A1 = 368.8554 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 2.97904355077650E+004 
Estimated standard deviation : 2.96004945843840E+001 
Mean of residuals            : -8.20285611207832E-011 
Number of Iterations         : 11 
R-squared                    : 0.93515 
Adjusted R-squared           : 0.93133 
F-Statistic                  : 245.12595 
 
Parameter Coefficient  Varied Standard error 
PK1  9.174553828425E+000 Yes 0.0891077 
A0  7.173284286978E+002 Yes 5.78648 
A1  3.688553545145E+002 Yes 17.4237 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.2908 -0.5974   
2 -0.2908 1.0000  0.0656   
3 -0.5974 0.0656  1.0000   
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 653.04 nm 
[Initial paramater estimates] 
PK1 = 9.021449 
A0 = 63.90412 
A1 = 31.46271 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.85903563620437E+002 
Estimated standard deviation : 2.33832244807882E+000 
Mean of residuals            : -1.72105362056402E-012 
Number of Iterations         : 10 
R-squared                    : 0.95615 
Adjusted R-squared           : 0.95357 
F-Statistic                  : 370.67026 
 
Parameter Coefficient  Varied Standard error 
PK1  9.021448544378E+000 Yes 0.0725552 
A0  6.390412473920E+001 Yes 0.460867 
A1  3.146270500199E+001 Yes 1.30252 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.2809 -0.5960   
2 -0.2809 1.0000  0.0591   
3 -0.5960 0.0591  1.0000   
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 685.94 nm 
 
[Initial paramater estimates] 
PK1 = 9.046354 
A0 = 332.9428 
A1 = 159.7469 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 4.99172365445060E+003 
Estimated standard deviation : 1.21167405518765E+001 
Mean of residuals            : -2.48763851485057E-010 
Number of Iterations         : 10 
R-squared                    : 0.95804 
Adjusted R-squared           : 0.95557 
F-Statistic                  : 388.10103 
 
Parameter Coefficient  Varied Standard error 
PK1  9.046353854199E+000 Yes 0.070732 
A0  3.329427891194E+002 Yes 2.38483 
A1  1.597469399056E+002 Yes 6.80521 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.2824 -0.5954   
2 -0.2824 1.0000  0.0597   
3 -0.5954 0.0597  1.0000   
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Eu(III)Complex 5 in MCB without KHP 1pKa Fit 
Results for nonlinear fit 700 nm 
 
[Initial paramater estimates] 
PK1 = 9.047542 
A0 = 559.5634 
A1 = 236.7965 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.49463407225795E+004 
Estimated standard deviation : 2.09665985926773E+001 
Mean of residuals            : 2.69255053313493E-010 
Number of Iterations         : 10 
R-squared                    : 0.96359 
Adjusted R-squared           : 0.96144 
F-Statistic                  : 449.86138 
 
Parameter Coefficient  Varied Standard error 
PK1  9.047542103745E+000 Yes 0.0656913 
A0  5.595633951557E+002 Yes 4.1264 
A1  2.367965291627E+002 Yes 11.7803 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.2825 -0.5954   
2 -0.2825 1.0000  0.0597   
3 -0.5954 0.0597  1.0000 
 | P a g e  
 
 
271
Table E4:  Complex 7 in MCB without KHP 
pH 
 
580 nm 
 
593 nm 
 
615 nm 
 
653 nm 
 
686 nm 
 
703 nm 
 
2.036 9.018921 39.50199 37.16164 3.571938 17.04198 22.8214 
2.089 9.176717 42.05157 38.17734 3.860089 17.53085 24.24519 
2.234 9.109066 41.3186 37.42147 3.934429 17.18196 23.37055 
2.48 9.63076 42.5901 38.89782 4.00751 17.38169 24.2912 
2.57 8.777876 40.9495 37.70302 3.652858 17.28327 23.293 
2.712 9.305861 41.73677 38.28578 3.833423 17.49679 23.85856 
3.04 8.883518 40.65905 37.26588 3.672124 16.81368 22.93902 
2.795 9.057775 41.05644 37.18943 3.746079 16.72367 23.04039 
3.202 9.227151 40.73834 37.93256 3.701778 17.17657 22.98778 
3.455 9.310441 41.15077 38.10065 3.921748 17.10158 23.33626 
3.9 9.31475 41.5947 38.536 3.514105 17.10585 23.10208 
3.83 9.042604 40.82191 37.89815 3.616464 16.93287 22.65738 
3.61 9.03078 41.23015 38.23111 3.755315 17.14525 23.35977 
3.7 9.093537 42.01402 38.28193 3.833684 17.25118 22.99015 
4.4 8.913075 40.06866 37.67798 3.659998 16.72119 22.66446 
9.131 18.70716 16.8848 24.76616 2.283224 11.50411 17.74611 
7.59 13.27324 29.2193 32.45764 3.063461 14.38656 19.87187 
6.1 8.74136 39.11382 36.51947 3.541076 16.34459 21.83517 
9.3 19.76696 15.26134 24.95588 2.384143 11.21522 17.35737 
4.75 9.832104 43.71656 41.03606 4.151778 18.02407 23.89696 
5.686 9.056525 40.33348 38.18675 3.566016 16.91787 22.5694 
5.15 9.188657 40.87913 38.29564 3.865413 17.17046 23.05496 
5.828 8.917207 40.12515 38.4607 3.703675 17.15668 23.1074 
5.3 9.543035 41.59506 39.06663 3.885269 17.32188 23.47002 
5.76 9.006239 39.73908 38.06776 3.647251 16.88611 22.42639 
5.15 9.125041 40.8679 38.52338 3.710527 16.97848 23.03475 
5.86 8.997209 40.34923 38.41415 3.770494 16.95149 23.11111 
6.462 8.997209 39.70687 37.51201 3.776748 16.73789 22.72645 
6.543 9.113293 39.46829 37.38093 3.707593 16.70143 22.472 
6.748 9.010166 39.95811 37.54989 3.783357 16.81192 22.53899 
7.11 9.235167 40.06427 37.19304 3.75496 16.75581 22.66415 
8.209 9.090235 39.95964 37.12696 3.680652 16.80019 22.30023 
7.68 10.24683 35.56054 36.05315 3.532537 15.9577 21.42305 
8.13 13.66461 22.93069 29.25729 2.574102 12.49872 17.42059 
8.3 14.95468 26.44779 31.26642 2.92833 14.05759 19.45432 
8.4 16.9088 22.59986 29.25088 2.753193 13.00028 19.20081 
11.102 19.23576 14.5863 25.01279 2.309195 11.0688 16.8913 
9.221 18.50754 16.97311 25.65395 2.360528 11.73063 17.29672 
9.131 17.7154 20.31077 28.62888 2.718638 12.64252 18.64718 
9.92 19.47592 16.00246 25.27393 2.26061 11.51951 17.43029 
9.1 18.40962 19.57542 29.89624 2.654403 12.96577 18.07942 
9.776 20.09877 14.54212 23.82224 2.190624 10.6909 17.1885 
9.66 19.10791 17.11818 27.87422 2.545023 12.25405 17.80682 
11.705 19.27056 13.58584 22.70109 2.061752 10.41209 16.87994 
11.173 18.70905 13.0161 22.17184 2.104066 9.980494 16.36304 
7.93 14.09591 29.92818 32.79905 3.305254 14.94384 20.93826 
7.93 14.03125 30.14358 32.73426 3.073264 14.80776 21.0726 
8.241 15.85888 23.84538 29.55911 2.998763 13.39 18.96475 
8.66 18.73119 18.62437 27.29952 2.488226 12.24844 18.64295 
9.159 20.21074 15.37648 24.39324 2.234545 11.57329 17.91834 
9.412 20.778 14.59016 23.37108 2.365207 10.93391 17.25284 
9.708 20.83962 14.10309 22.89581 2.238063 10.57637 17.43052 
10.005 21.06476 13.6221 22.58962 2.32312 10.60525 17.09846 
10.296 20.17791 13.32479 21.87313 2.229987 10.15804 16.6144 
10.383 19.70017 12.86007 21.30011 2.128994 10.09186 16.45347 
10.451 20.33855 13.23603 22.23866 2.035977 10.21455 17.05115 
10.541 20.16963 13.46782 21.72208 2.281112 10.31771 16.9247 
10.673 19.9552 13.35463 21.60919 2.239969 10.15095 16.70548 
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 580 nm  
 
[Initial paramater estimates] 
PK1 = 8.218037 
A0 = 9.093779 
A1 = 20.08134 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 5.86322013723637E+001 
Estimated standard deviation : 1.03249214280403E+000 
Mean of residuals            : 4.90003227768170E-013 
Number of Iterations         : 9 
R-squared                    : 0.95737 
Adjusted R-squared           : 0.95582 
F-Statistic                  : 617.60578 
 
Parameter Coefficient  Varied Standard error 
PK1  8.218037499586E+000 Yes 0.0665992 
A0  9.093778922915E+000 Yes 0.197175 
A1  2.008133708026E+001 Yes 0.263028 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  0.3233  0.4926   
2 0.3233  1.0000  0.0578   
3 0.4926  0.0578  1.0000   
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 592.94 nm  
 
[Initial paramater estimates] 
PK1 = 8.177916 
A0 = 40.89266 
A1 = 13.99905 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 3.15595847741551E+002 
Estimated standard deviation : 2.39543447469841E+000 
Mean of residuals            : 6.85971738583547E-013 
Number of Iterations         : 10 
R-squared                    : 0.96180 
Adjusted R-squared           : 0.96041 
F-Statistic                  : 692.32658 
 
Parameter Coefficient  Varied Standard error 
PK1  8.177915597212E+000 Yes 0.0629817 
A0  4.089266414889E+001 Yes 0.458594 
A1  1.399904543923E+001 Yes 0.604069 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3191 -0.4889   
2 -0.3191 1.0000  0.0554   
3 -0.4889 0.0554  1.0000  
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 615 nm  
 
[Initial paramater estimates] 
PK1 = 8.341026 
A0 = 37.99392 
A1 = 23.22033 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.46766482931752E+002 
Estimated standard deviation : 1.63354874670150E+000 
Mean of residuals            : -2.46258966882144E-012 
Number of Iterations         : 10 
R-squared                    : 0.94066 
Adjusted R-squared           : 0.93850 
F-Statistic                  : 435.89748 
 
Parameter Coefficient  Varied Standard error 
PK1  8.341026383804E+000 Yes 0.0796541 
A0  3.799391925896E+001 Yes 0.309483 
A1  2.322033019218E+001 Yes 0.431034 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3356 -0.5084   
2 -0.3356 1.0000  0.0672   
3 -0.5084 0.0672  1.0000  
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 653.04 nm  
[Initial paramater estimates] 
PK1 = 8.216227 
A0 = 3.756226 
A1 = 2.227853 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.92125891980468E+000 
Estimated standard deviation : 1.86900990794819E-001 
Mean of residuals            : 1.30846602709877E-014 
Number of Iterations         : 9 
R-squared                    : 0.92990 
Adjusted R-squared           : 0.92735 
F-Statistic                  : 364.80392 
 
Parameter Coefficient  Varied Standard error 
PK1  8.216227048839E+000 Yes 0.0866573 
A0  3.756226052081E+000 Yes 0.0356965 
A1  2.227852758514E+000 Yes 0.0475907 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3232 -0.4924   
2 -0.3232 1.0000  0.0577   
3 -0.4924 0.0577  1.0000  
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 685.94 nm  
 
[Initial paramater estimates] 
PK1 = 8.28279 
A0 = 17.0485 
A1 = 10.68018 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 2.50971628401996E+001 
Estimated standard deviation : 6.75508735428338E-001 
Mean of residuals            : -3.12893269722955E-016 
Number of Iterations         : 9 
R-squared                    : 0.94570 
Adjusted R-squared           : 0.94373 
F-Statistic                  : 478.97111 
 
Parameter Coefficient  Varied Standard error 
PK1  8.282790321796E+000 Yes 0.0757072 
A0  1.704850483657E+001 Yes 0.128473 
A1  1.068018474765E+001 Yes 0.17516 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3300 -0.5001   
2 -0.3300 1.0000  0.0624   
3 -0.5001 0.0624  1.0000   
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Eu(III)complex 7 in MCB without KHP 
Results for nonlinear 1pKa Fit 703 nm  
 
[Initial paramater estimates] 
PK1 = 8.084887 
A0 = 23.08789 
A1 = 17.06947 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 58 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 2.80069576871179E+001 
Estimated standard deviation : 7.13594711648743E-001 
Mean of residuals            : 1.01240002372817E-012 
Number of Iterations         : 9 
R-squared                    : 0.93522 
Adjusted R-squared           : 0.93286 
F-Statistic                  : 396.99656 
 
Parameter Coefficient  Varied Standard error 
PK1  8.084887029383E+000 Yes 0.0839442 
A0  2.308788761702E+001 Yes 0.137395 
A1  1.706947434879E+001 Yes 0.176121 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3094 -0.4826   
2 -0.3094 1.0000  0.0511   
3 -0.4826 0.0511  1.0000   
 | P a g e  
 
 
278
Table E5:  Complex 5 in Water 
pH 
 
580 nm 
 
593 nm 
 
616 nm 
 
653 nm 
 
686 nm 
 
700 nm 
 
1.89 184.3495 757.5199 658.6595 59.21292 305.3577 517.6694 
2.569 191.8092 788.2394 676.0637 60.68227 310.0902 533.5911 
2.969 192.0077 795.1722 689.8506 61.78461 317.8637 536.5387 
3.13 196.0352 803.4358 699.526 63.00753 321.2828 542.2555 
3.35 195.1807 801.14 702.4911 62.16301 323.7544 544.2304 
3.689 197.6151 809.7134 699.2607 63.22436 323.1023 547.5717 
3.698 194.8846 805.7063 703.4588 61.56657 321.7393 545.3578 
3.825 198.4539 809.0768 701.4655 62.46199 323.7696 548.577 
4.042 196.8673 799.4653 699.565 62.71805 320.5756 546.6083 
4.375 197.3572 808.257 696.9099 62.26994 325.5774 547.2878 
4.795 196.3206 811.0889 699.9565 61.66362 321.9992 547.7372 
5.21 198.1039 800.1104 698.5717 61.97143 320.1256 546.4984 
5.398 203.9506 825.6872 716.6693 63.69745 331.5274 552.1426 
5.789 201.6318 812.8804 706.5741 63.48131 326.1329 554.2812 
5.902 198.9117 818.1832 713.2211 63.09072 330.7667 553.9396 
6.014 205.8602 811.6509 714.1716 63.52386 332.3515 556.4669 
6.33 199.5831 781.6427 694.3349 60.35399 322.9432 538.8073 
6.8 206.3995 830.1756 721.696 64.78285 335.9355 561.4416 
6.485 203.4051 811.2666 708.7524 64.25299 333.2972 552.414 
7.179 203.3354 807.4875 708.4608 63.39521 330.6143 556.6631 
6.963 200.633 764.6931 675.8947 60.67384 317.117 523.2955 
7.064 204.0868 763.8388 677.2546 61.15548 315.7415 527.0772 
7.245 214.2067 703.8189 642.9781 56.33001 295.5341 494.7468 
7.749 221.0903 673.6494 628.8132 56.33971 287.5481 481.263 
8.275 248.3836 573.6673 577.1117 51.99474 259.1734 433.4363 
8.645 264.8663 517.3972 550.042 47.77931 246.6835 408.6101 
8.205 217.9028 698.5002 643.6962 56.68527 292.9313 491.8618 
8.989 287.7796 403.7613 478.033 41.48519 212.7179 346.8142 
7.8 257.4459 555.3839 580.881 50.02658 256.7005 422.6779 
8.21 222.6935 666.2631 632.6204 55.20226 285.081 480.6864 
9.445 311.0316 320.1701 470.3271 38.43673 194.3806 298.1468 
9.848 317.5209 191.4067 342.4972 29.99405 151.7482 226.8269 
10.498 318.372 184.017 342.3402 29.30731 149.9083 223.1408 
10.33 318.2306 175.1089 321.4289 27.82008 144.0217 218.3494 
10.803 315.8904 205.5085 378.5991 30.70507 158.3967 231.3869 
11.08 320.1266 173.6463 328.418 29.09633 144.2694 215.0247 
11.335 318.0231 175.1918 333.8505 28.33884 144.8318 220.7039 
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 580 nm 
[Initial paramater estimates] 
PK1 = 8.529524 
A0 = 198.8802 
A1 = 319.717 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 2.87782939219027E+003 
Estimated standard deviation : 9.20011092035160E+000 
Mean of residuals            : 1.41569380467748E-010 
Number of Iterations         : 10 
R-squared                    : 0.96475 
Adjusted R-squared           : 0.96268 
F-Statistic                  : 465.32641 
 
Parameter Coefficient  Varied Standard error 
PK1  8.529523623592E+000 Yes 0.0735237 
A0  1.988801880704E+002 Yes 1.95573 
A1  3.197169573776E+002 Yes 3.70821 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  0.3535  0.4567   
2 0.3535  1.0000  0.0608   
3 0.4567  0.0608  1.0000   
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 592.94 nm 
 
 [Initial paramater estimates] 
PK1 = 8.66228 
A0 = 794.7341 
A1 = 182.6688 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 5.62037095894085E+004 
Estimated standard deviation : 4.06577210630580E+001 
Mean of residuals            : -1.72982485992947E-009 
Number of Iterations         : 10 
R-squared                    : 0.97214 
Adjusted R-squared           : 0.97050 
F-Statistic                  : 593.10806 
 
Parameter Coefficient  Varied Standard error 
PK1  8.662280032790E+000 Yes 0.0671875 
A0  7.947341105825E+002 Yes 8.53284 
A1  1.826687656596E+002 Yes 16.8561 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3520 -0.4592   
2 -0.3520 1.0000  0.0650   
3 -0.4592 0.0650  1.0000   
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 616.02 nm 
 
[Initial paramater estimates] 
PK1 = 8.773084 
A0 = 694.0275 
A1 = 341.6401 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 2.40969345003827E+004 
Estimated standard deviation : 2.66220466466858E+001 
Mean of residuals            : -8.00788523329714E-010 
Number of Iterations         : 11 
R-squared                    : 0.96335 
Adjusted R-squared           : 0.96119 
F-Statistic                  : 446.79866 
 
Parameter Coefficient  Varied Standard error 
PK1  8.773084251968E+000 Yes 0.0797235 
A0  6.940274535499E+002 Yes 5.52633 
A1  3.416400663926E+002 Yes 11.3289 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3485 -0.4660   
2 -0.3485 1.0000  0.0693   
3 -0.4660 0.0693  1.0000   
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 653.04 nm 
 
[Initial paramater estimates] 
PK1 = 8.729027 
A0 = 61.92849 
A1 = 29.10421 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.80618254030522E+002 
Estimated standard deviation : 2.30484307256113E+000 
Mean of residuals            : -1.69887950835546E-011 
Number of Iterations         : 9 
R-squared                    : 0.96850 
Adjusted R-squared           : 0.96664 
F-Statistic                  : 522.62748 
 
Parameter Coefficient  Varied Standard error 
PK1  8.729026898468E+000 Yes 0.0728451 
A0  6.192849135425E+001 Yes 0.480556 
A1  2.910420632132E+001 Yes 0.970398 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3501 -0.4628   
2 -0.3501 1.0000  0.0675   
3 -0.4628  0.0675  1.0000  
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 685.94 nm 
 
[Initial paramater estimates] 
PK1 = 8.691616 
A0 = 321.2804 
A1 = 148.7264 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 5.31293873809889E+003 
Estimated standard deviation : 1.25005161518128E+001 
Mean of residuals            : 2.24442571510090E-010 
Number of Iterations         : 11 
R-squared                    : 0.96682 
Adjusted R-squared           : 0.96486 
F-Statistic                  : 495.30459 
 
Parameter Coefficient  Varied Standard error 
PK1  8.691616359178E+000 Yes 0.0740867 
A0  3.212803978737E+002 Yes 2.61597 
A1  1.487263658358E+002 Yes 5.21719 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  -0.3513 -0.4606   
2 -0.3513 1.0000  0.0660   
3 -0.4606 0.0660  1.0000   
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Eu(III)Complex 5 in Water  
Results for nonlinear fit 700 nm 
 
Results for nonlinear fit 
 
[Initial paramater estimates] 
PK1 = 8.726345 
A0 = 540.9201 
A1 = 220.5824 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.53948169964044E+004 
Estimated standard deviation : 2.12788330316388E+001 
Mean of residuals            : -9.73308559124406E-010 
Number of Iterations         : 11 
R-squared                    : 0.97173 
Adjusted R-squared           : 0.97007 
F-Statistic                  : 584.35699 
 
Parameter Coefficient  Varied Standard error 
PK1  8.726344738705E+000 Yes 0.0688407 
A0  5.409200552467E+002 Yes 4.43778 
A1  2.205824160931E+002 Yes 8.95323 
 
 
[Correlation matrix] 
        1               2    3   
 
1 1.0000             -0.3502  -0.4626   
2 -0.3502  1.0000  0.0674   
3         -0.4626  0.0674  1.0000 
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UV-vis Spectroscopy 
Table E6:  Complex 5 in MCB with KHP 
pH 
 
270 nm 
 
1.98 1.305625 
2.197 1.320841 
2.469 1.347536 
2.503 1.365916 
2.651 1.394075 
2.796 1.418099 
2.93 1.446764 
3.47 1.44661 
3.885 1.448236 
3.95 1.388812 
4.32 1.328537 
4.47 1.234064 
4.71 1.139309 
4.9 1.054316 
4.959 0.875898 
5.32 0.711834 
6.101 0.700737 
6.642 0.692219 
6.978 0.679651 
7.171 0.675923 
7.224 0.68923 
7.423 0.682015 
8.204 0.67018 
8.172 0.67453 
8.381 0.678296 
8.47 0.683334 
8.675 0.681853 
8.71 0.675737 
9.382 0.678191 
9.484 0.685397 
9.495 0.686253 
9.705 0.692435 
9.889 0.6963 
10.048 1.079838 
10.395 0.697999 
10.501 0.699021 
10.91 0.717802 
11.505 0.714721 
12.555 0.726859 
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Eu(III)Complex 5 in MCB (UV-vis data)  
Results for nonlinear 3pKa fit 270nm 
[Initial paramater estimates] 
PK1 = 2.836829 
PK2 = 5.107513 
PK3 = 11.12444 
A1 = 1.260615 
A2 = 1.119702 
A3 = 0.8905569 
A4 = 0.9298276 
 
[Model] 
h=10^(-x) 
k1=10^(-pK1) 
k2=10^(-pK2) 
k3=10^(-pK3) 
den=k1*k2*k3+h*k1*k2+h^2*k1+h^3 
y=(a1*h^3+a2*h^2*k1+a3*h*k1*k2+a4*k1*k2*k3)/den 
 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 7 
Number of parameters varied  : 7 
Sum of squares of errors     : 7.45425820948338E-003 
Estimated standard deviation : 1.52625544731659E-002 
Mean of residuals            : -6.25884894125747E-016 
Number of Iterations         : 9 
R-squared                    : 0.98838 
Adjusted R-squared           : 0.98621 
F-Statistic                  : 453.81952 
 
Parameter Coefficient  Varied Standard error 
PK1  2.836829195770E+000 Yes 0.244515 
PK2  5.107512524344E+000 Yes 0.103099 
PK3  1.112444172140E+001 Yes 0.625016 
A1  1.260614674132E+000 Yes 0.0201748 
A2  1.119701705581E+000 Yes 0.0149151 
A3  8.905569487869E-001 Yes 0.00390635 
A4  9.298276224933E-001 Yes 0.0159935 
 
 
 
 
 
 
 | P a g e  
 
 
287
[Correlation matrix] 
   1     2    3    4    5    6    7 
  
 
1 1.0000  0.5186  -0.0208  -0.8690  -0.7051  -0.0550  -0.0066 
  
2 0.5186 1.0000  -0.0903  -0.2892  -0.8194  -0.2381  -0.0288 
  
3 -0.0208 -0.0903  1.0000  0.0106  0.0368  0.3796  0.6539 
  
4 -0.8690 -0.2892  0.0106  1.0000  0.4256  0.0280  0.0034 
  
5 -0.7051 -0.8194  0.0368  0.4256  1.0000  0.0971  0.0117 
  
6 -0.0550 -0.2381  0.3796  0.0280  0.0971  1.0000  0.1212 
  
7 -0.0066 -0.0288  0.6539  0.0034  0.0117  0.1212  1.0000 
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Table E7:  Complex 9 in MCB with KHP 
pH 
 
280 nm 
 
1.961 0.9422 
2.023 0.947905 
2.268 0.956222 
2.49 0.970745 
2.79 0.989895 
3.141 1.018736 
3.372 1.015012 
3.81 1.006344 
4.016 0.979469 
4.4 0.933777 
4.527 0.894786 
4.881 0.812545 
5.1 0.744871 
5.297 0.681434 
5.6752 0.61693 
6.056 0.557943 
6.258 0.547851 
6.441 0.540642 
6.718 0.518937 
6.95 0.528551 
7.235 0.526409 
7.332 0.512557 
7.706 0.520525 
7.834 0.518232 
8.176 0.518073 
8.38 0.517918 
8.612 0.538678 
8.8 0.517412 
8.855 0.534553 
9.065 0.520146 
9.221 0.519238 
9.467 0.515455 
9.287 0.537765 
9.288 0.517573 
9.687 0.510972 
9.458 0.512126 
9.722 0.518102 
9.785 0.517064 
11.758 0.517733 
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Eu(III)complex 9 in  MCB UV-vis 280 nm 
Results for nonlinear 2pKa Fit 
[Initial paramater estimates] 
PK1 = 2.550131 
PK2 = 4.972754 
A0 = 0.9164963 
A1 = 1.040775 
A2 = 0.5202184 
 
[Model] 
h=10^(-x) 
k1=10^(-pk1) 
k2=10^(-pk2) 
alpha=h^2+k1*h+k1*k2 
y=(a0*h^2+a1*k1*h+a2*k1*k2)/alpha 
 
[Results] 
Number of data points        : 39 
Number of paramaters         : 5 
Number of parameters varied  : 5 
Sum of squares of errors     : 1.77142460479367E-003 
Estimated standard deviation : 7.21808310220949E-003 
Mean of residuals            : 4.00090061686144E-016 
Number of Iterations         : 9 
R-squared                    : 0.99885 
Adjusted R-squared           : 0.99871 
F-Statistic                  : 7367.03517 
Parameter Coefficient  Varied Standard error 
PK1  2.550131396450E+000 Yes 0.161552 
PK2  4.972753964626E+000 Yes 0.0187795 
A0  9.164963493518E-001 Yes 0.0133008 
A1  1.040775403424E+000 Yes 0.00607356 
A2  5.202184093968E-001 Yes 0.001511 
 
[Correlation matrix] 
   1                 2    3                  4           5   
 
1 1.0000             -0.4893  0.9024               0.6522  0.0673 
  
2 -0.4893  1.0000  -0.3190  -0.7636           -0.2776 
  
3 0.9024             -0.3190  1.0000               0.4230  0.0433 
  
4 0.6522            -0.7636      0.4230    1.0000  0.1098  
5 0.0673            -0.2776      0.0433    0.1098  1.0000 
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Table E8:  Complex 5 in MCB without KHP 
pH 
 
308 nm 
 
1.778 0.03559 
2.245 0.039326 
2.333 0.045816 
2.697 0.044506 
2.821 0.035366 
3.145 0.03277 
3.358 0.041104 
3.778 0.041157 
4.239 0.047476 
4.495 0.031677 
4.9 0.050038 
5.409 0.043017 
5.697 0.040264 
5.964 0.045388 
5.97 0.046874 
6.15 0.044815 
6.239 0.040149 
6.33 0.039593 
6.385 0.054566 
6.385 0.053091 
6.67 0.04096 
7.096 0.041237 
7.211 0.056847 
7.298 0.043575 
7.498 0.042582 
7.649 0.064904 
7.993 0.050136 
8.453 0.0782 
8.785 0.067091 
8.88 0.073117 
8.95 0.07764 
9.089 0.081186 
9.496 0.105292 
10.039 0.102942 
10.352 0.114364 
10.467 0.131605 
11.501 0.123583 
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Eu(III)Complex 5 in MCB without KHP (UV-vis)  
Results for nonlinear fit 308 nm 
[Initial paramater estimates] 
PK1 = 9.021969 
A0 = 0.04373711 
A1 = 0.1217163 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.96453463798658E-003 
Estimated standard deviation : 7.60134399491413E-003 
Mean of residuals            : 1.64419625741944E-017 
Number of Iterations         : 9 
R-squared                    : 0.92259 
Adjusted R-squared           : 0.91804 
F-Statistic                  : 202.60771 
 
Parameter Coefficient  Varied Standard error 
PK1  9.021969354471E+000 Yes 0.0981306 
A0  4.373710630057E-002 Yes 0.00149809 
A1  1.217163226822E-001 Yes 0.00423492 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  0.2809  0.5960   
2 0.2809  1.0000  0.0591   
3 0.5960  0.0591  1.0000   
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Table E9:  Complex 7 in MCB without KHP 
pH 
 
263 nm 
 
2.036 0.21903
2.89 0.339009
2.48 0.328977
2.57 0.40531
2.795 0.28414
3.203 0.29896
3.61 0.342286
3.455 0.18832
11.1173 0.25599
8.3 0.26474
8.4 0.15205
6.543 0.15642
10.27 0.11595
11.1 0.305644
9.92 0.317564
9.1 0.25929
3.04 0.371807
11.705 0.11154
5.25 0.357616
9.3 0.18639
8.5 0.2867
3.534 0.308422
3.9 0.333055
5.76 0.491057
5.76 0.491546
5.828 0.315592
5.3 0.339477
6.1 0.397148
6.748 0.19368
3.534 0.308422
3.9 0.333055
5.76 0.491057
5.76 0.491546
5.828 0.315592
5.3 0.339477
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Table E10:  Complex 5 in Water 
pH 
 
313 nm 
 
1.89 0.033986 
2.569 0.031918 
2.969 0.026391 
3.13 0.031801 
3.35 0.035397 
3.689 0.038327 
3.698 0.041915 
3.825 0.02916 
4.042 0.044423 
4.375 0.034841 
4.795 0.033683 
5.21 0.030099 
5.398 0.040167 
5.789 0.035012 
5.902 0.042825 
6.014 0.03708 
6.33 0.043045 
6.8 0.042745 
6.485 0.040072 
7.179 0.040905 
6.963 0.045435 
7.064 0.048394 
7.245 0.048875 
7.749 0.051128 
8.275 0.06805 
8.645 0.070917 
8.205 0.056578 
8.989 0.090072 
7.8 0.065264 
8.21 0.048044 
9.445 0.096376 
9.848 0.115295 
10.498 0.116143 
10.33 0.12162 
10.803 0.116196 
11.08 0.12438 
11.335 0.115513 
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Eu(III)Complex 5 in Water UV-vis  
Results for nonlinear fit 313 nm 
[Initial paramater estimates] 
PK1 = 8.700094 
A0 = 0.03822352 
A1 = 0.1183201 
 
[Model] 
H=10^(-x) 
K1=10^(-pK1) 
Alpha=H+K1 
Y=(A0*H+A1*K1)/Alpha 
 
 
[Results] 
Number of data points        : 37 
Number of paramaters         : 3 
Number of parameters varied  : 3 
Sum of squares of errors     : 1.42838630518005E-003 
Estimated standard deviation : 6.48161723006382E-003 
Mean of residuals            : -3.43918269367604E-017 
Number of Iterations         : 9 
R-squared                    : 0.95885 
Adjusted R-squared           : 0.95643 
F-Statistic                  : 396.17175 
 
Parameter Coefficient  Varied Standard error 
PK1  8.700093530930E+000 Yes 0.0830246 
A0  3.822351864155E-002 Yes 0.00135527 
A1  1.183201085184E-001 Yes 0.00271045 
 
 
[Correlation matrix] 
   1    2    3   
 
1 1.0000  0.3510  0.4610   
2 0.3510  1.0000  0.0664   
3 0.4610  0.0664  1.0000   
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F:  Lifetime Measurements 
Complex 5 (with MCB + KHP) in Water (pH 4.710) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 11:36:36 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                               240.00                580.00                20        10      
 
Lifetimes Report 
 
Report Time : Mon 30 Jan 11:36:36 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                  580.00                20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    3.149±0.1          13.8404±0.9           0.0245±0.0       0.0244       
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Complex 5 (with MCB +KHP) in D2O (pH 4.695)  
 Lifetimes Report 
 
Report Time : Tue 31 Jan 12:01:25 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                              240.00                  580.00             20        10      
 
Lifetimes Report 
Report Time : Tue 31 Jan 12:01:25 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                240.00                   580.00         20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.569±0.0           4.6882±0.1           0.0237±0.0       0.0264    
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Complex 5 (with MCB + KHP) in Water (pH 5.320) 
Lifetimes Report 
Report Time : Mon 30 Jan 12:03:35 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                240.00                 580.00              20        10      
 
Lifetimes Report 
 
Report Time : Mon 30 Jan 12:03:35 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                    580.00             20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    3.120±0.1          18.7102±0.8           0.0004±0.0       0.0224       
 
 
 | P a g e  
 
 
298
Complex 5 (with MCB +KHP) in D2O (pH 5.321)  
Lifetimes Report 
Report Time : Tue 31 Jan 12:16:31 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                     580.00            20        10      
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 12:16:31 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                      580.00            20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.568±0.0           7.9435±0.1           0.0192±0.0       0.0248       
 | P a g e  
 
 
299
Complex 5 (with MCB + KHP) in Water (pH 7.423) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 12:22:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                240.00            580.00                 20        10      
Lifetimes Report 
Report Time : Mon 30 Jan 12:22:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                 240.00                580.00            20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.849±0.1          16.5018±0.6           0.0360±0.0       0.0239       
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Complex 5 (with MCB +KHP) in D2O (pH 7.424)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 12:49:15 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                             240.00                      580.00          20        10      
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 12:49:15 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                       580.00                20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.601±0.0          17.5452±0.1           0.0342±0.0       0.0253     
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Complex 5 (with MCB + KHP) in Water (pH 8.172) 
Lifetimes Report 
Report Time : Mon 30 Jan 12:35:52 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                              240.00                 580.00                20        10      
 
Lifetimes Report 
Report Time : Mon 30 Jan 12:35:52 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                    580.00                20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.592±0.1          13.3319±0.5           0.0385±0.0       0.0231      
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Complex 5 (with MCB +KHP) in D2O (pH 8.174)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 01:12:28 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                  240.00          580.00                  20        10      
Lifetimes Report 
 
Report Time : Tue 31 Jan 01:12:28 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                                240.00                 580.00              20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.637±0.0          18.1833±0.1           0.0365±0.0       0.0258       
 
 | P a g e  
 
 
303
Complex 5 (with MCB + KHP) in Water (pH 8.710) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 01:36:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                               240.00              580.00                 20        10      
 
 
Lifetimes Report 
Report Time : Mon 30 Jan 01:36:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                          240.00                       580.00             20        10      
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.799±0.1          14.8444±0.6           0.0593±0.0       0.0237     
 
 
 | P a g e  
 
 
304
Complex 5 (with MCB +KHP) in D2O (pH 8.714)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 01:47:47 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                  580.00                20        10      
 
 
Lifetimes Report 
Report Time : Tue 31 Jan 01:47:47 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                     580.00                20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.808±0.0          23.2327±0.1           0.0147±0.0       0.0280     
 
 
 | P a g e  
 
 
305
Complex 5 (with MCB + KHP) in Water (pH 9.382) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 01:53:06 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________
___ 
 580 nm           50             240.00          580.00         20        10      
Lifetimes Report 
 
Report Time : Mon 30 Jan 01:53:06 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                  580.00                20        10      
 
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.953±0.1          15.7803±0.7           0.0292±0.0       0.0234     
 
 
 | P a g e  
 
 
306
Complex 5 (with MCB +KHP) in D2O (pH 9.382)  
Lifetimes Report 
Report Time : Tue 31 Jan 02:06:23 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________
___ 
 580 nm           50             240.00          580.00         20        10      
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 02:06:23 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                   580.00               20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.971±0.0          15.4437±0.1           0.0479±0.0       0.0250       
 
 
 
 | P a g e  
 
 
307
Complex 5 (with MCB + KHP) in Water (pH 9.484) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 02:11:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                         240.00                   580.00                  20        10      
Lifetimes Report 
 
Report Time : Mon 30 Jan 02:11:29 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                          240.00                     580.00               20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.727±0.1          13.3816±0.5           0.0190±0.0       0.0216       
 
 | P a g e  
 
 
308
Complex 5 (with MCB +KHP) in D2O (pH 9.485)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 02:21:59 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                 580.00                20        10      
 
Lifetimes Report 
Report Time : Tue 31 Jan 02:21:59 PM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                             240.00                580.00               20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    1.115±0.0          15.8620±0.1           0.0196±0.0       0.0242       
 
 
 | P a g e  
 
 
309
Complex 5 in Water (pH 4.375) 
Lifetimes Report 
Report Time : Mon 30 Jan 09:51:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                          240.00                   580.00                20        10      
Lifetimes Report 
 
Report Time : Mon 30 Jan 09:51:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                 580.00                 20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.374±0.0          30.3587±0.4           0.0038±0.0       0.0210      
 
 | P a g e  
 
 
310
 
Complex 5 in D2O (pH 4.375) 
Lifetimes Report 
 
Report Time : Tue 31 Jan 09:16:39 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                         240.00                   580.00                 20        10      
 
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 09:16:39 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                 580.00                   20        10      
 
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.556±0.0          28.4077±0.1           0.0145±0.0       0.0351       
 
 | P a g e  
 
 
311
Complex 5 in Water (4.795) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 10:12:20 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                             240.00                580.00                20        10      
Lifetimes Report 
Report Time : Mon 30 Jan 10:12:20 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                 580.00                 20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.331±0.0          30.1144±0.4           0.0437±0.0       0.0212       
 
 
 | P a g e  
 
 
312
Complex 5 in D2O (pH 4.799) 
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:00:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                          240.00                   580.00                 20        10      
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:00:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                        240.00                   580.00                  20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.559±0.0          28.4178±0.1           0.0600±0.0       0.0323     
 | P a g e  
 
 
313
Complex 5 in Water (pH 8.275) 
 
Lifetimes Report 
 
Report Time : Mon 30 Jan 10:38:49 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                   580.00               20        10      
 
Lifetimes Report 
 
Report Time : Mon 30 Jan 10:38:49 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                        240.00                580.00                       20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.453±0.0          32.2414±0.5           0.0326±0.0       0.0254       
 
 
 
 | P a g e  
 
 
314
Complex 5 in D2O (pH 8.298)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:28:45 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                            240.00                   580.00                 20        10      
 
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:28:45 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                 580.00                20        10      
 
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.987±0.0          74.7819±0.2           0.0432±0.0       0.0461       
 | P a g e  
 
 
315
Complex 5 in Water (pH 8.645) 
Lifetimes Report 
 
Report Time : Mon 30 Jan 10:55:28 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                          240.00               580.00                    20        10      
Lifetimes Report 
 
Report Time : Mon 30 Jan 10:55:28 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                           240.00                      580.00            20        10      
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    2.392±0.0          33.3749±0.4           0.0385±0.0       0.0253       
 
 | P a g e  
 
 
316
Complex 5 in D2O (pH 8.646)  
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:55:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________
___ 
 580 nm           50             240.00          580.00         20        10      
 
 
Lifetimes Report 
 
Report Time : Tue 31 Jan 10:55:46 AM 2012 
Software version: 1.1(132) 
Operator:  
 
Data name  Number of cycles  Ex. Wavelength  Em. Wavelength  Ex. Slit  Em. Slit   
______________________________________________________________________________ 
 580 nm           50                             240.00                      580.00         20        10      
 
 
Single Exponential Result Table 
Sample Name: 580 nm 
Equation: A1 exp(-k1*time) + C 
 
Start (ms):      0.00      
Stop  (ms):      100.00    
 
        k1                  A1                   C             S.D.        
      (ms-1)                                                               
__________________________________________________________________________ 
    0.924±0.0          66.8742±0.2           0.0060±0.0       0.0480       
 
 | P a g e  
 
 
317
 
